HomeInvestingCommoditiesOutside the BoxOutside the BoxIf China’s demand slows, gold’s price will decline. Much is riding on U.S.-China politics.Published: Oct. 21, 2025 at 7:45 a.m. ET
If someone told you in January to put $10,000 into gold GC00 instead of the Nasdaq Composite COMP or a bitcoin BTCUSD exchange-traded fund and that you’d thank them by October, you might not have believed it.
But gold has outshone them all; it is outperforming every major stock index from Shanghai to New York. The precious metal currently is at an all-time high and approaching $4,400 an ounce — yet there’s no global recession that typically would cause a flight to the safety of gold. On Oct. 15, JP Morgan Chase JPM Chief Executive Jamie Dimon said during a Fortune magazine event that “gold could easily to go $5,000 or $10,000 in environments like this.”
MARION, NC / ACCESS Newswire / October 21, 2025 / Greene Concepts Inc. (OTCID:INKW), owner and operator of a 60,000 sq. ft. bottling and beverage facility in Marion, NC, announces that its redesigned corporate website, continues to gain strong traction and visibility, driving increased product sales, investor interest, and partnership inquiries nationwide.
2025-10-21 11:516mo ago
2025-10-21 07:456mo ago
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Registration Link Below for October 28, 2025 12 PM EST Presentation and Live Q&A
October 21, 2025 7:45 AM EDT | Source: Phio Pharmaceuticals Corp.
King of Prussia, Pennsylvania--(Newsfile Corp. - October 21, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update on the company's proprietary INTASYL siRNA technology and progress on the on-going clinical trial with lead compound PH-762 for treatment of skin cancers. Recently, positive interim safety and efficacy results were reported in the on-going Phase 1b dose escalation clinical trial with the INTASYL compound PH-762 for the treatment of skin cancer.
Phio's presentation and live Q&A will take place on Tuesday, October 28, 2025, at 12:00 PM EST in the live Virtual Non-Deal Roadshow Series hosted by Renmark Financial Communications Inc. A replay of the event may be accessed on the Renmark Financial Communications Inc. website at https://www.renmarkfinancial.com/vndrs.
"All stakeholders, investors, and other individual followers are invited to join this event to learn more about Phio Pharmaceuticals and our continuing pursuit of innovative pathways towards a cancer free future using our INTASYL technology," stated Robert Bitterman, CEO and Chairman of Phio Pharmaceuticals.
Please Note: If the link does not work, please copy and paste into your browser. To ensure smooth connectivity, please access the link above using the latest version of Google Chrome.
About Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company advancing its INTASYL® gene silencing technology focused on immuno-oncology therapeutics. Phio's INTASYL compounds are designed to enhance the body's immune cells to more effectively kill cancer cells. Phio's lead clinical program is an INTASYL compound, PH-762, that silences the PD-1 gene implicated in various forms of skin cancer. The on-going Phase 1b trial (NCT# 06014086) is evaluating PH-762 for the treatment of cutaneous squamous cell carcinoma, melanoma and Merkel cell carcinoma. PH-762 is a potential non-surgical treatment for skin cancers.
For additional information, visit the Company's website, www.phiopharma.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as "intends," "believes," "anticipates," "indicates," "plans," "expects," "suggests," "may," "would," "should," "potential," "designed to," "will," "ongoing," "estimate," "forecast," "target," "predict," "could" and similar references, although not all forward-looking statements contain these words. Examples of forward-looking statements contained in this press release include, among others, the possibility that our INTASYL® siRNA gene silencing technology will make the body's immune cells more effective in killing cancer cells, the potential for additional potential applications across the INTASYL portfolio, expectations regarding timing of enrollment, and statements regarding our commercial and clinical strategy, development plans and timelines and other future events.
These statements are based only on our current beliefs, expectations and assumptions and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements as a result of a number of important factors, including, but not limited to, the impact to our business and operations by inflationary pressures, rising interest rates, recession fears, the development of our product candidates, results from our preclinical and clinical activities, our ability to execute on business strategies, our ability to develop our product candidates with collaboration partners, and the success of any such collaborations, the timeline and duration for advancing our product candidates into clinical development, the timing or likelihood of regulatory filings and approvals, the success of our efforts to commercialize our product candidates if approved, our ability to manufacture and supply our product candidates for clinical activities, and for commercial use if approved, the scope of protection we are able to establish and maintain for intellectual property rights covering our technology platform, our ability to obtain future financing, market and other conditions and those identified in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q under the caption "Risk Factors" and in other filings the Company periodically makes with the SEC. Readers are urged to review these risk factors and to not act in reliance on any forward-looking statements, as actual results may differ from those contemplated by our forward-looking statements. Phio does not undertake to update forward-looking statements to reflect a change in its views, events or circumstances that occur after the date of this release, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270981
2025-10-21 11:516mo ago
2025-10-21 07:456mo ago
Jacobs to Hold Its Fiscal Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast
, /PRNewswire/ -- Jacobs (NYSE: J) plans to release its fiscal fourth quarter and full year 2025 earnings results before market open on Thursday, Nov. 20, 2025, and will host a conference call at 10:00 a.m. ET, during which management will make a presentation focusing on the company's results and operating trends.
Interested parties can listen to the conference call via a webcast and view accompanying slides at jacobs.com.
About Jacobs
At Jacobs, we're challenging today to reinvent tomorrow – delivering outcomes and solutions for the world's most complex challenges. With approximately $12 billion in annual revenue and a team of almost 45,000, we provide end-to-end services in advanced manufacturing, cities & places, energy, environmental, life sciences, transportation and water. From advisory and consulting, feasibility, planning, design, program and lifecycle management, we're creating a more connected and sustainable world. See how at jacobs.com and connect with us on LinkedIn, Instagram, X and Facebook.
We use any of the following to comply with our disclosure obligations under Regulation FD: press releases, SEC filings, public conference calls, or our website. We routinely post important information on our website at www.jacobs.com, including information that may be deemed to be material. We encourage investors and others interested in the company to monitor these distribution channels for material disclosures.
Certain statements contained in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that do not directly relate to any historical or current fact. When used herein, words such as "expects," "anticipates," "believes," "seeks," "estimates," "plans," "intends," "future," "will," "would," "could," "can," "may," and similar words are intended to identify forward-looking statements. We base these forward-looking statements on management's current estimates and expectations, as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain and are not guarantees of future performance. There are a variety of factors that could cause actual results to differ materially from our forward-looking statements including, but not limited to, the risks and uncertainties discussed in our filings with the Securities and Exchange Commission. The company is not under any duty to update any of the forward-looking statements after the date of this press release to conform to actual results, except as required by applicable law.
For additional information contact:
Investors
Bert Subin
[email protected]
Media
Louise White
[email protected]
SOURCE Jacobs
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-21 11:516mo ago
2025-10-21 07:456mo ago
Peabody to Announce Results for the Quarter Ended Sept. 30, 2025
, /PRNewswire/ -- Peabody (NYSE: BTU) will discuss its third quarter 2025 financial results in an investor conference call on Thursday, Oct. 30, 2025, at 10:00 a.m. Central Time.
Interested participants may access the call using the following phone numbers:
U.S. Toll Free 1 833 816 1387
Canada Toll Free 1 855 669 9657
International Toll 1 412 317 0480
The call will also be webcast and accessible via the homepage at www.peabodyenergy.com or by clicking here. Following the live event, a replay will be available on the site.
Peabody's third quarter 2025 earnings release will be distributed via PR Newswire before the market opens on Oct. 30 and will be posted to the company's website at that time.
About Peabody:
Peabody is a leading coal producer, providing essential products for the production of affordable, reliable energy and steel. Our commitment to sustainability underpins everything we do and shapes our strategy for the future. For further information, visit PeabodyEnergy.com.
Contact:
Vic Svec / Kala Finklang
[email protected]
SOURCE Peabody
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-21 11:516mo ago
2025-10-21 07:456mo ago
AGNC Investment: Don't Fall For The 14% Yield Trap
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-21 11:516mo ago
2025-10-21 07:456mo ago
Prediction: This Is How Much NVIDIA Will be Worth At The End of 2026
Nvidia (NASDAQ:NVDA ) has been continuously delivering higher and higher gains, and its quarterly earnings reports have exceeded earnings expectations longer than any bull would have imagined two years ago.
2025-10-21 11:516mo ago
2025-10-21 07:506mo ago
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
79 clinical sites across 23 US states are currently enrolling patients in BriaCell’s pivotal Phase 3 study in metastatic breast cancer (MBC) Dartmouth Cancer Center, Cedars-Sinai Medical Center, and Winship Cancer Institute of Emory University have now joined BriaCell’s extensive national network PHILADELPHIA and VANCOUVER, British Columbia, Oct. 21, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce the addition of several key large cancer centers to its ongoing pivotal Phase 3 clinical study (ClinicalTrials.gov as NCT06072612), notably Dartmouth Cancer Center, Cedars-Sinai Medical Center, and Winship Cancer Institute of Emory University. BriaCell anticipates reporting top line data as early as H1-2026.
The extensive national effort already includes the following noteworthy clinics: Mayo Clinic, Los Angeles Cancer Network, Smilow Cancer Hospital at Yale New Haven, Sylvester Comprehensive Cancer Center, Cancer Care Northwest, Hematology Oncology Associates of Fredericksburg, Northwestern University, Manhattan Hematology/Oncology Associates, New York Cancer and Bood Specialists, and Texas Oncology-Baylor Charles A. Sammons Cancer Center.
BriaCell’s pivotal Phase 3 clinical study is evaluating BriaCell’s lead clinical candidate, Bria-IMT, plus immune check point inhibitor versus physician’s choice of treatment in advanced metastatic breast cancer (Bria-ABC).
“We are encouraged by the strong engagement from major academic and leading community cancer centers which underscores confidence in BriaCell’s novel technology,” stated Dr. William V. Williams, BriaCell’s President & CEO. “We expect the addition of these clinical sites will further accelerate patient enrollment in BriaCell’s pivotal Phase 3 study of Bria-IMT regimen in MBC and support our mission to bring this therapy to patients with significant unmet medical needs.”
About BriaCell’s Pivotal Phase 3 Clinical Study of Bria-IMT Combination Regimen in MBC patients
BriaCell’s pivotal Phase 3 study of Bria-IMT plus an immune check point inhibitor (CPI) in metastatic breast cancer is ongoing.
Interim data will be analyzed once 144 patient events (deaths) occur, comparing the overall survival (OS) in patients treated with the Bria-IMT combination regimen versus those treated with physician’s choice as the primary endpoint. Positive results of the pivotal Phase 3 study could result in full approval and marketing authorization for Bria-IMT in MBC patients. The Bria-IMT combination regimen has received FDA Fast Track designation.
For additional information on BriaCell’s pivotal Phase 3 study of Bria-IMT and an immune check point inhibitor in metastatic breast cancer, please visit ClinicalTrials.gov NCT06072612.
About BriaCell Therapeutics Corp.
BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at https://briacell.com/.
Safe Harbor
This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements, including those about: the Company’s anticipated expansion of patient enrollment; the Company's anticipated timeline for analyzing and reporting interim and top line data in its ongoing pivotal Phase 3 clinical study; and the Company’s beliefs regarding its ability to bring their novel immunotherapy to patients with unmet medical needs; are based on BriaCell’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements, such as those are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading “Risks and Uncertainties” in the Company’s most recent Management’s Discussion and Analysis, under the heading “Risk Factors” in the Company’s most recent Annual Information Form, and under “Risks and Uncertainties” in the Company’s other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available under the Company's profiles on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date, and BriaCell Therapeutics Corp. undertakes no duty to update such information except as required under applicable law.
Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information
Company Contact:
William V. Williams, MD
President & CEO
1-888-485-6340 [email protected]
VANCOUVER, BC / ACCESS Newswire / October 21, 2025 / Banyan Gold Corp. (the "Company" or "Banyan") (TSXV:BYN)(OTCQB:BYAGF) is pleased to announce it has intersected high-grade gold at surface in the core of the Powerline Deposit ("Powerline") at its AurMac Project ("AurMac") in the prolific Tombstone Belt, Yukon, Canada. Selected Highlights Demonstrate Continuity of High-Grade in Core of Central Powerline Deposit: AX-25-697 - 2.69 g/t gold ("Au") over 11.8 metres ("m") within 0.65 g/t gold over 72.5m; including 29.3 g/t Au over 0.4m, 21.04 g/t Au over 0.4m, and 2.26 g/t Au over 3.4m.
2025-10-21 10:506mo ago
2025-10-21 06:306mo ago
Specificity Appoints Rob Gagne as Chief Technology Officer to Accelerate Global Expansion and Ad Tech Innovation
TAMPA, FLORIDA / ACCESS Newswire / October 21, 2025 / Specificity (OTCID:SPTY), the fast-scaling ad tech disruptor redefining digital marketing precision, today announced the appointment of Rob Gagne as Chief Technology Officer (CTO). With more than three decades of experience leading breakthrough technology initiatives across finance, enterprise software, and data systems, Gagne joins Specificity's powerhouse executive team to drive the company's next phase of global growth and technical dominance.
2025-10-21 10:506mo ago
2025-10-21 06:306mo ago
Acme United Reports 2% Increase In Net Sales For The Third Quarter Of 2025
SHELTON, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended September 30, 2025 were $49.1 million compared to $48.2 million in the third quarter of 2024, an increase of 2%. Net sales for the nine months ended September 30, 2025 were $149.0 million compared to $148.5 million in the same period in 2024.
Net income was $1.9 million, or $0.46 per diluted share, for the quarter ended September 30, 2025, compared to $2.2 million, or $0.54 per diluted share, for the same period in 2024, a decrease of 14% in net income and 15% in diluted earnings per share. Net income declined due to significantly lower tax expense in the third quarter of 2024, when the Company recorded a large excess tax benefit resulting from the exercise of stock options. The effective tax rate in the third quarter of 2024 was 8% compared to 22% in the same quarter of this year.
Net income for each of the nine month periods ended September 30, 2025 and 2024 was $8.3 million, or $2.03 per diluted share.
Chairman and CEO Walter C. Johnsen said, “We have continued to effectively manage through tariff-related uncertainties. Our first aid revenues increased 9% due to strong online and refill sales. Revenues from our Westcott cutting tools continued to be reduced, however, by the impact of the tariff environment on our customers, which has resulted in our customers’ cancellation of nearly all retail promotions. We are now experiencing increased promotional activity as buyers are again focused on growing sales.
Mr. Johnsen continued, “We are pleased that Acme United’s business continued to be profitable, with operating income increasing 3%. In addition, we continue to reduce debt and, as a result of our strong balance sheet, the Company is well-positioned for growth, both internally and through acquisitions, particularly in the first aid space.”
For the three months ended September 30, 2025, net sales in the U.S. segment increased 1% compared to the same period in 2024. Sales of first aid and medical products were strong. However, sales of school and office products were lower mainly due to the cancellation of customer orders as a result of tariff uncertainty. For the nine months ended September 30, 2025, net sales in the U.S. segment decreased 1% compared to the same period in 2024.
European net sales for the three months ended September 30, 2025 increased 13% in U.S. dollars and 6% in local currency compared to the same period of 2024, mainly due to higher sales of school and office products into the ecommerce channel. Net sales for the nine months ended September 30, 2025 increased 1% in U.S. dollars and decreased 2% in local currency compared to the same period of 2024.
Net sales in Canada for the three months ended September 30, 2025 increased 5% in U.S. dollars and 7% in local currency compared to the same period in 2024. Net sales for the nine months ended September 30, 2025 increased 14% in U.S. dollars and 16% in local currency compared to the first nine months of 2024. The increases in sales for both periods were due to strong sales of first-aid products.
Gross margin was 39.1% in the three months ended September 30, 2025 versus 38.5% in the same period last year. Gross margin was 39.8% for the nine-month period ended September 30, 2025 compared to 39.0% for the same period in 2024.
The Company’s bank debt less cash as of September 30, 2025 was $23.1 million compared to $26.7 million as of September 30, 2024. During the twelve-month period ended September 30, 2025, the Company distributed approximately $2.3 million in dividends on its common stock and generated approximately $11.1 million in free cash flow, before the purchase for cash of a new $6 million facility in Tennessee in July 2025 to expand the Company’s Spill Magic business.
Conference Call and Webcast Information
Acme United will hold a conference call to discuss its quarterly results, which will be broadcast on Tuesday, October 21, 2025, at 12:00 p.m. ET. To listen or participate in a question-and-answer session, dial 877-407-0784. International callers may dial 201-689-8560. The confirmation code is 13756138. You may access the live webcast of the conference call through the Investor Relations section of the Company’s website, www.acmeunited.com. A replay may be accessed under Investor Relations, Audio Archives.
About Acme United
ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include First Aid Only®, First Aid Central®, PhysiciansCare®, Pac-Kit®, Spill Magic®, Westcott®, Clauss®, DMT®, Med-Nap and Elite First Aid. For more information, visit www.acmeunited.com.
Forward Looking Statements
The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,” “potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.
Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results.
These risks and uncertainties include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of volatility in global economic conditions, including the impact on the Company’s suppliers and customers; (iii) international trade policies of the United States or foreign governments and their impact on demand for our products and our competitive position, including the imposition of new tariffs, changes in existing tariff rates or the threat of any such action;*1(iv) the continuing adverse impact of inflation, including product costs, and interest rates; (v) potential adverse effects on the Company, its customers, and suppliers resulting from the conflicts in Ukraine and the Middle East; (vi) additional disruptions in the Company’s supply chains, whether caused by pandemics, natural disasters, including trucker shortages, strikes, port closures or otherwise; (vii) labor related costs the Company has and may continue to incur, including costs of acquiring and training new employees and rising wages and benefits; (viii) currency fluctuations; (ix) the Company’s ability to effectively manage its inventory in a rapidly changing business environment; (x) changes in client needs and consumer spending habits; (xi) the impact of competition; (xii) the impact of technological changes including, specifically, the growth of online marketing and sales activity; and (xiii) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; and (xiv) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.
CONTACT:Paul G. DriscollAcme United Corporation1 Waterview DriveShelton, CT 06484Phone: (203) 254-6060 ACME UNITED CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF INCOMETHIRD QUARTER REPORT 2025(Unaudited) Three Months Ended Three Months EndedAmounts in 000's except per share data September 30, 2025 September 30, 2024 Net sales$49,063 $48,166 Cost of goods sold 29,868 29,602 Gross profit 19,195 18,564 Selling, general and administrative expenses 16,188 15,638 Operating income 3,007 2,926 Interest expense 451 568 Interest income (29) (33)Net interest expense 422 535 Other expense (income), net 146 (17)Income before income tax expense 2,439 2,408 Income tax expense 536 182 Net income$1,903 $2,226 Shares outstanding - basic 3,802 3,726 Shares outstanding - diluted 4,168 4,104 Earnings per share - basic$0.50 $0.60 Earnings per share - diluted 0.46 0.54 ACME UNITED CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF INCOMETHIRD QUARTER REPORT 2025(Unaudited) Nine Months Ended Nine Months EndedAmounts in 000's except per share data September 30, 2025 September 30, 2024 Net sales$149,018 $148,547 Cost of goods sold 89,756 89,960 Gross profit 59,262 58,587 Selling, general and administrative expenses 47,438 46,728 Operating income 11,824 11,859 Interest expense 1,310 1,622 Interest income (88) (105)Net interest expense 1,222 1,517 Other income, net (44) (90)Income before income tax expense 10,646 10,432 Income tax expense 2,338 2,117 Net income$8,308 $8,315 Shares outstanding - basic 3,781 3,686 Shares outstanding - diluted 4,091 4,087 Earnings per share - basic$2.20 $2.26 Earnings per share - diluted 2.03 2.03 ACME UNITED CORPORATIONCONDENSED CONSOLIDATED BALANCE SHEETSTHIRD QUARTER REPORT 2025(Unaudited) Amounts in $000's September 30, 2025 September 30, 2024Assets Current assets: Cash and cash equivalents$5,146 $5,702 Accounts receivable, net 30,034 31,349 Inventories 60,163 55,990 Prepaid expenses and other current assets 3,363 5,733 Total current assets 98,706 98,774 Property, plant and equipment, net 38,691 30,892 Operating lease right of use asset 7,261 4,808 Intangible assets, less accumulated amortization 18,476 22,810 Goodwill 9,908 8,189 Total assets$173,042 $165,473 Liabilities and stockholders' equity Current liabilities: Accounts payable$6,488 $7,008 Operating lease liability - short term 1,427 1,550 Mortgage payable - short term 450 433 Other current liabilities 13,722 13,403 Total current liabilities 22,087 22,394 Long-term debt 18,255 22,018 Mortgage payable - long term 9,556 9,970 Operating lease liability - long term 5,900 3,357 Deferred income taxes 1,465 899 Other non-current liabilities 15 518 Total liabilities 57,278 59,156 Total stockholders' equity 115,764 106,317 Total liabilities and stockholders' equity$173,042 $165,473
, /PRNewswire/ -- General Motors (NYSE: GM) today reported third-quarter 2025 revenue of $48.6 billion, net income attributable to stockholders of $1.3 billion, and EBIT-adjusted of $3.4 billion.
GM is also updating its 2025 full-year earnings guidance:
Updated 2025 guidance
Previous 2025 guidance
Net income attributable to stockholders
$7.7 billion - $8.3 billion
$7.7 billion - $9.5 billion
EBIT-adjusted
$12.0 billion - $13.0 billion
$10.0 billion - $12.5 billion
Automotive operating cash flow
$19.2 billion - $21.2 billion
$17.0 billion - $20.5 billion
Adjusted automotive free cash flow
$10.0 billion - $11.0 billion
$7.5 billion - $10.0 billion
EPS-diluted
$8.30 - $9.05
$8.22 - $9.97
EPS-diluted-adjusted
$9.75 - $10.50
$8.25 - $10.00
An overview of quarterly results and financial highlights appears below. Visit the GM Investor Relations website to download the company's earnings deck and GM Chair and CEO Mary Barra's Letter to Shareholders.
Conference call for investors and analysts
Mary Barra and GM Chief Financial Officer Paul Jacobson will host a conference call for the investment community at 8:30 a.m. ET today to discuss these results.
Conference call details are as follows:
1-800-857-9821 (U.S.)
1-517-308-9481 (international/caller-paid)
Conference call passcode: General Motors
An audio replay will be available on the GM Investor Relations website in the Events section.
Results Overview
Three Months Ended
($M) except per share amounts
September 30,
2025
September 30,
2024
Change
% Change
Revenue
$ 48,591
$ 48,757
$ (166)
(0.3) %
Net income attributable to stockholders
$ 1,327
$ 3,056
$ (1,729)
(56.6) %
EBIT-adjusted
$ 3,376
$ 4,115
$ (739)
(18.0) %
Net income margin
2.7 %
6.3 %
(3.6) ppts
(57.1) %
EBIT-adjusted margin
6.9 %
8.4 %
(1.5) ppts
(17.9) %
Automotive operating cash flow
$ 6,070
$ 7,863
$ (1,793)
(22.8) %
Adjusted automotive free cash flow
$ 4,201
$ 5,834
$ (1,633)
(28.0) %
EPS-diluted
$ 1.35
$ 2.68
$ (1.33)
(49.6) %
EPS-diluted-adjusted
$ 2.80
$ 2.96
$ (0.16)
(5.4) %
GMNA EBIT-adjusted
$ 2,506
$ 3,982
$ (1,476)
(37.1) %
GMNA EBIT-adjusted margin
6.2 %
9.7 %
(3.5) ppts
(36.1) %
GMI EBIT-adjusted(a)
$ 226
$ 42
$ 184
n.m.
China equity income (loss)(a)
$ 80
$ (137)
$ 217
n.m.
GM Financial EBT-adjusted
$ 804
$ 687
$ 117
17.0 %
(a)
n.m. = not meaningful
General Motors (NYSE:GM) is driving the future of transportation, leveraging advanced technology to build safer, smarter, and lower emission cars, trucks, and SUVs. GM's Buick, Cadillac, Chevrolet, and GMC brands offer a broad portfolio of innovative gasoline-powered vehicles and the industry's widest range of EVs, as we move to an all-electric future. Learn more at GM.com.
Cautionary Note on Forward-Looking Statements : This press release and related comments by management may include "forward-looking statements" within the meaning of the U.S. federal securities laws. Forward-looking statements are any statements other than statements of historical fact and represent our current judgment about possible future events. In making these statements, we rely upon assumptions and analysis based on our experience and perception of historical trends, current conditions, and expected future developments, as well as other factors we consider appropriate under the circumstances. We believe these judgments are reasonable, but these statements are not guarantees of any future events or financial results, and our actual results may differ materially due to a variety of factors, many of which are described in our most recent Annual Report on Form 10-K and our other filings with the U.S. Securities and Exchange Commission. We caution readers not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other factors that affect the subject of these statements, except where we are expressly required to do so by law.
Guidance Reconciliations
The following table reconciles expected Net income attributable to stockholders to expected EBIT-adjusted (dollars in billions):
Year Ending December 31, 2025
Updated
Previous
Net income attributable to stockholders
$ 7.7-8.3
$ 7.7-9.5
Income tax expense
1.8-2.2
1.6-2.3
Automotive interest income, net
(0.1)
(0.0)
Adjustments(a)
2.6
0.7
EBIT-adjusted
$ 12.0-13.0
$ 10.0-12.5
(a)
Refer to the reconciliation of Net income attributable to stockholders to EBIT-adjusted and segment profit (loss) for adjustment details. These expected financial results do not include the potential impact of future adjustments related to special items.
The following table reconciles expected EPS-diluted to expected EPS-diluted-adjusted:
Year Ending December 31, 2025
Updated
Previous
Diluted earnings per common share
$ 8.30-9.05
$ 8.22-9.97
Adjustments(a)
1.45
0.03
EPS-diluted-adjusted
$ 9.75-10.50
$ 8.25-10.00
(a)
Refer to the reconciliation of diluted earnings per common share to EPS-diluted-adjusted for adjustment details. These expected financial results do not include the potential impact of future adjustments related to special items.
The following table reconciles expected automotive net cash provided by operating activities to expected adjusted automotive free cash flow (dollars in billions):
Year Ending December 31, 2025
Updated
Previous
Net automotive cash provided by operating activities
$ 19.2-21.2
$ 17.0-20.5
Less: Capital expenditures
10.0-11.0
10.0-11.0
Adjustments
0.8
0.5
Adjusted automotive free cash flow(a)
$ 10.0-11.0
$ 7.5-10.0
(a)
These expected financial results do not include the potential impact of future adjustments related to special items.
General Motors Company and Subsidiaries1
Combining Income Statement Information
(In millions) (Unaudited)
Three Months Ended September 30, 2025
Three Months Ended September 30, 2024
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Combined
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Combined
Net sales and revenue
Automotive
$ 44,256
$ —
$ —
$ —
$ 44,256
$ 44,735
$ 26
$ —
$ (26)
$ 44,735
GM Financial
—
—
4,337
(2)
4,335
—
—
4,031
(10)
4,021
Total net sales and revenue
44,256
—
4,337
(2)
48,591
44,735
26
4,031
(36)
48,757
Costs and expenses
Automotive and other cost of
sales
41,937
—
—
(1)
41,936
38,768
240
—
(1)
39,007
GM Financial interest,
operating and other
expenses
—
—
3,542
—
3,542
—
—
3,354
—
3,353
Automotive and other selling,
general and
administrative expense
2,038
—
—
(1)
2,037
2,544
203
—
(1)
2,745
Total costs and expenses
43,975
—
3,542
(2)
47,515
41,312
442
3,354
(2)
45,105
Operating income (loss)
281
—
795
—
1,076
3,424
(417)
678
(33)
3,651
Automotive interest expense
206
—
—
3
209
206
30
—
(30)
206
Interest income and other non-
operating income, net
473
—
—
3
475
379
11
—
4
394
Equity income (loss)
68
—
9
—
77
(132)
—
10
—
(122)
Income (loss) before income
taxes
$ 615
$ —
$ 804
$ —
$ 1,419
$ 3,465
$ (435)
$ 687
$ —
$ 3,717
Income tax expense (benefit)
127
709
Net income (loss)
1,293
3,008
Net loss (income) attributable
to noncontrolling interests
35
48
Net income (loss)
attributable to
stockholders
$ 1,327
$ 3,056
Net income (loss)
attributable to common
stockholders
$ 1,297
$ 3,029
Nine Months Ended September 30, 2025
Nine Months Ended September 30, 2024
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Combined
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Combined
Net sales and revenue
Automotive
$ 126,985
$ 1
$ —
$ —
$ 126,986
$ 128,007
$ 76
$ —
$ (76)
$ 128,008
GM Financial
—
—
12,756
(9)
12,747
—
—
11,761
(29)
11,732
Total net sales and revenue
126,985
1
12,756
(9)
139,732
128,007
76
11,761
(105)
139,740
Costs and expenses
Automotive and other cost of
sales
116,255
163
—
(2)
116,416
109,958
1,662
—
(2)
111,618
GM Financial interest,
operating and other
expenses
—
—
10,599
—
10,600
—
—
9,569
(1)
9,568
Automotive and other selling,
general and administrative
expense
6,054
111
—
(3)
6,161
6,813
482
—
(3)
7,292
Total costs and expenses
122,309
274
10,599
(5)
133,177
116,771
2,144
9,569
(5)
128,478
Operating income (loss)
4,676
(273)
2,156
(4)
6,555
11,237
(2,067)
2,192
(100)
11,262
Automotive interest expense
557
30
—
(27)
560
631
158
—
(158)
631
Interest income and other non-
operating income, net
1,174
2
(1)
(23)
1,151
785
29
(1)
(58)
756
Equity income (loss)
182
—
37
—
219
(366)
—
55
—
(311)
Income (loss) before income
taxes
$ 5,474
$ (301)
$ 2,193
$ —
$ 7,366
$ 11,026
$ (2,196)
$ 2,246
$ —
$ 11,076
Income tax expense (benefit)
1,326
2,238
Net income (loss)
6,040
8,837
Net loss (income) attributable
to noncontrolling interests
(33)
132
Net income (loss)
attributable to
stockholders
$ 6,007
$ 8,969
Net income (loss)
attributable to common
stockholders
$ 6,510
$ 8,914
1
Certain columns and rows may not add due to rounding.
General Motors Company and Subsidiaries1
Basic and Diluted Earnings per Share
(Unaudited)
The following table summarizes basic and diluted earnings per share (in millions, except per share amounts):
Three Months Ended
Nine Months Ended
September 30,
2025
September 30,
2024
September 30,
2025
September 30,
2024
Basic earnings per share
Net income (loss) attributable to stockholders
$ 1,327
$ 3,056
$ 6,007
$ 8,969
Adjustments(a)
(30)
(27)
503
(55)
Net income (loss) attributable to common stockholders
$ 1,297
$ 3,029
$ 6,510
$ 8,914
Weighted-average common shares outstanding
944
1,116
965
1,136
Basic earnings per common share
$ 1.37
$ 2.71
$ 6.75
$ 7.85
Diluted earnings per share
Net income (loss) attributable to common stockholders –
diluted
$ 1,297
$ 3,029
$ 6,510
$ 8,914
Weighted-average common shares outstanding – diluted
964
1,131
980
1,147
Diluted earnings per common share
$ 1.35
$ 2.68
$ 6.64
$ 7.77
Potentially dilutive securities(b)
—
6
—
6
(a)
Includes a $593 million return from the preferred shareholders related to the redemption of Cruise preferred shares from noncontrolling interest holders in the nine months ended September 30, 2025.
(b)
Potentially dilutive securities attributable to outstanding stock options, Performance Stock Units and Restricted Stock Units (RSUs) at September 30, 2025 and 2024 were excluded from the computation of diluted earnings per share (EPS) because the securities would have had an antidilutive effect.
General Motors Company and Subsidiaries1
Combining Balance Sheet Information
(In millions, except per share amounts) (Unaudited)
September 30, 2025
December 31, 2024
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Combined
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Combined
ASSETS
Current Assets
Cash and cash equivalents
$ 15,019
$ 72
$ 7,820
$ —
$ 22,910
$ 14,470
$ 308
$ 5,094
$ —
$ 19,872
Marketable debt securities
6,771
—
21
—
6,792
7,265
—
—
—
7,265
Accounts and notes receivable, net(a)
16,276
76
1,782
(1,009)
17,125
11,498
22
1,988
(681)
12,827
GM Financial receivables, net(d)
—
—
44,902
(381)
44,521
—
—
46,760
(398)
46,362
Inventories
15,322
—
—
(4)
15,318
14,569
—
—
(5)
14,564
Other current assets
2,844
11
5,109
5
7,970
2,816
38
4,799
2
7,655
Total current assets
56,233
159
59,634
(1,390)
114,636
50,618
369
58,640
(1,082)
108,545
Non-current Assets
GM Financial receivables, net(c)
—
—
45,300
—
45,300
—
—
46,750
(276)
46,474
Equity in net assets of
nonconsolidated affiliates
5,178
—
1,095
—
6,272
5,896
—
1,206
—
7,102
Property, net
51,731
97
110
—
51,938
51,729
69
107
—
51,904
Goodwill and intangible assets, net
3,104
1
1,348
—
4,452
2,642
570
1,339
—
4,551
Equipment on operating leases, net
—
—
33,609
—
33,609
—
—
31,586
—
31,586
Deferred income taxes
22,940
—
(1,270)
—
21,669
21,149
1,899
(1,795)
—
21,254
Other assets(b)
8,789
52
1,451
—
10,292
9,340
41
1,323
(2,359)
8,346
Total non-current assets
91,740
150
81,642
—
173,532
90,756
2,579
80,516
(2,635)
171,216
Total Assets
$ 147,973
$ 309
$ 141,276
$ (1,390)
$ 288,168
$ 141,374
$ 2,948
$ 139,156
$ (3,717)
$ 279,761
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable (principally
trade)(a)
$ 27,543
$ 5
$ 703
$ (933)
$ 27,317
$ 25,446
$ 200
$ 714
$ (681)
$ 25,680
Short-term debt and current portion of
long-term debt
Automotive(a)(d)
873
7
—
(457)
424
2,413
7
—
(279)
2,141
GM Financial
—
—
36,053
—
36,053
—
—
37,291
—
37,291
Cruise(d)
—
—
—
—
—
—
119
—
(119)
—
Accrued liabilities
24,730
130
4,641
—
29,501
24,949
548
5,661
(4)
31,154
Total current liabilities
53,146
142
41,397
(1,390)
93,295
52,808
874
43,666
(1,082)
96,265
Non-current Liabilities
Long-term debt
Automotive(b)
15,619
71
—
—
15,690
13,288
2,397
—
(2,359)
13,327
GM Financial
—
—
80,336
—
80,336
—
—
76,973
—
76,973
Cruise(c)
—
—
—
—
—
—
276
—
(276)
—
Postretirement benefits other than
pensions
3,947
—
—
—
3,947
3,990
—
—
—
3,990
Pensions
5,976
—
9
—
5,985
5,772
—
7
—
5,779
Other liabilities
16,914
292
3,306
—
20,512
14,635
297
2,904
—
17,836
Total non-current liabilities
42,458
363
83,651
—
126,471
37,686
2,970
79,885
(2,635)
117,906
Total Liabilities
95,604
505
125,048
(1,390)
219,766
90,494
3,844
123,551
(3,717)
214,171
Equity
Common stock, $0.01 par value
9
—
—
—
9
10
—
—
—
10
Additional paid-in capital(e)
18,477
1,794
1,137
(1,112)
20,295
19,632
1,187
1,196
(1,172)
20,843
Retained earnings
42,355
(1,990)
16,495
1
56,862
40,203
(2,647)
15,916
1
53,472
Accumulated other comprehensive
loss
(9,389)
—
(1,403)
—
(10,792)
(9,744)
(3)
(1,506)
—
(11,253)
Total stockholders' equity
51,453
(196)
16,228
(1,111)
66,374
50,100
(1,464)
15,606
(1,170)
63,072
Noncontrolling interests(e)
917
—
—
1,111
2,028
780
568
—
1,170
2,518
Total Equity
52,369
(196)
16,228
—
68,402
50,880
(896)
15,606
—
65,590
Total Liabilities and Equity
$ 147,973
$ 309
$ 141,276
$ (1,390)
$ 288,168
$ 141,374
$ 2,948
$ 139,156
$ (3,717)
$ 279,761
(a)
Eliminations primarily include GM Financial accounts and notes receivable of $0.6 billion due from Automotive; Automotive accounts receivable of $0.3 billion primarily due from GM Financial; and Cruise accounts receivable of $0.1 billion due from Automotive at September 30, 2025; and GM Financial accounts and notes receivable of $0.5 billion due from Automotive; and Automotive accounts receivable of $0.2 billion primarily due from GM Financial and Cruise at December 31, 2024.
(b)
Eliminations primarily related to convertible note issued by Cruise to Automotive and deferral agreement between Cruise and Automotive as regards to engineering, capital spending, restructuring and other costs incurred by Automotive on behalf of Cruise resulting in a long-term payable for Cruise offset by a long-term receivable for Automotive at December 31, 2024.
(c)
Eliminations primarily related to intercompany loans due from Cruise to GM Financial at December 31, 2024.
(d)
Eliminations primarily related to GM Financial accounts receivable due from Automotive and Cruise.
(e)
Primarily reclassification of GM Financial Cumulative Perpetual Preferred Stock, Series A, B and C. The preferred stock is classified as noncontrolling interests in our consolidated balance sheets.
General Motors Company and Subsidiaries1
Combining Cash Flow Information
(In millions) (Unaudited)
Nine Months Ended September 30, 2025
Nine Months Ended September 30, 2024
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Combined
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Combined
Cash flows from operating activities
Net income (loss)
$ 4,732
$ (302)
$ 1,610
$ —
$ 6,040
$ 8,944
$ (1,743)
$ 1,637
$ —
$ 8,837
Depreciation and impairment of
Equipment on operating leases, net
—
—
3,675
—
3,675
—
—
3,633
—
3,633
Depreciation, amortization and
impairment charges on Property, net
6,375
12
25
—
6,412
4,871
623
29
—
5,523
Foreign currency remeasurement and
transaction (gains) losses
276
—
9
—
285
(231)
—
2
—
(228)
Undistributed earnings of
nonconsolidated affiliates, net
433
—
(37)
—
396
(232)
—
(55)
—
(287)
Pension contributions and OPEB
payments
(432)
—
(1)
—
(433)
(815)
—
—
—
(815)
Pension and OPEB income, net
21
—
1
—
23
49
—
1
—
50
Provision (benefit) for deferred taxes
(64)
—
191
—
127
970
(455)
881
—
1,396
Change in other operating assets and
liabilities(a)(c)
1,787
(511)
594
1,678
3,548
5,618
(175)
(1,014)
(6,549)
(2,120)
Net cash provided by (used in)
operating activities
Principal collections and recoveries on
finance receivables(a)(b)
—
—
29,539
(3,016)
26,524
—
—
23,524
1
23,526
Proceeds from sale of finance receivables
—
—
2,005
—
2,005
—
—
—
—
—
Purchases of leased vehicles
—
—
(12,609)
—
(12,609)
—
—
(11,243)
—
(11,243)
Proceeds from termination of leased
vehicles
—
—
7,780
—
7,780
—
—
8,627
—
8,627
Other investing activities(b)
(3,353)
—
1
901
(2,451)
(1,999)
—
1
1,256
(742)
Net cash provided by (used in)
investing activities
(8,777)
(2)
(1,574)
(2,120)
(12,473)
(10,204)
(4)
(10,329)
6,535
(14,004)
Cash flows from financing activities
Net increase (decrease) in short-term
debt
(10)
—
23
—
13
(1)
—
87
—
85
Proceeds from issuance of debt
(original maturities greater than
three months)(b)
2,019
555
35,103
(555)
37,122
64
1,044
38,142
(1,087)
38,163
Payments on debt (original maturities
greater than three months)
(1,862)
(4)
(35,502)
(24)
(37,391)
(128)
(7)
(31,882)
6
(32,012)
Payment to purchase common stock
(3,512)
—
—
—
(3,512)
(2,378)
—
—
—
(2,378)
Issuance (redemption) of subsidiary
stock(b)
—
—
—
(29)
(29)
—
255
—
(255)
—
Dividends paid(c)
(401)
—
(1,169)
1,050
(519)
(408)
—
(1,469)
1,350
(526)
Other financing activities
(160)
—
(114)
—
(274)
(65)
(162)
(142)
—
(369)
Net cash provided by (used in)
financing activities
(3,926)
551
(1,658)
442
(4,591)
(2,916)
1,130
4,735
14
2,963
Effect of exchange rate changes on
cash, cash equivalents and
restricted cash
163
1
73
—
237
(84)
—
(67)
—
(151)
Net increase (decrease) in cash, cash
equivalents and restricted cash
588
(250)
2,909
—
3,246
5,969
(625)
(547)
—
4,798
Cash, cash equivalents and restricted
cash at beginning of period
14,561
322
8,081
—
22,964
12,310
1,359
8,249
—
21,917
Cash, cash equivalents and restricted
cash at end of period
$ 15,148
$ 72
$ 10,990
$ —
$ 26,210
$ 18,279
$ 734
$ 7,702
$ —
$ 26,715
(a)
Includes eliminations of $2.7 billion and $5.3 billion in the nine months ended September 30, 2025 and 2024 primarily driven by purchases/collections of wholesale finance receivables resulting from vehicles sold by GM to dealers that have arranged their inventory floor plan financing through GM Financial.
(b)
Eliminations include intercompany funding activity from Automotive and GM Financial to Cruise in the nine months ended September 30, 2025 and 2024.
(c)
Eliminations include dividends issued by GM Financial to Automotive in the nine months ended September 30, 2025 and 2024.
Note:
Certain intercompany transactions that are eliminated in consolidation are presented on a net basis.
General Motors Company and Subsidiaries1
The following tables summarize key financial information (dollars in millions):
GMNA
GMI
Corporate
Eliminations
Total
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Total
Three Months Ended September 30, 2025
Net sales and revenue
$ 40,551
$ 3,645
$ 60
$ —
$ 44,256
$ —
$ 4,337
$ (2)
$ 48,591
Expenditures for property
$ 2,011
$ 92
$ 11
$ —
$ 2,113
$ —
$ 17
$ —
$ 2,130
Depreciation and amortization
$ 1,703
$ 114
$ 4
$ —
$ 1,821
$ —
$ 1,245
$ —
$ 3,066
Impairment charges
$ 1,044
$ —
$ —
$ —
$ 1,044
$ —
$ —
$ —
$ 1,044
Equity income (loss)(a)(b)
$ 214
$ 83
$ (16)
$ —
$ 281
$ —
$ 9
$ —
$ 290
GMNA
GMI
Corporate
Eliminations
Total
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Total
Three Months Ended September 30, 2024
Net sales and revenue
$ 41,157
$ 3,517
$ 62
$ —
$ 44,735
$ 26
$ 4,031
$ (36)
$ 48,757
Expenditures for property
$ 2,128
$ 91
$ 10
$ —
$ 2,229
$ 3
$ 6
$ 8
$ 2,245
Depreciation and amortization
$ 1,491
$ 131
$ 27
$ —
$ 1,650
$ 6
$ 1,217
$ —
$ 2,873
Impairment charges
$ —
$ —
$ —
$ —
$ —
$ —
$ —
$ —
$ —
Equity income (loss)(a)(b)
$ 309
$ (132)
$ —
$ —
$ 177
$ —
$ 10
$ —
$ 187
GMNA
GMI
Corporate
Eliminations
Total
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Total
Nine Months Ended September 30, 2025
Net sales and revenue
$ 117,424
$ 9,398
$ 163
$ —
$ 126,985
$ 1
$ 12,756
$ (9)
$ 139,732
Expenditures for property
$ 5,729
$ 274
$ 50
$ —
$ 6,054
$ 2
$ 27
$ —
$ 6,083
Depreciation and amortization
$ 4,933
$ 347
$ 39
$ —
$ 5,319
$ 5
$ 3,701
$ —
$ 9,026
Impairment charges
$ 1,044
$ 18
$ —
$ —
$ 1,063
$ —
$ —
$ —
$ 1,063
Equity income (loss)(a)(b)
$ 469
$ 208
$ (30)
$ —
$ 647
$ —
$ 37
$ —
$ 684
GMNA
GMI
Corporate
Eliminations
Total
Automotive
Cruise
GM
Financial
Reclassifications
/Eliminations
Total
Nine Months Ended September 30, 2024
Net sales and revenue
$ 117,981
$ 9,897
$ 130
$ —
$ 128,007
$ 76
$ 11,761
$ (105)
$ 139,740
Expenditures for property
$ 7,220
$ 258
$ 18
$ —
$ 7,495
$ 4
$ 16
$ 81
$ 7,597
Depreciation and amortization
$ 4,415
$ 403
$ 53
$ —
$ 4,871
$ 18
$ 3,662
$ —
$ 8,551
Impairment charges
$ —
$ —
$ —
$ —
$ —
$ 605
$ —
$ —
$ 605
Equity income (loss)(a)(b)
$ 766
$ (343)
$ —
$ —
$ 423
$ —
$ 55
$ —
$ 477
(a)
Includes Automotive China joint ventures (Automotive China JVs) equity income (loss) of $80 million and $197 million in the three and nine months ended September 30, 2025 and $(137) million and $(347) million in the three and nine months ended September 30, 2024.
(b)
Equity earnings related to Ultium Cells Holdings LLC, an equally owned joint venture with LG Energy Solution, are presented in Automotive and other cost of sales as this entity is integral to the operations of our business by providing battery cells for our electric vehicles (EVs). Equity earnings related to Ultium Cells Holdings LLC were $213 million and $465 million in the three and nine months ended September 30, 2025 and $309 million and $788 million in the three and nine months ended September 30, 2024.
General Motors Company and Subsidiaries
Supplemental Material1
(Unaudited)
General Motors Company (GM) uses both generally accepted accounting principles (GAAP) and non-GAAP financial measures for operational and financial decision making, and to assess Company and segment business performance. Our non-GAAP measures include: earnings before interest and taxes (EBIT)-adjusted, presented net of noncontrolling interests; earnings before income taxes (EBT)-adjusted for our General Motors Financial Company, Inc. (GM Financial) segment; earnings per share (EPS)-diluted-adjusted; effective tax rate-adjusted (ETR-adjusted); return on invested capital-adjusted (ROIC-adjusted) and adjusted automotive free cash flow. GM's calculation of these non-GAAP measures may not be comparable to similarly titled measures of other companies due to potential differences between companies in the method of calculation. As a result, the use of these non-GAAP measures has limitations and should not be considered superior to, in isolation from, or as a substitute for, related U.S. GAAP measures.
These non-GAAP measures allow management and investors to view operating trends, perform analytical comparisons and benchmark performance between periods and among geographic regions to understand operating performance without regard to items we do not consider a component of our core operating performance. Furthermore, these non-GAAP measures allow investors the opportunity to measure and monitor our performance against our externally communicated targets and evaluate the investment decisions being made by management to improve ROIC-adjusted. Management uses these measures in its financial, investment and operational decision-making processes, for internal reporting and as part of its forecasting and budgeting processes. Further, our Board of Directors uses certain of these and other measures as key metrics to determine management performance under our performance-based compensation plans. For these reasons, we believe these non-GAAP measures are useful for our investors.
EBIT-adjusted (Most comparable GAAP measure: Net income attributable to stockholders) EBIT-adjusted is presented net of noncontrolling interests and is used by management and can be used by investors to review our consolidated operating results because it excludes automotive interest income, automotive interest expense and income taxes as well as certain additional adjustments that are not considered part of our core operations. Examples of adjustments to EBIT include, but are not limited to, impairment charges on long-lived assets and other exit costs resulting from strategic shifts in our operations or discrete market and business conditions, and certain costs arising from legal matters. For EBIT-adjusted and our other non-GAAP measures, once we have made an adjustment in the current period for an item, we will also adjust the related non-GAAP measure in any future periods in which there is an impact from the item. Our corresponding measure for our GM Financial segment is EBT-adjusted because interest income and interest expense are an integral part of its financial performance.
EPS-diluted-adjusted (Most comparable GAAP measure: Diluted earnings per common share) EPS-diluted-adjusted is used by management and can be used by investors to review our consolidated diluted EPS results on a consistent basis. EPS-diluted-adjusted is calculated as net income attributable to common stockholders-diluted less adjustments noted above for EBIT-adjusted and certain income tax adjustments divided by weighted-average common shares outstanding-diluted. Examples of income tax adjustments include the establishment or release of significant deferred tax asset valuation allowances.
ETR-adjusted (Most comparable GAAP measure: Effective tax rate) ETR-adjusted is used by management and can be used by investors to review the consolidated effective tax rate for our core operations on a consistent basis. ETR-adjusted is calculated as Income tax expense less the income tax related to the adjustments noted above for EBIT-adjusted and the income tax adjustments noted above for EPS-diluted-adjusted divided by Income before income taxes less adjustments. When we provide an expected adjusted effective tax rate, we cannot provide an expected effective tax rate without unreasonable efforts because the U.S. GAAP measure may include significant adjustments that are difficult to predict.
ROIC-adjusted (Most comparable GAAP measure: Return on equity) ROIC-adjusted is used by management and can be used by investors to review our investment and capital allocation decisions. We define ROIC-adjusted as EBIT-adjusted for the trailing four quarters divided by ROIC-adjusted average net assets, which is the average equity balances adjusted for average automotive debt and interest liabilities, exclusive of finance leases; average automotive net pension and other postretirement benefits (OPEB) liabilities; and average automotive net income tax assets during the same period.
Adjusted automotive free cash flow (Most comparable GAAP measure: Net automotive cash provided by operating activities) Adjusted automotive free cash flow is used by management and can be used by investors to review the liquidity of our automotive operations and to measure and monitor our performance against our capital allocation program and evaluate our automotive liquidity against the substantial cash requirements of our automotive operations. We measure adjusted automotive free cash flow as automotive operating cash flow from operations less capital expenditures adjusted for management actions. Management actions can include voluntary events such as discretionary contributions to employee benefit plans or nonrecurring specific events such as a closure of a facility that are considered special for EBIT-adjusted purposes.
The following table reconciles Net income attributable to stockholders to EBIT-adjusted and segment profit (loss) (dollars in millions):
Three Months Ended
Nine Months Ended
September 30,
2025
September 30,
2024
September 30,
2025
September 30,
2024
Net income attributable to stockholders(a)
$ 1,327
$ 3,056
$ 6,007
$ 8,969
Income tax expense (benefit)
127
709
1,326
2,238
Automotive interest expense
209
206
560
631
Automotive interest income
(220)
(274)
(611)
(688)
Adjustments
EV strategic realignment(b)
1,592
—
1,592
—
OnStar Smart Driver(c)
300
—
300
—
Cruise restructuring(d)
25
—
90
583
Headquarters relocation(e)
16
34
50
34
Ultium strategic realignment(f)
—
—
330
—
China restructuring actions(g)
—
—
140
—
Restructuring actions(h)
—
190
87
190
GMI plant wind down(i)
—
43
33
146
Buick dealer strategy(j)
—
150
—
321
Total adjustments
1,933
417
2,622
1,274
EBIT-adjusted
3,376
4,115
9,903
12,424
Operating segments
GM North America (GMNA)
2,506
3,982
8,207
12,254
GM International (GMI)
226
42
460
82
Cruise
—
(383)
(273)
(1,284)
GM Financial(k)
804
687
2,193
2,246
Total operating segments
3,536
4,327
10,587
13,299
Corporate and eliminations(l)
(160)
(213)
(684)
(874)
EBIT-adjusted
$ 3,376
$ 4,115
$ 9,903
$ 12,424
(a)
Net of net loss (income) attributable to noncontrolling interests.
(b)
These adjustments were excluded because they relate to our planned strategic realignment of our EV capacity and manufacturing footprint to expected consumer demand.
(c)
These adjustments were excluded because they relate to investigations and litigation associated with our former OnStar Smart Driver product.
(d)
These adjustments were excluded because they relate to restructuring charges resulting from the plan to combine the Cruise and GM technical efforts to advance autonomous and assisted driving, the indefinite delay of the Cruise Origin and the voluntary pausing in 2023 of Cruise's driverless, supervised and manual AV operations in the U.S. The adjustments primarily consist of non-cash restructuring charges, supplier-related charges and employee separation costs.
(e)
These adjustments were excluded because they relate to the GM headquarters relocation, primarily consisting of accelerated depreciation and other relocation expenditures.
(f)
These adjustments were excluded because they relate to Ultium Cells Holdings LLC charges from a strategic realignment to have the right manufacturing and cell capabilities in place to meet EV demand and expected growth.
(g)
These adjustments were excluded because they relate to restructuring activities associated with our operations in China, including an other-than-temporary impairment and restructuring charges recorded in equity earnings associated with our Automotive China JVs.
(h)
These adjustments were excluded because they relate to employee separation charges.
(i)
These adjustments were excluded because they relate to the wind down of our manufacturing operations in Colombia and Ecuador.
(j)
These adjustments were excluded because they relate to strategic activities to transition certain Buick dealers out of our dealer network as part of Buick's EV strategy.
(k)
GM Financial amounts represent EBT-adjusted.
(l)
GM's automotive interest income and interest expense, corporate expenditures, legacy costs from the Opel/Vauxhall Business (primarily pension costs) and certain revenues and expenses that are not part of a reportable segment are recorded centrally in Corporate.
The following table reconciles diluted earnings per common share to EPS-diluted-adjusted (dollars in millions, except per share amounts):
Three Months Ended
Nine Months Ended
September 30, 2025
September 30, 2024
September 30, 2025
September 30, 2024
Amount
Per Share
Amount
Per Share
Amount
Per Share
Amount
Per Share
Diluted earnings per common share
$ 1,297
$ 1.35
$ 3,029
$ 2.68
$ 6,510
$ 6.64
$ 8,914
$ 7.77
Adjustments(a)
1,933
2.01
417
0.37
2,622
2.67
1,274
1.11
Tax effect on adjustments(b)
(536)
(0.56)
(96)
(0.08)
(606)
(0.62)
(290)
(0.25)
Return from preferred shareholders(c)
—
—
—
—
(593)
(0.60)
—
—
EPS-diluted-adjusted
$ 2,694
$ 2.80
$ 3,350
$ 2.96
$ 7,933
$ 8.09
$ 9,898
$ 8.63
(a)
Refer to the reconciliation of Net income attributable to stockholders to EBIT-adjusted and segment profit (loss) for adjustment details.
(b)
The tax effect of each adjustment is determined based on the tax laws and valuation allowance status of the jurisdiction to which the adjustment relates.
(c)
This adjustment consists of a return from the preferred shareholders related to the redemption of Cruise preferred shares from noncontrolling interest holders in the nine months ended September 30, 2025.
The following table reconciles our effective tax rate to ETR-adjusted (dollars in millions):
Three Months Ended
Nine Months Ended
September 30, 2025
September 30, 2024
September 30, 2025
September 30, 2024
Income
before
income
taxes
Income
tax
expense
(benefit)
Effective
tax rate
Income
before
income
taxes
Income
tax
expense
(benefit)
Effective
tax rate
Income
before
income
taxes
Income
tax
expense
(benefit)
Effective
tax rate
Income
before
income
taxes
Income
tax
expense
(benefit)
Effective
tax rate
Effective tax rate
$ 1,419
$ 127
8.9 %
$ 3,717
$ 709
19.1 %
$ 7,366
$ 1,326
18.0 %
$ 11,076
$ 2,238
20.2 %
Adjustments(a)
1,933
536
418
96
2,622
606
1,342
290
ETR-adjusted
$ 3,352
$ 663
19.8 %
$ 4,135
$ 805
19.5 %
$ 9,988
$ 1,932
19.3 %
$ 12,418
$ 2,528
20.4 %
(a)
Refer to the reconciliation of Net income attributable to stockholders to EBIT-adjusted and segment profit (loss) for adjustment details. These adjustments include Net income attributable to noncontrolling interests where applicable. The tax effect of each adjustment is determined based on the tax laws and valuation allowance status of the jurisdiction to which the adjustment relates.
We define return on equity (ROE) as Net income (loss) attributable to stockholders for the trailing four quarters divided by average equity for the same period. Management uses average equity to provide comparable amounts in the calculation of ROE. The following table summarizes the calculation of ROE (dollars in billions):
Four Quarters Ended
September 30, 2025
September 30, 2024
Net income attributable to stockholders
$ 3.0
$ 11.1
Average equity(a)
$ 65.2
$ 69.5
ROE
4.7 %
15.9 %
(a)
Includes equity of noncontrolling interests where the corresponding earnings (loss) are included in Net income attributable to stockholders.
The following table summarizes the calculation of ROIC-adjusted (dollars in billions):
Four Quarters Ended
September 30, 2025
September 30, 2024
EBIT-adjusted(a)
$ 12.4
$ 14.2
Average equity(b)
$ 65.2
$ 69.5
Add: Average automotive debt and interest liabilities (excluding finance leases)
16.1
16.3
Add: Average automotive net pension & OPEB liability
8.7
9.8
Less: Average automotive and other net income tax asset
(22.9)
(22.7)
ROIC-adjusted average net assets
$ 67.1
$ 73.0
ROIC-adjusted
18.5 %
19.4 %
(a)
Refer to the reconciliation of Net income attributable to stockholders to EBIT-adjusted and segment profit (loss) for adjustment details.
(b)
Includes equity of noncontrolling interests where the corresponding earnings (loss) are included in EBIT-adjusted.
The following table reconciles Net automotive cash provided by operating activities to adjusted automotive free cash flow (dollars in millions):
Three Months Ended
Nine Months Ended
September 30,
2025
September 30,
2024
September 30,
2025
September 30,
2024
Net automotive cash provided by operating activities
$ 6,070
$ 7,863
$ 13,127
$ 19,174
Less: Capital expenditures
(2,113)
(2,229)
(6,054)
(7,495)
Add: Buick dealer strategy
243
100
708
376
Add: Restructuring actions
—
74
139
74
Add: GMI plant wind down
—
26
12
35
Add: China restructuring actions
1
—
10
—
Less: Ultium strategic realignment
—
—
(103)
—
Add: Employee separation costs
—
—
—
58
Adjusted automotive free cash flow
$ 4,201
$ 5,834
$ 7,840
$ 12,222
Vehicle Sales
GM presents both wholesale and total vehicle sales data to assist in the analysis of our revenue and market share. Wholesale vehicle sales data consists of sales to GM's dealers and distributors as well as sales to the U.S. government, and excludes vehicles sold by our joint ventures. Wholesale vehicle sales data correlates to GM's revenue recognized from the sale of vehicles, which is the largest component of Automotive net sales and revenue. In the nine months ended September 30, 2025, 26.4% of GM's wholesale vehicle sales volume was generated outside the U.S. The following table summarizes wholesale vehicle sales by our Automotive operations (vehicles in thousands):
Three Months Ended
Nine Months Ended
September 30,
2025
September 30,
2024
September 30,
2025
September 30,
2024
GMNA
840
893
2,516
2,588
GMI
137
140
346
383
Total
977
1,033
2,862
2,971
Total vehicle sales data represents: (1) retail sales (i.e., sales to consumers who purchase new vehicles from dealers or distributors); (2) fleet sales (i.e., sales to large and small businesses, governments and daily rental car companies); and (3) sales of courtesy transportation vehicles (i.e., vehicles previously used by dealers that were sold to the end consumer). Total vehicle sales data includes all sales by joint ventures on a total vehicle basis, not based on our percentage ownership interest in the joint venture. Certain joint venture agreements in China allow for the contractual right to report vehicle sales of non-GM trademarked vehicles by those joint ventures, which are included in the total vehicle sales we report for China. While total vehicle sales data does not correlate directly to the revenue GM recognizes during a particular period, we believe it is indicative of the underlying demand for GM's vehicles. Total vehicle sales data represents management's good faith estimate based on sales reported by our dealers, distributors and joint ventures; commercially available data sources such as registration and insurance data; and internal estimates and forecasts when other data is not available.
The following table summarizes industry and GM total vehicle sales and GM's related competitive position by geographic region (vehicles in thousands):
Three Months Ended
Nine Months Ended
September 30, 2025
September 30, 2024
September 30, 2025
September 30, 2024
Industry
GM
Market
Share
Industry
GM
Market
Share
Industry
GM
Market
Share
Industry
GM
Market
Share
North America
United States
4,187
710
17.0 %
4,000
660
16.5 %
12,516
2,150
17.2 %
12,026
1,950
16.2 %
Other
1,015
127
12.5 %
985
130
13.2 %
3,008
384
12.8 %
2,884
376
13.0 %
Total North America
5,202
837
16.1 %
4,985
790
15.8 %
15,523
2,534
16.3 %
14,910
2,326
15.6 %
Asia/Pacific, Middle East
and Africa
China(a)
6,901
469
6.8 %
6,585
426
6.5 %
19,299
1,359
7.0 %
18,123
1,240
6.8 %
Other
5,598
150
2.7 %
5,536
150
2.7 %
16,603
369
2.2 %
16,310
382
2.3 %
Total Asia/Pacific, Middle
East and Africa
12,499
619
5.0 %
12,121
576
4.8 %
35,903
1,729
4.8 %
34,433
1,622
4.7 %
South America
Brazil
711
72
10.1 %
715
82
11.4 %
1,910
192
10.0 %
1,858
223
12.0 %
Other
455
35
7.7 %
365
28
7.7 %
1,266
95
7.5 %
991
82
8.3 %
Total South America
1,166
107
9.2 %
1,079
110
10.3 %
3,176
287
9.0 %
2,849
305
10.7 %
Total in GM markets
18,868
1,563
8.3 %
18,185
1,476
8.1 %
54,602
4,549
8.3 %
52,193
4,253
8.1 %
Total Europe
3,883
1
— %
3,724
1
— %
12,493
2
— %
12,541
2
— %
Total Worldwide(b)
22,751
1,564
6.9 %
21,910
1,477
6.7 %
67,095
4,552
6.8 %
64,734
4,255
6.6 %
United States
Cars
658
12
1.8 %
731
38
5.2 %
2,080
44
2.1 %
2,207
141
6.4 %
Trucks
1,143
369
32.3 %
1,093
337
30.9 %
3,417
1,115
32.6 %
3,137
987
31.5 %
Crossovers
2,387
330
13.8 %
2,176
284
13.1 %
7,018
992
14.1 %
6,683
822
12.3 %
Total United States
4,187
710
17.0 %
4,000
660
16.5 %
12,516
2,150
17.2 %
12,026
1,950
16.2 %
China(a)
SGMS
130
98
381
372
SGMW
339
329
978
868
Total
6,901
469
6.8 %
6,585
426
6.5 %
19,299
1,359
7.0 %
18,123
1,240
6.8 %
(a)
Includes sales by the Automotive China JVs: SAIC General Motors Sales Co., Ltd. (SGMS) and SAIC GM Wuling Automobile Co., Ltd. (SGMW).
(b)
Cuba, Iran, North Korea, Syria and certain regions of Ukraine are subject to broad economic sanctions. Accordingly, these countries are excluded from industry sales data and corresponding calculation of market share.
As discussed above, total vehicle sales and market share data provided in the table above includes fleet vehicles. Certain fleet transactions, particularly sales to daily rental car companies, are generally less profitable than retail sales to end customers. The following table summarizes estimated fleet sales and those sales as a percentage of total vehicle sales (vehicles in thousands):
Three Months Ended
Nine Months Ended
September 30,
2025
September 30,
2024
September 30,
2025
September 30,
2024
GMNA
148
127
498
447
GMI
106
107
269
274
Total fleet sales
254
234
767
721
Fleet sales as a percentage of total vehicle sales
16.3 %
15.9 %
16.9 %
17.0 %
North America capacity two-shift utilization
118.3 %
109.1 %
115.1 %
106.4 %
SOURCE General Motors
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
"I am very pleased with our teams' focus on reinvigorating organic top-line growth and improving operational performance resulting in another strong quarter," said William Brown, 3M Chairman and CEO. "The 3M excellence model helped accelerate organic sales growth, increase margins, grow EPS double-digits and generate robust free cash flow. This progress gives us the confidence to raise our full-year margin and EPS guidance which positions us well to achieve the strategic and financial commitments we made at our Investor Day earlier this year."
Third -quarter highlights:
Q3 2025
Q3 2024
GAAP EPS from continuing operations (GAAP EPS)
$ 1.55
$ 2.48
Special items:
Net costs for significant litigation
0.19
0.51
(Increase) decrease in value of Solventum ownership
0.13
(1.05)
Manufactured PFAS products
—
0.04
Loss on business divestitures
0.30
—
Transformation costs
0.02
—
Adjusted EPS from continuing operations (adjusted EPS)
$ 2.19
$ 1.98
Memo:
GAAP operating income margin
22.2 %
20.9 %
Adjusted operating income margin
24.7 %
23.0 %
GAAP EPS of $1.55 and operating margin of 22.2%.
Adjusted EPS of $2.19, up 10% year-on-year.
Adjusted operating income margin of 24.7%, an increase of 170 basis points year-on-year.
Sales of $6.5 billion, up 3.5% year-on-year with organic sales up 2.6% year-on-year.
Adjusted sales of $6.3 billion, up 4.1% year-on-year with adjusted organic sales up 3.2% year-on-year.
3M returned $0.9 billion to shareholders via dividends and share repurchases.
Cash from operations of $1.8 billion.
Adjusted free cash flow of $1.3 billion.
This document includes reference to certain non-GAAP measures. See the "Supplemental Financial Information Non-GAAP Measures" section for applicable information.
Updated full-year guidance
3M updated its full-year 2025 guidance given the company's performance in the first nine months of the year.
Adjusted total sales growth1 of >2.5 percent, reflecting adjusted organic sales growth1 of >2 percent.
Adjusted operating income margin expansion1 of 180 bps to 200 bps.
Adjusted EPS1 in the range of $7.95 to $8.05.
Adjusted operating cash flow1 of $5.2 to $5.4 billion, contributing to >100 percent adjusted free cash flow conversion1.
1As further discussed at 4 within the "Supplemental Financial Information Non-GAAP Measures" sections, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items.
Conference call
3M will conduct an investor teleconference at 9 a.m. ET (8 a.m. CT) today. Investors can access this conference via the following:
Live webcast at https://investors.3M.com
Webcast replay at https://investors.3m.com/financials/quarterly-earnings
Consolidated financial statements and supplemental financial information non-GAAP measures
View the Financial Statement Information on 3M's website: https://investors.3m.com/financials/quarterly-earnings
Forward-looking statements
This document contains forward-looking statements. You can identify these statements by the use of words such as "plan," "expect," "aim," "believe," "project," "target," "anticipate," "intend," "estimate," "will," "should," "could," "would," "forecast," "future," "outlook," "guidance" and other words and terms of similar meaning. Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any such forward-looking statements depending on a variety of factors. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation; recession; military conflicts; trade restrictions such as sanctions, tariffs, reciprocal and retaliatory tariffs, and other tariff-related measures; regulatory requirements, legal actions, or enforcement; and natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) liabilities and the outcome of contingencies related to certain fluorochemicals; known as "PFAS," including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's plans to exit PFAS manufacturing and work to discontinue use of PFAS across its product portfolio; (4) risks related to the class-action settlement ("PWS Settlement") to resolve claims by public water suppliers in the United States regarding PFAS, as well as risks related to other settlements related to PFAS; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q, and 8-K (Reports), as well as compliance risks related to legal or regulatory requirements, government contract requirements, policies and practices, or other matters that require or encourage the Company or its customers, suppliers, vendors, or channel partners to conduct business in a certain way; (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, tariffs, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays when implementing new business systems and solutions, including with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information or operational technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the spin-off of the Company's Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment; risks under the agreements and obligations entered into in connection with the spin-off; and (16) matters relating to Combat Arms Earplugs ("CAE") and related products, including those related to, the August 2023 settlement that is intended to resolve, to the fullest extent possible, all litigation and alleged claims involving the CAE sold or manufactured by the Company's subsidiary Aearo Technologies and certain of its affiliates ("Aearo Entities") and/or the Company ("CAE Settlement"). A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). Changes in such assumptions or factors could produce significantly different results. The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.
About 3M
3M (NYSE: MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M.com/news.
Please note that the company announces material financial, business and operational information using the 3M investor relations website, SEC filings, press releases, public conference calls and webcasts. The company also uses the 3M News Center and social media to communicate with our customers and the public about the company, products and services and other matters. It is possible that the information 3M posts on the News Center and social media could be deemed to be material information. Therefore, the company encourages investors, the media and others interested in 3M to review the information posted on 3M's News Center and the social media channels such as @3M or @3MNews.
Contacts
3M
Investor Contacts:
Diane Farrow, 612-202-2449
or
Eric Herron, 651-233-0043
Media Contact:
[email protected]
SOURCE 3M Company
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-21 10:506mo ago
2025-10-21 06:306mo ago
PermRock Royalty Trust Declares Monthly Cash Distribution
, /PRNewswire/ -- PermRock Royalty Trust (NYSE: PRT) (the "Trust") today declared a monthly cash distribution to record holders of its trust units representing beneficial interests in the Trust ("Trust Units") as of October 31, 2025, and payable on November 17, 2025, in the amount of $384,018.36 ($0.031565 per Trust Unit), based principally upon production during the month of August 2025.
The following table displays underlying oil and natural gas sales volumes and average received wellhead prices attributable to the current and prior month net profits interest calculations:
Underlying Sales Volumes
Average Price
Oil
Natural Gas
Oil
Natural Gas
Bbls
Bbls/D
Mcf
Mcf/D
(per Bbl)
(per Mcf)
Current Month
22,490
725
25,914
836
$58.06
$2.31
Prior Month
20,993
677
15,784
509
$65.79
$3.94
Oil cash receipts for the properties underlying the Trust totaled $1.31 million for the current month, a decrease of $0.07 million from the prior month's distribution period. This decrease was primarily due to a decrease in oil prices that was not offset by the increase in oil sales volumes.
Natural gas cash receipts for the properties underlying the Trust totaled $0.06 million for the current month. This amount is essentially unchanged from the prior month's distribution period because the decrease in natural gas prices was offset by the increase in natural gas sales volumes.
Total direct operating expenses, including marketing, lease operating expenses, and workover expenses, were $0.61 million, an increase of $0.18 million from the prior month's distribution period. This increase was related to completion of workover projects and the implementation of a chemical treatment program. Severance and ad valorem taxes included in this month's net profits calculation were $0.14 million. Total capital expenditures during the production month of August 2025 were $0.04 million. T2S Permian Acquisition II LLC ("T2S") informed the Trust that this amount was related to capital additions to a well operated by a third-party operator.
T2S informed the Trust that this month's net profits calculation included the application of $0.10 million net to the Trust of funds previously reserved by T2S to cover capital obligations and expenses.
About PermRock Royalty Trust
PermRock Royalty Trust is a Delaware statutory trust formed to own a net profits interest representing the right to receive 80% of the net profits from the sale of oil and natural gas production from certain properties owned and operated by T2S in the Permian Basin of West Texas. For more information on PermRock Royalty Trust, please visit our website at www.permrock.com.
Certain statements contained in this press release constitute "forward-looking statements." These forward-looking statements represent the Trust's and T2S's expectations or beliefs concerning future events, and it is possible that the results described in this press release will not be achieved. These forward-looking statements include the amount and date of any anticipated distribution to unitholders, future cash retentions, advancements or recoupments from distributions, and statements regarding T2S's operations and the resulting impact on the computation of the Trust's net profits. The amount of cash received or expected to be received by the Trust (and its ability to pay distributions) has been and will continue to be directly affected by volatility in commodity prices and oversupply. Other important factors that could cause actual results to differ materially from those projected in the forward-looking statements include expenses of the Trust and reserves for anticipated future expenses, uncertainties in estimating the cost of drilling activities and risks associated with drilling and operating oil and natural gas wells.
Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, the Trust does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for the Trust to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in the Trust's Annual Report on Form 10-K filed with the SEC on March 31, 2025, and other public filings filed with the SEC. The risk factors and other factors noted in the Trust's public filings with the SEC could cause its actual results to differ materially from those contained in any forward-looking statement. The Trust's filed reports are or will be available over the Internet at the SEC's website at http://www.sec.gov.
Contact:
PermRock Royalty Trust
Argent Trust Company, Trustee
Nancy Willis, Director of Royalty Trust Services,
Trust Administrator
Toll-free: (855) 588-7839
Fax: (214) 559-7010
Website: www.permrock.com
e-mail: [email protected]
SOURCE PermRock Royalty Trust
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-21 10:506mo ago
2025-10-21 06:306mo ago
Equifax Delivers Results Above Third Quarter Guidance; Raising Full Year Guidance
, /PRNewswire/ -- Equifax® (NYSE: EFX) today announced financial results for the quarter ended September 30, 2025.
Third quarter 2025 revenue of $1.545 billion up 7% and $25 million above the midpoint of Guidance, despite headwinds from U.S. Hiring and Mortgage markets.
Third quarter U.S. Mortgage revenue up a strong 13% despite decline in underlying Mortgage market.
Workforce Solutions third quarter revenue up 5%. Verification Services revenue up 5% led by strong high single digit Government growth, with Non-Mortgage growth of 7% and Mortgage growth of 2%.
USIS third quarter revenue up 11% with strong Mortgage revenue growth of 26% and Non-Mortgage revenue growth of 5%.
International third quarter revenue up 6% on a reported basis with 7% growth on a local currency basis led by Latin America and Canada.
Raising full year 2025 Vitality Index to 13%, above our 10% long-term goal, from strong 16% Vitality in the quarter leveraging new EFX Cloud and EFX.AI with double digit Vitality Index across all business units.
Returned approximately $360 million of cash to shareholders, including repurchasing 1.2 million shares for $300 million.
Raising 2025 Guidance given strong third quarter results. Increasing full-year reported revenue by $40 million and Adjusted EPS by $0.12 per share.
Increased 2025 free cash flow Guidance from $900+ million to $950 million to $975 million from strong operating performance.
Introduced new Mortgage Scores pricing structure to support a competitive credit scoring market and reduce mortgage costs for American homebuyers and the mortgage industry.
"Equifax delivered strong third quarter revenue of $1.545 billion, up 7% on both a reported and local currency basis, that was $25 million above the midpoint of our July Guidance. This was led by strong 13% U.S. Mortgage revenue growth, strong Workforce Solutions Government vertical results, and continued momentum in New Product Innovation with a Vitality Index of 16% despite headwinds from the U.S. Mortgage and Hiring markets. Workforce Solutions delivered 5% revenue growth, driven by Verification Services revenue growth of 5% led by Non-Mortgage revenue growth of 7% from strong high single digit growth in Government and double digit growth in Consumer Lending businesses. USIS delivered strong revenue growth of 11%, well above their 6 to 8% Long Term Financial Framework. USIS revenue growth was led by very strong 26% Mortgage revenue growth and Non-Mortgage revenue growth of 5%. International delivered 7% local currency revenue growth led by Latin America and Canada. We were pleased with the strong Equifax results in a challenging market environment," said Mark W. Begor, Equifax Chief Executive Officer.
"Given our strong third quarter results, we are raising our full year 2025 reported revenue Guidance midpoint by $40 million with local currency growth of about 7% and increasing our full year Adjusted EPS Guidance by $0.12 per share. We also increased our 2025 free cash flow Guidance from $900+ million to between $950 million and $975 million from our strong operating cash flow and a cash conversion ratio of over 100%, above our Long Term Financial Framework of 95%+. Given our strong free cash flow and balance sheet, we returned about $360 million of cash to shareholders in the third quarter, including repurchasing 1.2 million Equifax shares for $300 million under our $3 billion share repurchase program. Our ability to deliver significant excess free cash flow to shareholders is a big milestone for Equifax as we move post-Cloud to fully focus on growth, innovation, new products, and free cash generation to continue investing in EFX for growth and return cash to shareholders.
Recently, Equifax introduced a new Mortgage Score pricing structure to support a competitive credit scoring market and reduce mortgage costs for American homebuyers and the mortgage industry. Equifax is offering VantageScore® 4.0 mortgage credit scores in 2026 at an over 50% reduction to FICO mortgage scores, and we plan to keep the price of Vantage 4.0 credit scores flat in 2027. Equifax will also offer free VantageScore 4.0 credit scores to all Equifax customers in mortgage, automotive, card and consumer finance who purchase competing FICO scores for the remainder of 2025 and throughout 2026 to drive conversion. With these steps, lenders can see the value that the VantageScore 4.0 credit score's inclusion of alternative data, or information not historically included in traditional credit reports, can bring – making it possible to score 33 million more U.S. adults.
We continued to execute very well against our EFX2027 Strategic Priorities in the quarter, despite market headwinds. We are pivoting to leveraging our new Cloud capabilities to accelerate New Product Innovation leveraging our differentiated data assets, and investing in new products, data, analytics, and EFX.AI capabilities which are expected to drive growth in 2025 and beyond. We are energized about our second half momentum of the New Equifax that is expected to deliver higher growth, margins, and accelerating free cash flow, and returning cash to shareholders in the future."
Financial Results Summary
The Company reported revenue of $1,544.9 million in the third quarter of 2025, up 7% on both a reported and local currency basis compared to the third quarter of 2024.
Net income attributable to Equifax of $160.2 million was up 13% in the third quarter of 2025 compared to $141.3 million in the third quarter of 2024.
Diluted EPS attributable to Equifax was $1.29 per share in the third quarter of 2025, up 14% compared to $1.13 per share in the third quarter of 2024.
Workforce Solutions Third Quarter Results
Total revenue was $649.4 million in the third quarter of 2025, up 5% compared to the third quarter of 2024. Operating margin for Workforce Solutions was 43.8% in the third quarter of 2025 compared to 43.2% in the third quarter of 2024. Adjusted EBITDA margin for Workforce Solutions was 51.2% in the third quarter of 2025 compared to 51.6% in the third quarter of 2024.
Verification Services revenue was $553.6 million, up 5% compared to the third quarter of 2024.
Employer Services revenue was $95.8 million, up 1% compared to the third quarter of 2024.
USIS Third Quarter Results
Total revenue was $530.2 million in the third quarter of 2025, up 11% compared to the third quarter of 2024. Operating margin for USIS was 23.2% in the third quarter of 2025 compared to 20.6% in the third quarter of 2024. Adjusted EBITDA margin for USIS was 35.2% in the third quarter of 2025 compared to 33.9% in the third quarter of 2024.
Online Information Solutions revenue was $467.5 million, up 12% compared to the third quarter of 2024.
Financial Marketing Services revenue was $62.7 million, up 9% compared to the third quarter of 2024.
International Third Quarter Results
Total revenue was $365.3 million in the third quarter of 2025, up 6% and up 7% compared to the third quarter of 2024 on a reported and local currency basis, respectively. Operating margin for International was 15.8% in the third quarter of 2025 compared to 13.9% in the third quarter of 2024. Adjusted EBITDA margin for International was 31.3% in the third quarter of 2025 compared to 27.7% in the third quarter of 2024.
Latin America revenue was $102.1 million, up 6% compared to the third quarter of 2024 on a reported basis and up 9% on a local currency basis.
Europe revenue was $102.3 million, up 8% compared to the third quarter of 2024 on a reported basis and up 4% on a local currency basis.
Asia Pacific revenue was $90.1 million, up 2% compared to the third quarter of 2024 on a reported basis and up 4% on a local currency basis.
Canada revenue was $70.8 million, up 9% compared to the third quarter of 2024 on a reported basis and up 11% on a local currency basis.
Adjusted EPS and Adjusted EBITDA Margin
Adjusted EPS attributable to Equifax was $2.04 in the third quarter of 2025, up 10% compared to the third quarter of 2024.
Adjusted EBITDA margin was 32.7% in the third quarter of 2025, flat compared to the third quarter of 2024.
These financial measures exclude certain items as described further in the Non-GAAP Financial Measures section below.
2025 Fourth Quarter and Full Year Guidance
Q4 2025
FY 2025
Low-End
High-End
Low-End
High-End
Reported Revenue
$1.506 billion
$1.536 billion
$6.030 billion
$6.060 billion
Reported Revenue Growth
6.1 %
8.2 %
6.1 %
6.7 %
Local Currency Growth (1)
5.5 %
7.6 %
6.5 %
7.1 %
Organic Local Currency Growth (1)
5.5 %
7.6 %
6.5 %
7.1 %
Adjusted Earnings Per Share
$1.98 per share
$2.08 per share
$7.55 per share
$7.65 per share
(1) Refer to page 8 for definitions. Additionally, the definitions can be found in the Non-GAAP Financial Measures below.
About Equifax
At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by approximately 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit www.equifax.com.
Earnings Conference Call and Audio Webcast
In conjunction with this release, Equifax will host a conference call on October 21, 2025 at 8:30 a.m. (ET) via a live audio webcast. To access the webcast and related presentation materials, go to the Investor Relations section of our website at www.equifax.com. The discussion will be available via replay at the same site shortly after the conclusion of the webcast. This press release is also available at that website.
Non-GAAP Financial Measures
This earnings release presents adjusted EPS attributable to Equifax which is diluted EPS attributable to Equifax adjusted (to the extent noted above for different periods) for acquisition-related amortization expense of certain acquired intangibles, accrual for legal and regulatory matters related to the 2017 cybersecurity incident, foreign currency impact of certain intercompany loans, acquisition-related costs other than acquisition amortization, income tax effect of stock awards recognized upon vesting or settlement, Argentina highly inflationary foreign currency adjustment, realignment of resources and other costs and antitrust litigation costs. All adjustments are net of tax, with a reconciling item with the aggregated tax impact of the adjustments. This earnings release also presents (i) adjusted EBITDA and adjusted EBITDA margin, which is defined as consolidated net income attributable to Equifax plus net interest expense, income taxes, depreciation and amortization, and also excludes certain one-time items, (ii) local currency revenue change, which is calculated by conforming 2025 results using 2024 exchange rates, (iii) organic local currency revenue growth, which is defined as local currency revenue growth, adjusted to reflect an increase in prior year Equifax revenue from the revenue of acquired companies in the prior year period, (iv) free cash flow, which is defined as cash provided by operating activities less capital expenditures, and (v) cash conversion, which is defined as the ratio of free cash flow to adjusted net income. These are important financial measures for Equifax but are not financial measures as defined by GAAP.
These non-GAAP financial measures should be reviewed in conjunction with the relevant GAAP financial measures and are not presented as an alternative measure of net income or EPS as determined in accordance with GAAP.
Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures and related notes are presented in the Q&A. This information can also be found under "Investor Relations/Financial Information/Non-GAAP Financial Measures" on our website at www.equifax.com.
Forward-Looking Statements
This release contains forward-looking statements and forward-looking information. These statements can be identified by expressions of belief, expectation or intention, as well as statements that are not historical fact. These statements are based on certain factors and assumptions including with respect to foreign exchange rates, revenue growth, results of operations and financial performance, strategic initiatives, business plans, prospects and opportunities, the U.S. mortgage market, economic conditions and effective tax rates.
While Equifax believes these factors and assumptions to be reasonable based on information currently available, they may prove to be incorrect. Several factors could cause actual results to differ materially from those expressed or implied in the forward-looking statements. These factors relate to (i) actions taken by us, including, but not limited to, restructuring actions, strategic initiatives (such as our cloud technology transformation), capital investments and asset acquisitions or dispositions, as well as (ii) developments beyond our control, including, but not limited to, changes in the U.S. mortgage market environment and changes more generally in U.S. and worldwide economic conditions (such as changes in interest rates and inflation levels and the evolving impact of tariffs) that materially impact consumer spending, home prices, investment values, consumer debt, unemployment rates and the demand for Equifax's products and services. Deteriorations in economic conditions or increases in interest rates could lead to a decline in demand for our products and services and negatively impact our business. It may also impact financial markets and corporate credit markets, which could adversely impact our access to financing or the terms of any financing.
Other risk factors relevant to our business include: (i) any compromise of Equifax, customer or consumer information due to security breaches and other disruptions to our information technology infrastructure; (ii) the failure to achieve and maintain key industry or technical certifications; (iii) the failure to realize the anticipated benefits of our cloud technology transformation strategy; (iv) operational disruptions and strain on our resources caused by our transition to cloud-based technologies; (v) our ability to meet customer requirements for high system availability and response time performance; (vi) effects on our business if we provide inaccurate or unreliable data to customers; (vii) our ability to maintain access to credit, employment, financial and other data from external sources; (viii) the impact of competition; (ix) our ability to maintain relationships with key customers and business partners; (x) our ability to successfully introduce new products, services and analytical capabilities; (xi) the impact on the demand for some of our products and services due to the availability of free or less expensive consumer information; (xii) our ability to comply with our obligations under settlement agreements arising out of a material cybersecurity incident in 2017; (xiii) potential adverse developments in new and pending legal proceedings, government investigations and regulatory enforcement actions; (xiv) changes in, and the effects of, laws, regulations and government policies governing our business, including oversight by the Consumer Financial Protection Bureau in the U.S., the U.K. Financial Conduct Authority and Information Commissioner's Office in the U.K., and the Office of Australian Information Commission and the Australian Competition and Consumer Commission in Australia; (xv) the impact of privacy, cybersecurity or other data-related laws and regulations; (xvi) the economic, political and other risks associated with international sales and operations; (xvii) the impact on our reputation and business from our responsible business commitments and disclosures; (xviii) our ability to realize the anticipated strategic and financial benefits from our acquisitions, joint ventures and other alliances; (xix) any damage to our reputation due to our dependence on outsourcing certain portions of our operations; (xx) the termination or suspension of our government contracts; (xxi) the impact of infringement or misappropriation of intellectual property by us against third parties or by third parties against us; (xxii) an increase in our cost of borrowing and our ability to access the capital markets due to a credit rating downgrade; (xxiii) our ability to hire and retain key personnel; (xxiv) the impact of adverse changes in the financial markets and corresponding effects on our retirement and post-retirement pension plans; (xxv) the impact of health epidemics, pandemics and similar outbreaks on our business; and (xxvi) risks associated with our use of certain artificial intelligence and machine learning models and systems.
A summary of additional risks and uncertainties can be found in our Annual Report on Form 10-K for the year ended December 31, 2024 including without limitation under the captions "Item 1. Business -- Governmental Regulation," "-- Forward-Looking Statements" and "Item 1A. Risk Factors" and in our other filings with the U.S. Securities and Exchange Commission. Forward-looking statements are given only as at the date of this release and Equifax disclaims any obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
EQUIFAX INC.
CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended September 30,
2025
2024
(In millions, except per share amounts)
(Unaudited)
Operating revenue
$ 1,544.9
$ 1,441.8
Operating expenses:
Cost of services (exclusive of depreciation and amortization below)
663.2
645.2
Selling, general and administrative expenses
434.1
380.4
Depreciation and amortization
183.3
169.1
Total operating expenses
1,280.6
1,194.7
Operating income
264.3
247.1
Interest expense
(52.2)
(56.3)
Other income, net
3.2
3.0
Consolidated income before income taxes
215.3
193.8
Provision for income taxes
(53.8)
(51.1)
Consolidated net income
161.5
142.7
Less: Net income attributable to noncontrolling interests including redeemable noncontrolling interests
(1.3)
(1.4)
Net income attributable to Equifax
$ 160.2
$ 141.3
Basic earnings per common share:
Net income attributable to Equifax
$ 1.30
$ 1.14
Weighted-average shares used in computing basic earnings per share
123.1
123.9
Diluted earnings per common share:
Net income attributable to Equifax
$ 1.29
$ 1.13
Weighted-average shares used in computing diluted earnings per share
124.1
125.2
Dividends per common share
$ 0.50
$ 0.39
EQUIFAX INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
September 30, 2025
December 31, 2024
(In millions, except par values)
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents
$ 189.0
$ 169.9
Trade accounts receivable, net of allowance for doubtful accounts of $19.3 and $16.9 at
September 30, 2025 and December 31, 2024, respectively
1,015.0
957.6
Prepaid expenses
143.0
134.9
Other current assets
116.1
98.2
Total current assets
1,463.1
1,360.6
Property and equipment:
Capitalized internal-use software and system costs
3,003.3
2,817.5
Data processing equipment and furniture
244.7
229.6
Land, buildings and improvements
290.1
285.0
Total property and equipment
3,538.1
3,332.1
Less accumulated depreciation and amortization
(1,621.6)
(1,440.2)
Total property and equipment, net
1,916.5
1,891.9
Goodwill
6,664.7
6,547.8
Indefinite-lived intangible assets
94.7
94.7
Purchased intangible assets, net
1,368.5
1,521.0
Other assets, net
324.3
343.4
Total assets
$ 11,831.8
$ 11,759.4
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt and current maturities of long-term debt
$ 759.3
$ 687.7
Accounts payable
156.2
138.2
Accrued expenses
298.7
251.1
Accrued salaries and bonuses
245.4
215.8
Deferred revenue
110.5
115.5
Other current liabilities
413.4
403.2
Total current liabilities
1,983.5
1,811.5
Long-term debt
4,053.8
4,322.8
Deferred income tax liabilities, net
376.4
351.6
Long-term pension and other postretirement benefit liabilities
Common stock, $1.25 par value: Authorized shares - 300.0;
Issued shares - 189.3 at September 30, 2025 and December 31, 2024;
Outstanding shares - 122.6 and 124.0 at September 30, 2025 and December 31, 2024, respectively
236.6
236.6
Paid-in capital
2,003.2
1,915.2
Retained earnings
6,330.3
6,018.6
Accumulated other comprehensive loss
(551.3)
(722.7)
Treasury stock, at cost, 66.1 and 64.7 shares at September 30, 2025 and December 31, 2024,
respectively
(3,074.4)
(2,644.9)
Stock held by employee benefits trusts, at cost, 0.6 shares at September 30, 2025 and
December 31, 2024
(5.9)
(5.9)
Total Equifax shareholders' equity
4,938.5
4,796.9
Noncontrolling interests
18.7
17.5
Total shareholders' equity
4,957.2
4,814.4
Total liabilities, redeemable noncontrolling interests, and shareholders' equity
$ 11,831.8
$ 11,759.4
EQUIFAX INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine Months Ended September 30,
2025
2024
(In millions)
(Unaudited)
Operating activities:
Consolidated net income
$ 487.9
$ 433.9
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization
540.8
506.9
Stock-based compensation expense
63.9
71.9
Deferred income taxes
29.6
(45.2)
Gain on sale of equity investment
(0.8)
—
Changes in assets and liabilities, excluding effects of acquisitions:
Accounts receivable, net
(45.6)
(47.8)
Other assets, current and long-term
(10.3)
(13.3)
Current and long term liabilities, excluding debt
79.4
93.3
Cash provided by operating activities
1,144.9
999.7
Investing activities:
Capital expenditures
(351.4)
(392.6)
Cash received from divestitures
0.8
—
Cash used in investing activities
(350.6)
(392.6)
Financing activities:
Net short-term payments
(204.1)
(195.9)
Payments on long-term debt
—
(695.6)
Proceeds from issuance of long-term debt
1.7
649.8
Treasury stock purchases
(427.4)
—
Dividends paid to Equifax shareholders
(172.0)
(144.8)
Distributions paid to noncontrolling interests
(6.2)
(4.4)
Proceeds from exercise of stock options and employee stock purchase plan
38.1
67.5
Payment of taxes related to settlement of equity awards
(13.6)
(16.4)
Debt issuance costs
—
(5.2)
Cash used in financing activities
(783.5)
(345.0)
Effect of foreign currency exchange rates on cash and cash equivalents
8.3
(10.7)
Increase in cash and cash equivalents
19.1
251.4
Cash and cash equivalents, beginning of period
169.9
216.8
Cash and cash equivalents, end of period
$ 189.0
$ 468.2
Common Questions & Answers (Unaudited)
(Dollars in millions)
1. Can you provide a further analysis of operating revenue by operating segment?
Operating revenue consists of the following components:
(In millions)
Three Months Ended September 30,
Local
Currency
Organic
Local
Currency
Operating revenue:
2025
2024
$ Change
% Change
% Change (1)
% Change (2)
Verification Services
$ 553.6
$ 524.9
$ 28.7
5 %
5 %
Employer Services
95.8
95.1
0.7
1 %
1 %
Total Workforce Solutions
649.4
620.0
29.4
5 %
5 %
Online Information Solutions (3)
467.5
419.1
48.4
12 %
12 %
Financial Marketing Services
62.7
57.8
4.9
9 %
9 %
Total U.S. Information Solutions
530.2
476.9
53.3
11 %
11 %
Latin America
102.1
96.7
5.4
6 %
9 %
9 %
Europe
102.3
94.9
7.4
8 %
4 %
4 %
Asia Pacific
90.1
88.5
1.6
2 %
4 %
4 %
Canada
70.8
64.8
6.0
9 %
11 %
11 %
Total International
365.3
344.9
20.4
6 %
7 %
7 %
Total operating revenue
$ 1,544.9
$ 1,441.8
$ 103.1
7 %
7 %
7 %
(1)
Local currency revenue change is calculated by conforming 2025 results using 2024 exchange rates.
(2)
Organic local currency revenue growth is defined as local currency revenue growth, adjusted to reflect an increase in prior year Equifax revenue from the revenue of acquired companies in the prior year period. This adjustment is made for 12 months following the acquisition.
(3)
Prior to the first quarter of 2025, Mortgage Solutions was historically reported separately from Online Information Solutions. Beginning in 2025, Mortgage Solutions results are included in Online Information Solutions within the U.S. Information Solutions operating segment. The change has been applied retrospectively for all periods presented within this earnings release.
2. What is the estimate of the change in overall U.S. mortgage hard pull credit inquiry volume that is included in the 2025 fourth quarter and full year guidance provided?
The change year over year in total U.S. mortgage hard pull credit inquiries received by Equifax in the third quarter of 2025 was a decline of 7%. The guidance provided on page 3 assumes a change year over year in total U.S. mortgage market credit inquiries received by Equifax in the fourth quarter of 2025 and for the full year 2025 to be down high single digits.
Reconciliations of Non-GAAP Financial Measures to the Comparable GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share amounts)
A. Reconciliation of net income attributable to Equifax to adjusted net income attributable to Equifax and adjusted diluted EPS attributable to Equifax, defined as net income and EPS, respectively, each adjusted for acquisition-related amortization expense of certain acquired intangibles, accrual for legal and regulatory matters related to the 2017 cybersecurity incident, foreign currency impact of certain intercompany loans, acquisition-related costs other than acquisition amortization, income tax effect of stock awards recognized upon vesting or settlement, Argentina highly inflationary foreign currency adjustment, realignment of resources and other costs, antitrust litigation costs and aggregated tax impact of these adjustments:
Three Months Ended September 30,
(In millions, except per share amounts)
2025
2024
$ Change
% Change
Net income attributable to Equifax
$ 160.2
$ 141.3
$ 18.9
13 %
Acquisition-related amortization expense of certain acquired intangibles (1)
62.7
64.6
(1.9)
(3) %
Accrual for legal and regulatory matters related to the 2017 cybersecurity incident (2)
0.3
0.1
0.2
nm
Foreign currency impact of certain intercompany loans (3)
(0.1)
0.1
(0.2)
nm
Acquisition-related costs other than acquisition amortization (4)
8.9
15.9
(7.0)
(44) %
Income tax effects of stock awards that are recognized upon vesting or settlement (5)
(0.5)
(3.1)
2.6
(84) %
Argentina highly inflationary foreign currency adjustment (6)
0.7
0.3
0.4
nm
Realignment of resources and other costs (7)
43.9
41.6
2.3
6 %
Antitrust litigation costs (8)
4.3
—
4.3
nm
Tax impact of adjustments (9)
(27.5)
(29.0)
1.5
(5) %
Adjusted net income attributable to Equifax
$ 252.9
$ 231.8
$ 21.1
9 %
Adjusted diluted EPS attributable to Equifax
$ 2.04
$ 1.85
$ 0.19
10 %
Weighted-average shares used in computing diluted EPS
124.1
125.2
nm - not meaningful
(1)
During the third quarter of 2025, we recorded acquisition-related amortization expense of certain acquired intangibles of $62.7 million ($50.2 million, net of tax). We calculate this financial measure by excluding the impact of acquisition-related amortization expense and including a benefit to reflect the significant cash income tax savings resulting from the income tax deductibility of amortization for certain acquired intangibles. The $12.5 million of tax is comprised of $16.7 million of tax expense, net of $4.2 million of a cash income tax benefit. During the third quarter of 2024, we recorded acquisition-related amortization expense of certain acquired intangibles of $64.6 million ($51.4 million, net of tax). The $13.2 million of tax is comprised of $17.3 million of tax expense, net of $4.1 million of a cash income tax benefit. See the Notes to this reconciliation for additional detail.
(2)
During the third quarter of 2025 and 2024, we recorded an accrual for legal and regulatory matters related to the 2017 cybersecurity incident of $0.3 million ($0.2 million, net of tax) and $0.1 million, respectively. See the Notes to this reconciliation for additional detail.
(3)
During the third quarter of 2025 and 2024, we recorded a foreign currency gain of $0.1 million and a foreign currency loss of $0.1 million, respectively, on certain intercompany loans. The impact was recorded to the Other income, net line item within the Consolidated Statements of Income. See the Notes to this reconciliation for additional detail.
(4)
During the third quarter of 2025 and 2024, we recorded $8.9 million ($6.2 million, net of tax) and $15.9 million ($12.2 million, net of tax), respectively, for acquisition-related costs other than acquisition amortization. These costs primarily related to integration costs resulting from recent acquisition activity and were recorded in operating income. See the Notes to this reconciliation for additional detail.
(5)
During the third quarter of 2025 and 2024, we recorded a tax benefit of $0.5 million and $3.1 million, respectively, related to the tax effects of deductions for stock compensation in excess of amounts recorded for compensation costs. See the Notes to this reconciliation for additional detail.
(6)
Argentina experienced multiple periods of increasing inflation rates, devaluation of the peso, and increasing borrowing rates. As such, Argentina was deemed a highly inflationary economy by accounting policymakers in 2018. During the third quarter of 2025 and 2024, we recorded a foreign currency loss of $0.7 million and $0.3 million, respectively, related to the impact of remeasuring the peso denominated monetary assets and liabilities as a result of Argentina being a highly inflationary economy. See the Notes to this reconciliation for additional detail.
(7)
During the third quarter of 2025, we recorded $43.9 million ($32.8 million, net of tax) of restructuring charges for the realignment of resources and other costs, which predominantly relate to the reduction of headcount to support the Company's global strategic objectives. During the third quarter of 2024, we recorded $41.6 million ($29.5 million, net of tax) of restructuring charges for the realignment of resources and other costs. These restructuring charges predominantly related to our ongoing efforts toward completion of our technology transformation in order to support the Company's strategic objectives. See the Notes to this reconciliation for additional detail.
(8)
During the third quarter of 2025, we recorded costs related to antitrust litigation pertaining to our Workforce Solutions business unit in the amount of $4.3 million ($3.2 million, net of tax). See the Notes to this reconciliation for additional detail.
(9)
During the third quarter of 2025, we recorded the tax impact of adjustments of $27.5 million comprised of (i) acquisition-related amortization expense of certain acquired intangibles of $12.5 million ($16.7 million of tax expense, net of $4.2 million of cash income tax benefit), (ii) a tax adjustment of $0.1 million related to an accrual for legal and regulatory matters related to the 2017 cybersecurity incident, (iii) a tax adjustment of $2.7 million related to acquisition-related costs other than acquisition amortization, (iv) a tax adjustment of $11.1 million related to restructuring charges, and (v) a tax adjustment of $1.1 million related to antitrust litigation costs.
During the third quarter of 2024, we recorded the tax impact of adjustments of $29.0 million comprised of (i) acquisition-related amortization expense of certain acquired intangibles of $13.2 million ($17.3 million of tax expense, net of $4.1 million of cash income tax benefit), (ii) a tax adjustment of $3.7 million related to acquisition-related costs other than acquisition amortization, and (iii) a tax adjustment of $12.1 million related to the realignment of resources and other costs.
B. Reconciliation of net income attributable to Equifax to adjusted EBITDA, defined as net income excluding income taxes, interest expense, net, depreciation and amortization expense, accrual for legal and regulatory matters related to the 2017 cybersecurity incident, foreign currency impact of certain intercompany loans, acquisition-related costs other than acquisition amortization, Argentina highly inflationary foreign currency adjustment, realignment of resources and other costs, antitrust litigation costs and presentation of adjusted EBITDA margin:
Three Months Ended September 30,
(In millions)
2025
2024
$ Change
% Change
Revenue
$ 1,544.9
$ 1,441.8
$ 103.1
7 %
Net income attributable to Equifax
$ 160.2
$ 141.3
$ 18.9
13 %
Income taxes
53.8
51.1
2.7
5 %
Interest expense, net*
49.5
52.4
(2.9)
(6) %
Depreciation and amortization
183.3
169.1
14.2
8 %
Accrual for legal and regulatory matters related to 2017 cybersecurity incident (1)
0.3
0.1
0.2
nm
Foreign currency impact of certain intercompany loans (2)
(0.1)
0.1
(0.2)
nm
Acquisition-related amounts other than acquisition amortization (3)
8.9
15.9
(7.0)
(44) %
Argentina highly inflationary foreign currency adjustment (4)
0.7
0.3
0.4
nm
Realignment of resources and other costs (5)
43.9
41.6
2.3
6 %
Antitrust litigation costs (6)
4.3
—
4.3
nm
Adjusted EBITDA, excluding the items listed above
$ 504.8
$ 471.9
$ 32.9
7 %
Adjusted EBITDA margin
32.7 %
32.7 %
nm - not meaningful
*Excludes interest income of $2.7 million in 2025 and $3.9 million in 2024.
(1)
During the third quarter of 2025 and 2024, we recorded an accrual for legal and regulatory matters related to the 2017 cybersecurity incident of $0.3 million ($0.2 million, net of tax) and $0.1 million, respectively. See the Notes to this reconciliation for additional detail.
(2)
During the third quarter of 2025 and 2024, we recorded a foreign currency gain of $0.1 million and a foreign currency loss of $0.1 million, respectively, on certain intercompany loans. The impact was recorded to the Other income, net line item within the Consolidated Statements of Income. See the Notes to this reconciliation for additional detail.
(3)
During the third quarter of 2025 and 2024, we recorded $8.9 million ($6.2 million, net of tax) and $15.9 million ($12.2 million, net of tax), respectively, for acquisition-related costs other than acquisition amortization. These costs primarily related to integration costs resulting from recent acquisition activity and were recorded in operating income. See the Notes to this reconciliation for additional detail.
(4)
Argentina experienced multiple periods of increasing inflation rates, devaluation of the peso, and increasing borrowing rates. As such, Argentina was deemed a highly inflationary economy by accounting policymakers in 2018. During the third quarter of 2025 and 2024, we recorded a foreign currency loss of $0.7 million and $0.3 million, respectively, related to the impact of remeasuring the peso denominated monetary assets and liabilities as a result of Argentina being a highly inflationary economy. See the Notes to this reconciliation for additional detail.
(5)
During the third quarter of 2025, we recorded $43.9 million ($32.8 million, net of tax) of restructuring charges for the realignment of resources and other costs, which predominantly relate to the reduction of headcount to support the Company's global strategic objectives. During the third quarter of 2024, we recorded $41.6 million ($29.5 million, net of tax) of restructuring charges for the realignment of resources and other costs. These restructuring charges predominantly related to our ongoing efforts toward completion of our technology transformation in order to support the Company's strategic objectives. See the Notes to this reconciliation for additional detail.
(6)
During the third quarter of 2025, we recorded costs related to antitrust litigation pertaining to our Workforce Solutions business unit in the amount of $4.3 million ($3.2 million, net of tax). See the Notes to this reconciliation for additional detail.
C. Reconciliation of operating income by segment to Adjusted EBITDA, excluding depreciation and amortization expense, other income, net, noncontrolling interest, accrual for legal and regulatory matters related to the 2017 cybersecurity incident, foreign currency impact of certain intercompany loans, acquisition-related costs other than acquisition amortization, Argentina highly inflationary foreign currency adjustment, realignment of resources and other costs, antitrust litigation costs and presentation of adjusted EBITDA margin for each of the segments:
(In millions)
Three Months Ended September 30, 2025
Workforce
Solutions
U.S.
Information
Solutions
International
General
Corporate
Expense
Total
Revenue
$ 649.4
$ 530.2
$ 365.3
—
$ 1,544.9
Operating income
284.5
123.3
57.7
(201.2)
264.3
Depreciation and amortization
47.2
62.8
48.1
25.2
183.3
Other income (expense), net*
—
0.6
0.8
(0.9)
0.5
Noncontrolling interest
—
—
(1.3)
—
(1.3)
Adjustments (1)
1.0
(0.1)
9.1
48.0
58.0
Adjusted EBITDA
$ 332.7
$ 186.6
$ 114.4
$ (128.9)
$ 504.8
Operating margin
43.8 %
23.2 %
15.8 %
nm
17.1 %
Adjusted EBITDA margin
51.2 %
35.2 %
31.3 %
nm
32.7 %
nm - not meaningful
*Excludes interest income of $2.4 million in International and $0.3 million in General Corporate Expense.
(In millions)
Three Months Ended September 30, 2024
Workforce
Solutions
U.S.
Information
Solutions
International
General
Corporate
Expense
Total
Revenue
$ 620.0
$ 476.9
$ 344.9
—
$ 1,441.8
Operating income
267.6
98.1
48.1
(166.7)
247.1
Depreciation and amortization
44.9
61.0
43.6
19.6
169.1
Other income (expense), net*
—
—
1.2
(2.1)
(0.9)
Noncontrolling interest
—
—
(1.4)
—
(1.4)
Adjustments (1)
7.4
2.5
4.1
44.0
58.0
Adjusted EBITDA
$ 319.9
$ 161.6
$ 95.6
$ (105.2)
$ 471.9
Operating margin
43.2 %
20.6 %
13.9 %
nm
17.1 %
Adjusted EBITDA margin
51.6 %
33.9 %
27.7 %
nm
32.7 %
nm - not meaningful
*Excludes interest income of $2.1 million in International and $1.8 million in General Corporate Expense.
(1)
During the third quarter of 2025, we recorded pre-tax expenses of $0.3 million for an accrual for legal and regulatory matters related to the 2017 cybersecurity incident, $0.1 million for a foreign currency gain on certain intercompany loans, $8.9 million for acquisition-related costs other than acquisition amortization, $0.7 million for a foreign currency loss related to the impact of remeasuring the peso denominated monetary assets and liabilities as a result of Argentina being a highly inflationary economy, $43.9 million of restructuring charges for the realignment of resources and other costs and $4.3 million of antitrust litigation costs.
During the third quarter of 2024, we recorded pre-tax expenses of $0.1 million for an accrual for legal and regulatory matters related to the 2017 cybersecurity incident, $0.1 million for a foreign currency loss on certain intercompany loans, $15.9 million for acquisition-related costs other than acquisition amortization, $0.3 million for a foreign currency loss related to the impact of remeasuring the peso denominated monetary assets and liabilities as a result of Argentina being a highly inflationary economy, and $41.6 million of restructuring charges for the realignment of resources and other costs.
Notes to Reconciliations of Non-GAAP Financial Measures to the Comparable GAAP Financial Measures
Diluted EPS attributable to Equifax is adjusted for the following items:
Acquisition-related amortization expense - During the third quarter of 2025 and 2024, we recorded acquisition-related amortization expense of certain acquired intangibles of $62.7 million ($50.2 million, net of tax) and $64.6 million ($51.4 million, net of tax), respectively. We calculate this financial measure by excluding the impact of acquisition-related amortization expense and including a benefit to reflect the material cash income tax savings resulting from the income tax deductibility of amortization for certain acquired intangibles. These financial measures are not prepared in conformity with GAAP. Management believes excluding the impact of amortization expense is useful because excluding acquisition-related amortization, and other items that are not comparable, allows investors to evaluate our performance for different periods on a more comparable basis. Certain acquired intangibles result in material cash income tax savings which are not reflected in earnings. Management believes that including a benefit to reflect the cash income tax savings is useful as it allows investors to better value Equifax. Management makes these adjustments to earnings when measuring profitability, evaluating performance trends, setting performance objectives and calculating our return on invested capital.
Accrual for legal and regulatory matters related to the 2017 cybersecurity incident - Accrual for legal and regulatory matters related to the 2017 cybersecurity incident includes legal fees to respond to subsequent litigation and government investigations for both periods presented. During the third quarter of 2025 and 2024, we recorded an accrual for legal and regulatory matters related to the 2017 cybersecurity incident of $0.3 million ($0.2 million, net of tax) and $0.1 million, respectively. Management believes excluding these charges is useful as it allows investors to evaluate our performance for different periods on a more comparable basis. Management makes these adjustments to net income when measuring profitability, evaluating performance trends, setting performance objectives and calculating our return on invested capital. This is consistent with how management reviews and assesses Equifax's historical performance and is useful when planning, forecasting and analyzing future periods.
Foreign currency impact of certain intercompany loans - During the third quarter of 2025 and 2024, we recorded a gain of $0.1 million and a loss of $0.1 million, respectively, related to foreign currency impact of certain intercompany loans. Management believes excluding this charge is useful as it allows investors to evaluate our performance for different periods on a more comparable basis. This is consistent with how management reviews and assesses Equifax's historical performance and is useful when planning, forecasting and analyzing future periods.
Acquisition-related costs other than acquisition amortization - During the third quarter of 2025 and 2024, we recorded $8.9 million ($6.2 million, net of tax) and $15.9 million ($12.2 million, net of tax), respectively, for acquisition-related costs other than acquisition amortization. These costs primarily related to integration costs resulting from recent acquisitions and were recorded in operating income. Management believes excluding this charge from certain financial results provides meaningful supplemental information regarding our financial results, since a charge of such an amount is not comparable among the periods. This is consistent with how our management reviews and assesses Equifax's historical performance and is useful when planning, forecasting, and analyzing future periods.
Income tax effects of stock awards that are recognized upon vesting or settlement - During the third quarter of 2025 and 2024, we recorded a tax benefit of $0.5 million and $3.1 million, respectively, related to the tax effects of deductions for stock compensation in excess of amounts recorded for compensation costs. Management believes excluding this tax effect from financial results provides meaningful supplemental information regarding our financial results for the three months ended September 30, 2025 and 2024 because these amounts are non-operating and relate to income tax benefits or deficiencies for stock awards recognized when tax amounts differ from recognized stock compensation cost. This is consistent with how management reviews and assesses Equifax's historical performance and is useful when planning, forecasting and analyzing future periods.
Argentina highly inflationary foreign currency adjustment - Argentina experienced multiple periods of increasing inflation rates, devaluation of the peso, and increasing borrowing rates. As such, Argentina was deemed a highly inflationary economy by accounting policymakers. We recorded a foreign currency loss of $0.7 million and $0.3 million during the third quarter of 2025 and 2024, respectively, as a result of remeasuring the peso denominated monetary assets and liabilities due to Argentina being highly inflationary. Management believes excluding this charge is useful as it allows investors to evaluate our performance for different periods on a more comparable basis. This is consistent with how management reviews and assesses Equifax's historical performance and is useful when planning, forecasting and analyzing future periods.
Charge related to the realignment of resources and other costs - During the third quarter of 2025, we recorded $43.9 million ($32.8 million, net of tax) of restructuring charges for the realignment of resources and other costs, which predominantly relate to the reduction of headcount to support the Company's global strategic objectives. During the third quarter of 2024, we recorded $41.6 million ($29.5 million, net of tax) of restructuring charges for the realignment of resources and other costs. These restructuring charges predominantly related to our ongoing efforts toward completion of our technology transformation in order to support the Company's strategic objectives. Management believes excluding these charges from certain financial results provides meaningful supplemental information regarding our financial results for the three months ended September 30, 2025 and 2024 since the charges are not comparable among the periods. This is consistent with how our management reviews and assesses Equifax's historical performance and is useful when planning, forecasting and analyzing future periods.
Antitrust litigation costs - Antitrust litigation costs includes legal fees to respond to antitrust litigation pertaining to our Workforce Solutions business unit. During the third quarter of 2025, we recorded costs related to antitrust litigation pertaining to our Workforce Solutions business unit in the amount of $4.3 million ($3.2 million, net of tax). Management believes excluding these charges is useful as it allows investors to evaluate our performance for different periods on a more comparable basis, as these legal matters are outside of the normal course of Equifax's continuing business operations. Management makes these adjustments to net income when measuring profitability, evaluating performance trends, setting performance objectives and calculating our return on invested capital. This is consistent with how management reviews and assesses Equifax's historical performance and is useful when planning, forecasting and analyzing future periods.
Adjusted EBITDA and EBITDA margin - Management defines adjusted EBITDA as consolidated net income attributable to Equifax plus net interest expense, income taxes, depreciation and amortization, and also excludes certain one-time items. Management believes the use of adjusted EBITDA and adjusted EBITDA margin allows investors to evaluate our performance for different periods on a more comparable basis.
SOURCE Equifax Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-21 10:506mo ago
2025-10-21 06:306mo ago
Volatus Aerospace to Launch Innovation Centre and Drone Manufacturing Hub at Mirabel to Strengthen Canada's Defence Readiness and Support NATO Allies
TORONTO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT; OTCQB: TAKOF; Frankfurt: A3DP5Y/ABB.F) (“Volatus” or the “Company”) a Canadian leader in aerial intelligence and unmanned aircraft systems, is pleased to announce today the plans to establish the Volatus Mirabel Innovation Centre and Drone Manufacturing Hub at Montréal–Mirabel International Airport. This Made-in-Canada initiative will expand sovereign, NATO-aligned drone capacity, supporting the Canadian Armed Forces (CAF) and allied requirements while strengthening Canada’s industrial and defence resilience. The project directly aligns with recent Government of Canada priorities to rebuild, rearm, and reinvest in domestic capability and secure supply chains.
Located within the Mirabel Innovation Zone, Volatus Aerospace will establish its operations inside a 200,000-square-foot advanced and secure manufacturing facility. With the support of Aéroports de Montréal (ADM), the facility is designed for scalability and efficiency, enabling serial production of Canadian-built drone platforms to meet the growing needs of domestic defence programmes and allied markets.
The Mirabel Manufacturing Hub will enable serial production of Volatus’ proprietary drone platforms as well as the licensed manufacture of partner systems to meet NATO-aligned requirements and Canadian end-use needs. The hub will operate through a secure, domestic supply chain with full configuration control, quality assurance, and export compliance under applicable Canadian and allied regulatory frameworks.
“Investissement Québec International is proud to support Volatus in establishing its innovation center in Mirabel, at the heart of Québec’s aerospace ecosystem. This announcement underscores the value of our efforts to attract and assist companies that actively contribute to the vitality of one of the most dynamic sectors of our economy,” said Hubert Bolduc, President, Investissement Québec International.
“By combining an Innovation Centre for rapid integration and qualification with a dedicated Manufacturing Hub for serial production, Mirabel will become our anchor for Canadian-made, defence-grade drones,” said Glen Lynch, CEO of Volatus Aerospace Inc. “Our focus is to accelerate readiness for CAF missions, ISR, maritime, Arctic, and base security, while ensuring interoperable capability for NATO partners and a resilient Canadian supply chain.”
Recent federal initiatives underscore Canada’s growing commitment to domestic defence capability and the strategic importance of uncrewed systems. In 2025, the Government of Canada launched the new Defence Investment Agency to streamline major procurements, pledged $500 million in NATO-aligned support for Ukraine, and advanced multiple RPAS and C-UAS programmes, including the Skyranger R70 donation and Halifax-class maritime UAS contracts. With defence spending now targeting 2% of GDP, Canada is signalling sustained demand for Made-in-Canada deployable drone solutions at scale.
“These actions confirm that demand for drone capability is accelerating across CAF and NATO missions,” added Lynch. “Mirabel positions Volatus to respond decisively with Canadian production, allied interoperability, and a secure supply chain.”
This announcement marks the first in a series as Volatus strengthens its domestic defence manufacturing posture and collaborates with federal and provincial partners to build sovereign, Made-in-Canada capability.
About Volatus Aerospace Inc.
With more than a century of combined aviation expertise, Volatus Aerospace delivers innovative aerial solutions for intelligence, surveillance, and cargo, utilizing both piloted and remotely piloted aircraft (RPAS/drones). Volatus provides a complete ecosystem of aerial services, including operations, equipment sales, training, and mission support, helping industries integrate aerial capabilities safely, efficiently, and sustainably.
For additional Information, please contact:
Bill Mitoulas, Investor Relations
+1-416-479-9547 [email protected]
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.
Forward Looking Information
This news release contains statements that constitute "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs, and current expectations of the Company with respect to future business activities and operating performance. Often, but not always, forward-looking information and forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results "may", "could", "would", "might" or "will" (or other variations of the foregoing) be taken, occur, be achieved, or come to pass.
Forward-looking information is based on currently available competitive, financial, and economic data and operating plans, strategies, or beliefs of management as of the date of this news release, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors may be based on information currently available to the Company, including information obtained from third-party industry analysts and other third-party sources, and are based on management's current expectations or beliefs.
Any and all forward-looking information contained in this news release is expressly qualified by this cautionary statement. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Forward-looking information and forward-looking statements reflect the Company's current beliefs and is based on information currently available to it and on assumptions it believes to be not unreasonable in light of all of the circumstances. In some instances, material factors or assumptions are discussed in this news release in connection with statements containing forward-looking information. Such material factors and assumptions include, but not limited to, those factors set forth in the Company's annual and quarterly management’s discussion and analysis filed on www.sedarplus.ca. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. The forward-looking information contained herein is made as of the date of this news release and, other than as required by law, the Company disclaims any obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information.
2025-10-21 10:506mo ago
2025-10-21 06:306mo ago
Bimergen Energy Appoints Cole Johnson and Robert Brilon to be Co-CEOs
Newport Beach, CA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation [OTCQB: BESS] (“the Company” or “Bimergen”), a developer of utility-scale battery energy storage projects and an independent power provider, announced today the appointments of Cole W. Johnson and Robert J. Brilon to serve as its co-CEOs to lead the organization to the next stage of growth, effective today.
Cole W. Johnson is a highly accomplished executive with nearly two decades of experience in the energy industry. His leadership experience spans multiple sectors, including renewables, transmission, and oil and gas, where he has successfully executed and managed complex development operations. Throughout his career, Mr. Johnson has demonstrated consistent success in corporate finance, project finance, and operational execution, driving growth and profitability across diverse business lines. Since joining Bimergen last year as President and Board Director, he has been instrumental in expanding the Company’s portfolio of battery energy storage projects and securing $250 million in mezzanine and equity financing to advance developments from early stage through construction to commercial operation.
Robert J. Brilon has served as our Chief Financial Officer and Board Director since 2021 playing an instrumental role in the Company’s corporate financial management, capital structure and effectively managing SEC registrations and compliance. With additional background in operations, he has served in CEO, CFO and President capacities in several NASDAQ and NYSE listed companies spanning in several industries involving mostly AI, technology and manufacturing.
“I am honored to take on this responsibility and lead Bimergen alongside Bob into our next phase of growth,” said Cole Johnson, Co-CEO of Bimergen Energy. “We’ve recently secured $250 million in mezzanine and equity financing, unlocking over $1 billion in Tier-1 capacity to finance construction and equipment procurement. Bimergen is positioned for sustainable and scalable growth with strong upside potential. I believe our track record over the past year reflects the culture and drive of our team, and we’re excited for what lies ahead at Bimergen. Bob and I have worked together for the past 18 months, and I’m excited to continue building on that same success moving forward.”
Robert (Bob) Brilon, Chief Financial Officer and Co-CEO of Bimergen Energy commented “We find ourselves at a pivotal juncture for Bimergen, where our seasoned management team is executing our plan to bring 23 battery energy storage system development projects to be 2 Giga Watts of operational energy arbitrage revenues. The pieces to the puzzle are being assembled, with the most difficult piece, $250 million of project equity and mezzanine financing committed we are excited about our future success. I look forward to leading Bimergen with Cole as we are a good team with complimentary executive skill sets. As a team, we understand that besides execution of our operations we will communicate to our shareholders and future shareholders the progress and opportunities that we can capitalize on to enhance shareholder value in the near and long term.”
“In their expanded roles, our co-CEOs, Cole and Bob, offer extensive expertise in business operations and financial strategy within the BESS industry. With a proven history of driving revenue and achieving profitable growth, we are confident that they will foster accelerated and sustainable growth for our business where prudent financial and operational decisions will be crucial for long-term growth,” stated Benjamin Tran, Executive Chairman of Bimergen Energy.
About Bimergen Energy Corporation
Bimergen Energy Corporation [OTCQB: BESS] is a utility-scale Battery Energy Storage System (BESS) asset owner, project developer, and independent power provider focused on capitalizing on the demand for grid reliability and reducing energy price volatility. Bimergen partners with institutional investors to finance, construct, and operate energy storage facilities under long-term offtake agreements that ensure stable, contract-backed revenue. For more information, visit www.bimergen.com.
This press release may include, and oral statements made from time to time by representatives of the Company may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filing with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s filings with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact:
Dave Gentry
RedChip Companies Inc.
1-407-644-4256 | 1-800-REDCHIP (733-2447) [email protected]
2025-10-21 10:506mo ago
2025-10-21 06:306mo ago
BranchOut Food Reports Record Q3; Achieves $16M Annualized Production Run Rate, Current Notes Payable Cut by 92%
Record production – September was the highest output month in company history, producing over 38,500 kg of finished product, a $16M annualized run rate reaching the company’s estimated breakeven production level.Strong revenue – Q3 revenue reached approximately $3.2 million, bringing year-to-date revenue to $9.7 million, up 93% year over year.ATM program completed – The company successfully completed its At-The-Market (ATM) equity program, significantly strengthening the balance sheet.Current notes payable reduced by over 92% – Current notes payable declined from $6.39 million to approximately $0.5 million, with the remaining balance expected to be repaid shortly.Strawberry product success – The new strawberry item ranked among the top 10 best-selling products in its club category, earning national attention within the retailer’s organization.Capacity expansion – Committed to purchasing an additional EnWave REV™ 120kW machine, which will significantly increase production capacity to meet anticipated 2026 demand. BEND, Ore., Oct. 21, 2025 (GLOBE NEWSWIRE) -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in patented GentleDry™ dehydrated fruit and vegetable snacks, today announced record operational and financial results for the third quarter of 2025, highlighting major progress toward profitability, balance sheet strength, and capacity expansion.
Record Output Delivers $16 Million Production Run Rate Milestone
September marked the highest production month in BranchOut’s history, with more than 38,500 kilograms of finished product, reaching the company’s breakeven production level and establishing a $16 million annualized run rate. The Peru facility continues to make strong progress in scaling production, supporting multiple large warehouse club programs, as well as growing demand from industrial and retail customers.
During the quarter, BranchOut scaled up production of its strawberry item for a large warehouse club order in the Los Angeles region, as well as for its ingredient customer. The product initially proved technically challenging and costly to produce at scale, but the effort ultimately paid off. The team successfully optimized the process, achieving efficient, consistent production and establishing a reliable model for future strawberry runs. The item delivered exceptional sales velocity in the LA club region, ranking among the top 10 selling items and gaining national visibility within the club organization.
“This has been a transformative quarter,” said Eric Healy, CEO of BranchOut Food. “This year, and this quarter in particular, was defined by extensive scale-up and R&D efforts across our entire product portfolio. Each time we launch a new product, we invest heavily in the scale-up process to ensure quality, consistency, and efficiency. These efforts often extend production timelines and, in many cases, require air shipping to meet strict customer delivery dates.
Our third quarter marks a true turning point. With most of our R&D and scale-up investments now behind us, operations are positioned for greater efficiency and improved cost performance as we continue to scale.”
Throughout 2025, the company focused on building a strong foundation, establishing its full range of a dozen-plus products and mastering the production process for each. With that work now largely complete, BranchOut does not anticipate needing to repeat these scale-up investments. The company achieved a 17% gross margin for the quarter; however, excluding air shipments and transitioning to ocean freight, margins would be closer to 30%. Looking ahead, with R&D and scale-up efforts mostly behind it, production efficiencies are expected to increase substantially. Any new orders that lift output beyond 38,500 kilograms will be above breakeven and add approximately 50% contribution margin, positioning BranchOut for significantly stronger profitability in 2026.
Financial Highlights
Third quarter revenue totaled approximately $3.2 million, bringing year-to-date revenue to about $9.7 million, representing strong growth versus the prior year.
The company completed its ATM equity program during the quarter, providing growth capital while strengthening the balance sheet. As a result, current notes payable decreased from $6.39 million to just $0.5 million, a reduction of over 92%, with the remaining balance expected to be repaid shortly.
Healy added: “With a cleaner balance sheet, record output, and rising demand across multiple channels, we’re entering 2026 with the foundation built and the engine ready. The next 12 months will be about accelerating scale, driving profitability, and solidifying BranchOut as the category defining brand in dehydrated snacks.”
Growth Outlook and Capacity Expansion
In response to strong and growing demand, BranchOut has committed to purchasing an additional EnWave REV™ 120kW machine, which will further expand production capacity substantially in early 2026. Along with this investment, the company secured global exclusive rights to produce dragon fruit using EnWave’s REV™ technology. Dragon fruit is an emerging trend in the healthy snack and ingredient markets, and BranchOut is already engaged in several large sales opportunities centered around this product.
The company is also in advanced discussions with several of the nation’s largest retailers across multiple channels, in addition to its current customer base, setting the stage for an exceptional 2026.
Leadership Expansion
BranchOut is excited to announce the hiring of Jesse Thomas as Chief Marketing Officer following the successful completion of his contract role with the Company. Mr. Thomas brings extensive consumer-packaged-goods and e-commerce experience, having previously founded and sold his own CPG company. His focus will be on expanding BranchOut’s e-commerce initiatives and building out its retail brand strategy.
In connection with his appointment, the Company’s Compensation Committee approved the grant to Mr. Thomas of a stock option to purchase 50,000 shares of BranchOut common stock as an inducement material to Mr. Thomas entering into employment with the Company, in accordance with NASDAQ Listing Rule 5635(c)(4). The stock option has an exercise price per share equal to $2.09, the closing price of BranchOut’s common stock on the Nasdaq Capital Market on the date of grant, and vests in equal monthly installments over the three-year period following the date of grant, subject to continued employment on each vesting date.
BranchOut also announced the appointment of Jesse Thomas as Chief Marketing Officer, following his successful contract tenure. Thomas, founder of a CPG brand acquired by Laird Superfood, will lead BranchOut’s direct to consumer and digital brand strategy as the company expands its retail and e-commerce presence.
About BranchOut Food Inc.
BranchOut Food is a leading international food technology company, specializing in the production of high-quality dehydrated fruit and vegetable-based products through its proprietary GentleDry Technology. This next-generation dehydration method preserves up to 95% of the original nutrition of fresh produce, offering superior quality and taste. Protected by over 17 patents, BranchOut’s technology enables it to stand out as a trusted brand, ingredient and a private-label supplier. For more information, visit www.branchoutfood.com or follow us on social media here.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts of future events. Forward-looking statements may be identified using words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate", "plan," “position”, "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements with respect to the operations of BranchOut Food, Inc., (the Company) strategies, prospects and other aspects of the business of the Company are based on current expectations that are subject to known and unknown risks and uncertainties, which could cause actual results or outcomes to differ materially from expectations expressed or implied by such forward-looking statements. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Although it may voluntarily do so from time to time, the Company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.
2025-10-21 10:506mo ago
2025-10-21 06:306mo ago
Coca-Cola is about to report earnings. Here's what to expect
Coca-Cola is expected to announce its fiscal third-quarter earnings before the bell on Tuesday.
Here's what Wall Street analysts surveyed by LSEG are expecting the beverage giant to report:
Earnings per share: 78 cents expectedRevenue: $12.39 billion expectedIn recent quarters, Coke has reported weaker demand in some key markets, like the U.S. and Latin America. Still, analysts are broadly more bullish on the company than its rival PepsiCo, which is beginning a turnaround focused on reinvesting in its brands and cutting costs. Earlier this month, Pepsi reported better-than-expected quarterly earnings and revenue, despite another three months of weaker volume for its snacks and drinks.
For the full year, Coke is expecting comparable earnings per share to rise 3% and organic revenue growth of 5% to 6%.
The beverage giant is also reportedly looking to sell Costa Coffee, the British coffee chain it acquired in 2019 for $4.9 billion. Last quarter, Coke CEO James Quincey said that the company's investment in Costa hasn't yielded the growth in its ready-to-drink coffee and at-home Express machines that Coke expected at the time of the acquisition.
Shares of Coke have risen nearly 10% this year, increasing its market value to about $295 billion.
2025-10-21 10:506mo ago
2025-10-21 06:316mo ago
Lineage: Leading Cold-Storage REIT Trading At Fire-Sale Prices
SummaryLineage, the largest temperature-controlled warehouse REIT, is trading near all-time lows since 2024's IPO due to industry headwinds and recent guidance cuts.LINE maintains a solid 5.3% dividend yield with a sustainable payout ratio that could soon increase, and continues to invest in growth through partnerships and acquisitions.The stock trades at a significant discount to NAV, offering potential upside if occupancy rates improve and macroeconomic conditions become more favorable.I rate LINE a Buy for its resilient business model, industry leadership, and attractive valuation, while acknowledging ongoing risks from economic uncertainty.sinceLF/iStock via Getty Images
Introduction & Financials Lineage, Inc. (NASDAQ:LINE) serves over 13,000 customers across 19 countries through their warehouses, being the largest temperature-controlled warehouse REIT in the US and globally. Since LINE's IPO back in late July 2024, the stock is
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in LINE over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-10-21 10:506mo ago
2025-10-21 06:326mo ago
BranchOut Food Reports Record Q3; Achieves $16M Annualized Production Run Rate, Current Notes Payable Cut by 92%
Record production – September was the highest output month in company history, producing over 38,500 kg of finished product, a $16M annualized run rate reaching the company’s estimated breakeven production level.
Strong revenue – Q3 revenue reached approximately $3.2 million, bringing year-to-date revenue to $9.7 million, up 93% year over year.
ATM program completed – The company successfully completed its At-The-Market (ATM) equity program, significantly strengthening the balance sheet.
Current notes payable reduced by over 92% – Current notes payable declined from $6.39 million to approximately $0.5 million, with the remaining balance expected to be repaid shortly.
Strawberry product success – The new strawberry item ranked among the top 10 best-selling products in its club category, earning national attention within the retailer’s organization.
Capacity expansion – Committed to purchasing an additional EnWave REV™ 120kW machine, which will significantly increase production capacity to meet anticipated 2026 demand.
BEND, Ore., Oct. 21, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in patented GentleDry™ dehydrated fruit and vegetable snacks, today announced record operational and financial results for the third quarter of 2025, highlighting major progress toward profitability, balance sheet strength, and capacity expansion.
Record Output Delivers $16 Million Production Run Rate Milestone
September marked the highest production month in BranchOut’s history, with more than 38,500 kilograms of finished product, reaching the company’s breakeven production level and establishing a $16 million annualized run rate. The Peru facility continues to make strong progress in scaling production, supporting multiple large warehouse club programs, as well as growing demand from industrial and retail customers.
During the quarter, BranchOut scaled up production of its strawberry item for a large warehouse club order in the Los Angeles region, as well as for its ingredient customer. The product initially proved technically challenging and costly to produce at scale, but the effort ultimately paid off. The team successfully optimized the process, achieving efficient, consistent production and establishing a reliable model for future strawberry runs. The item delivered exceptional sales velocity in the LA club region, ranking among the top 10 selling items and gaining national visibility within the club organization.
“This has been a transformative quarter,” said Eric Healy, CEO of BranchOut Food. “This year, and this quarter in particular, was defined by extensive scale-up and R&D efforts across our entire product portfolio. Each time we launch a new product, we invest heavily in the scale-up process to ensure quality, consistency, and efficiency. These efforts often extend production timelines and, in many cases, require air shipping to meet strict customer delivery dates.
Our third quarter marks a true turning point. With most of our R&D and scale-up investments now behind us, operations are positioned for greater efficiency and improved cost performance as we continue to scale.”
Throughout 2025, the company focused on building a strong foundation, establishing its full range of a dozen-plus products and mastering the production process for each. With that work now largely complete, BranchOut does not anticipate needing to repeat these scale-up investments. The company achieved a 17% gross margin for the quarter; however, excluding air shipments and transitioning to ocean freight, margins would be closer to 30%. Looking ahead, with R&D and scale-up efforts mostly behind it, production efficiencies are expected to increase substantially. Any new orders that lift output beyond 38,500 kilograms will be above breakeven and add approximately 50% contribution margin, positioning BranchOut for significantly stronger profitability in 2026.
Financial Highlights
Third quarter revenue totaled approximately $3.2 million, bringing year-to-date revenue to about $9.7 million, representing strong growth versus the prior year.
The company completed its ATM equity program during the quarter, providing growth capital while strengthening the balance sheet. As a result, current notes payable decreased from $6.39 million to just $0.5 million, a reduction of over 92%, with the remaining balance expected to be repaid shortly.
Healy added: “With a cleaner balance sheet, record output, and rising demand across multiple channels, we’re entering 2026 with the foundation built and the engine ready. The next 12 months will be about accelerating scale, driving profitability, and solidifying BranchOut as the category-defining brand in dehydrated snacks.”
Growth Outlook and Capacity Expansion
In response to strong and growing demand, BranchOut has committed to purchasing an additional EnWave REV™ 120kW machine, which will further expand production capacity substantially in early 2026. Along with this investment, the company secured global exclusive rights to produce dragon fruit using EnWave’s REV™ technology. Dragon fruit is an emerging trend in the healthy snack and ingredient markets, and BranchOut is already engaged in several large sales opportunities centered around this product.
The company is also in advanced discussions with several of the nation’s largest retailers across multiple channels, in addition to its current customer base, setting the stage for an exceptional 2026.
Leadership Expansion
BranchOut is excited to announce the hiring of Jesse Thomas as Chief Marketing Officer following the successful completion of his contract role with the Company. Mr. Thomas brings extensive consumer-packaged-goods and e-commerce experience, having previously founded and sold his own CPG company. His focus will be on expanding BranchOut’s e-commerce initiatives and building out its retail brand strategy.
In connection with his appointment, the Company’s Compensation Committee approved the grant to Mr. Thomas of a stock option to purchase 50,000 shares of BranchOut common stock as an inducement material to Mr. Thomas’s entering into employment with the Company, in accordance with NASDAQ Listing Rule 5635(c)(4). The stock option has an exercise price per share equal to $2.09, the closing price of BranchOut’s common stock on the Nasdaq Capital Market on the date of grant, and vests in equal monthly installments over the three-year period following the date of grant, subject to continued employment on each vesting date.
BranchOut also announced the appointment of Jesse Thomas as Chief Marketing Officer, following his successful contract tenure. Thomas, founder of a CPG brand acquired by Laird Superfood, will lead BranchOut’s direct to consumer and digital brand strategy as the company expands its retail and e-commerce presence.
About BranchOut Food Inc.
BranchOut Food is a leading international food technology company, specializing in the production of high-quality dehydrated fruit and vegetable-based products through its proprietary GentleDry Technology. This next-generation dehydration method preserves up to 95% of the original nutrition of fresh produce, offering superior quality and taste. Protected by over 17 patents, BranchOut’s technology enables it to stand out as a trusted brand, ingredient and a private-label supplier. For more information, visit www.branchoutfood.com or follow us on social media here.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts of future events. Forward-looking statements may be identified using words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate”, “plan,” “position”, “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements with respect to the operations of BranchOut Food, Inc., (the Company) strategies, prospects and other aspects of the business of the Company are based on current expectations that are subject to known and unknown risks and uncertainties, which could cause actual results or outcomes to differ materially from expectations expressed or implied by such forward-looking statements. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Although it may voluntarily do so from time to time, the Company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.
The logo of General Motors is pictured in Santa Ana Tlapaltitlan, Mexico, July 29, 2025. REUTERS/Raquel Cunha/File Photo Purchase Licensing Rights, opens new tab
CompaniesOct 21 (Reuters) - General Motors
(GM.N), opens new tab lifted its financial outlook for the year and slightly lowered its expected hit from tariffs, as the automaker settles into a more stable trade landscape while confronting a dynamic electric vehicle market and new supply-chain snarls.
The company now expects its annual adjusted core profit to be between $12.0 billion to $13.0 billion, compared with its prior estimate of $10.0 billion to $12.5 billion. The Detroit automaker said tariffs would hit its bottom line less than anticipated, lowering its updated impact to a range of $3.5 billion to $4.5 billion, from a previous $4 billion to $5 billion.
Sign up here.
Shares rose 6% in premarket trading.
The auto giant earlier this month took a $1.6 billion charge from changes to its EV strategy. At the end of September, a $7,500 tax credit on battery-powered models went away, and there has been further loosening of regulations around vehicle emissions.
In a letter to shareholders, GM CEO Mary Barra said she expects the company to incur future charges related to EVs.
“By acting swiftly and decisively to address overcapacity, we expect to reduce EV losses in 2026 and beyond,” she said.
Revenue for the quarter ended September marginally fell to $48.6 billion from a year earlier.
Reporting by Nathan Gomes and Nora Eckert; Editing by Shilpi Majumdar and Nick Zieminski
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Atos SE (OTCPK:AEXAY) Q3 2025 Sales Call October 21, 2025 2:00 AM EDT
Company Participants
Philippe Salle - Chairman of the Board & CEO
Jacques-François de Prest - CFO & Member of Executive Board
Conference Call Participants
Frederic Boulan - BofA Securities, Research Division
Nicolas David - ODDO BHF Corporate & Markets, Research Division
Laurent Daure - Kepler Cheuvreux, Research Division
Sam Morton
Presentation
Operator
Ladies and gentlemen, welcome to the Atos Group Third Quarter 2025 Performance. The call will be structured in 2 parts. First, a presentation by the Atos Group management team represented by Philippe Salle, Chairman and CEO; and Jacques-François de Prest, CFO. [Operator Instructions]. I will now hand over to the management team. Gentlemen, please go ahead.
Philippe Salle
Chairman of the Board & CEO
Thank you, operator. Good morning, everybody, or good afternoon for some of you in Asia. So we're going to do a presentation and then after that, of course, taking all the questions you have. I'm, of course, together with Jacques-François, the CFO of the group; and Marie the IR of the group.
So let's start with the first slide. So we're going to -- go on one more. Okay. Perfect. So in Q3, first, the performance is in line, I would say, with the full year profitability and cash trajectory. I think it's very important. I understand, in fact, that probably the team has the credit on cash and cost. And of course, we're going -- we are spending now quite a lot of time, I would say, on the top line, and I will give you more info during this call. The second is on bottom left, the Genesis plan is in motion to restore the strong financial performance. I just want to highlight that Genesis, it's a 2-part project for me.
Recommended For You
2025-10-21 10:506mo ago
2025-10-21 06:346mo ago
Getinge AB (publ) (GNGBY) Q3 2025 Earnings Call Transcript
Getinge AB (publ) (OTCPK:GNGBY) Q3 2025 Earnings Call October 21, 2025 4:00 AM EDT
Company Participants
Mattias Perjos - CEO, President & Director
Agneta Palmer - Chief Financial Officer
Conference Call Participants
Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division
Mattias Vadsten - SEB, Research Division
Sten Gustafsson - ABG Sundal Collier Holding ASA, Research Division
Erik Cassel - Danske Bank A/S, Research Division
Ludvig Lundgren - Nordea Markets, Research Division
Ludwig Germunder - Handelsbanken Capital Markets AB, Research Division
Presentation
Operator
Welcome to the Getinge Q3 Report 2025 Presentation.
[Operator Instructions] Now I will hand the conference over to the speakers CEO, Mattias Perjos; and CFO, Agneta Palmer. Please go ahead.
Mattias Perjos
CEO, President & Director
Thank you very much, and welcome, everyone, to today's conference. Today, we will first look into our performance in the third quarter and then also reflect a bit on the current market situation and our expectations for the remainder of 2025.
So we can move over to Page #2, please. So if we start then by looking at the development of some of our long-term or strategic KPIs, we can see that we continue to clearly track in line with our plan to increase the share of sales from recurring revenue products and also accelerating the share of sales from high-margin products, like our Paragonix offering, our ECLS portfolio, consumables in infection prevention and BetaBags in Sterile Transfer. This is all supported by solid and effective quality processes as well. Sales from recurring revenue is now at 65% and the high-margin products make up more than 2/3 of sales today. When it comes to quality, the number of field actions in relation to sales has decreased significantly, and we see this positive trend to continue also in the third quarter of this year. These improvements should, of course, be achieved through responsible leverage and an attractive long-term return on invested capital.
Recommended For You
2025-10-21 10:506mo ago
2025-10-21 06:356mo ago
GM Financial Reports Third Quarter 2025 Operating Results
Third quarter net income of $589 millionThird quarter retail loan and operating lease originations of $13.8 billionEarning assets of $126.5 billion at September 30, 2025Available liquidity of $37.2 billion at September 30, 2025
FORT WORTH, Texas--(BUSINESS WIRE)--GENERAL MOTORS FINANCIAL COMPANY, INC. (“GM Financial” or the “Company”) announced net income of $589 million for the quarter ended September 30, 2025, compared to $499 million for the quarter ended September 30, 2024. Net income was $1.6 billion for both the nine months ended September 30, 2025 and September 30, 2024.
Retail loan originations were $8.8 billion for the quarter ended September 30, 2025, compared to $9.5 billion for the quarter ended June 30, 2025, and $9.4 billion for the quarter ended September 30, 2024. Retail loan originations for the nine months ended September 30, 2025 were $27.9 billion, compared to $26.3 billion for the nine months ended September 30, 2024. The outstanding balance of retail finance receivables was $75.9 billion at September 30, 2025, compared to $77.8 billion at June 30, 2025 and $74.4 billion at September 30, 2024.
Operating lease originations were $5.0 billion for the quarter ended September 30, 2025, compared to $5.4 billion for the quarter ended June 30, 2025 and $4.9 billion for the quarter ended September 30, 2024. Operating lease originations for the nine months ended September 30, 2025 were $15.3 billion, compared to $14.1 billion for the nine months ended September 30, 2024. Leased vehicles, net was $33.6 billion at September 30, 2025, compared to $33.2 billion at June 30, 2025 and $31.0 billion at September 30, 2024.
The outstanding balance of commercial finance receivables was $17.1 billion at September 30, 2025, compared to $16.7 billion at June 30, 2025 and $19.0 billion at September 30, 2024.
Retail finance receivables 31-60 days delinquent were 2.3% of the portfolio at both September 30, 2025 and September 30, 2024. Accounts more than 60 days delinquent were 0.9% of the portfolio at September 30, 2025 and 0.8% at September 30, 2024.
Annualized net charge-offs were 1.2% of average retail finance receivables for both the quarters ended September 30, 2025 and September 30, 2024. For the nine months ended September 30, 2025, annualized retail net charge-offs were 1.2%, compared to 1.1% for the nine months ended September 30, 2024.
The Company had total available liquidity of $37.2 billion at September 30, 2025, consisting of $7.8 billion of cash and cash equivalents, $25.4 billion of borrowing capacity on unpledged eligible assets, $0.9 billion of borrowing capacity on committed unsecured lines of credit, $1.0 billion of borrowing capacity on the Junior Subordinated Revolving Credit Facility from GM, and $2.0 billion of borrowing capacity on the GM Revolving 364-Day Credit Facility.
About GM Financial
General Motors Financial Company, Inc. is the wholly owned captive finance subsidiary of General Motors Company and is headquartered in Fort Worth, Texas. Additional materials addressing the Company’s results of operations for the quarter ended September 30, 2025 can be accessed via the Investor Relations section of the Company’s website at https://investor.gmfinancial.com.
General Motors Financial Company, Inc.
Condensed Consolidated Statements of Income
(Unaudited, in millions)
Three Months Ended September
30,
Nine Months Ended September
30,
2025
2024
2025
2024
Revenue
Finance charge income
$
2,060
$
1,965
$
6,132
$
5,627
Leased vehicle income
1,968
1,828
5,810
5,431
Other income
309
238
813
702
Total revenue
4,337
4,031
12,755
11,760
Costs and expenses
Operating expenses
545
478
1,581
1,416
Leased vehicle expenses
1,101
1,027
3,206
3,046
Provision for loan losses
244
298
926
676
Interest expense
1,651
1,550
4,886
4,431
Total costs and expenses
3,542
3,354
10,599
9,569
Equity income (loss)
9
10
37
55
Income (loss) before income taxes
804
687
2,193
2,246
Income tax expense (benefit)
215
189
594
601
Net income (loss)
589
499
1,598
1,646
Less: cumulative dividends on preferred stock
30
30
89
89
Net income (loss) attributable to common shareholder
$
560
$
469
$
1,510
$
1,557
Amounts may not add due to rounding.
Condensed Consolidated Balance Sheets
(Unaudited, in millions)
September 30, 2025
December 31, 2024
ASSETS
Cash and cash equivalents
$
7,820
$
5,094
Finance receivables, net of allowance for loan losses of $2,736 and $2,458
90,202
93,510
Leased vehicles, net
33,609
31,586
Goodwill and intangible assets
1,178
1,169
Equity in net assets of nonconsolidated affiliates
1,095
1,206
Related party receivables
613
473
Other assets
8,164
7,992
Total assets
$
142,680
$
141,030
LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities
Secured debt
$
49,394
$
49,573
Unsecured debt
66,994
64,691
Deferred income
2,535
2,389
Related party payables
317
106
Other liabilities
7,635
9,079
Total liabilities
126,876
125,838
Total shareholders' equity
15,804
15,193
Total liabilities and shareholders' equity
$
142,680
$
141,030
Amounts may not add due to rounding.
Operational and Financial Data
(Unaudited, Dollars in millions)
Amounts may not add due to rounding
Three Months Ended September
30,
Nine Months Ended September
30,
Originations
2025
2024
2025
2024
Retail finance receivables originations
$
8,812
$
9,371
$
27,910
$
26,323
Lease originations
4,956
4,874
15,338
14,146
Total originations
$
13,768
$
14,245
$
43,248
$
40,469
Three Months Ended September
30,
Nine Months Ended September
30,
Average Earning Assets
2025
2024
2025
2024
Average retail finance receivables
$
76,799
$
73,944
$
77,098
$
73,455
Average commercial finance receivables
16,589
17,449
17,138
15,770
Average finance receivables
93,388
91,393
94,236
89,225
Average leased vehicles, net
33,377
30,624
32,698
30,414
Average earning assets
$
126,765
$
122,017
$
126,934
$
119,638
Ending Earning Assets
September 30, 2025
December 31, 2024
Retail finance receivables
$
75,857
$
76,066
Commercial finance receivables
17,081
19,901
Leased vehicles, net
33,609
31,586
Ending earning assets
$
126,547
$
127,554
Finance Receivables
September 30, 2025
December 31, 2024
Retail
Retail finance receivables
$
75,857
$
76,066
Less: allowance for loan losses
(2,651
)
(2,400
)
Total retail finance receivables, net
73,206
73,667
Commercial
Commercial finance receivables
17,081
19,901
Less: allowance for loan losses
(85
)
(58
)
Total commercial finance receivables, net
16,996
19,843
Total finance receivables, net
$
90,202
$
93,510
Allowance for Loan Losses
September 30, 2025
December 31, 2024
Allowance for loan losses as a percentage of retail finance receivables
3.5
%
3.2
%
Allowance for loan losses as a percentage of commercial finance receivables
0.5
%
0.3
%
Delinquencies
September 30, 2025
September 30, 2024
Loan delinquency as a percentage of retail finance receivables:
31 - 60 days
2.3
%
2.3
%
Greater than 60 days
0.9
0.8
Total
3.2
%
3.1
%
Three Months Ended September
30,
Nine Months Ended September
30,
Charge-offs and Recoveries
2025
2024
2025
2024
Charge-offs
$
494
$
439
$
1,461
$
1,255
Less: recoveries
(257
)
(217
)
(778
)
(652
)
Net charge-offs
$
237
$
222
$
683
$
604
Net charge-offs as an annualized percentage of average retail finance receivables
1.2
%
1.2
%
1.2
%
1.1
%
Three Months Ended September
30,
Nine Months Ended September
30,
Operating Expenses
2025
2024
2025
2024
Operating expenses as an annualized percentage of average earning assets
1.7
%
1.6
%
1.7
%
1.6
%
More News From General Motors Financial Company, Inc.
Back to Newsroom
2025-10-21 10:506mo ago
2025-10-21 06:356mo ago
Here's What Traders Expect Intel Stock To Do After Earnings This Week
Key Takeaways
Intel shares are expected to see an above-average move after the chipmaker reports third-quarter results Thursday afternoon. Thursday's report will be the company's first since it agreed to give the federal government a nearly 10% stake, a deal that's attracted investors like AI chip giant Nvidia and buoyed Intel's stock.
Intel (INTC) is set to report third-quarter earnings after markets close Thursday, and traders expect the stock to be unusually volatile following the results.
Intel shares are expected to move nearly 10% in either direction the day after this week’s earnings report, according to recent options prices. A jump of that magnitude, based on Monday's closing price, would put shares at about $42, their highest price since April 2024. Alternately, shares could decline 10% to end the week at just above $32.
Intel shares have moved an average of 6.5% after its four most recent earnings reports. In July, the stock dropped more than 8% after it reported an unexpected loss and issued a disappointing third-quarter forecast. The last time Intel shares rose on an earnings report was this time last year, when the company touted “solid progress” on its turnaround plan.
Why This Is Important
Intel's stock has surged in recent months, boosted by optimism about the federal government's stake in the chipmaker and what it means for its troubled foundry business. Expectations for a large post-earnings move likely reflect the stock's recent run-up and uncertainty about how recent investments will affect operations in the near term.
Thursday’s report will be Intel’s first since the federal government took an approximately 10% stake in the company. That deal with the Trump administration may have been a turning point for the embattled chipmaker, which has since received additional investments from Japanese venture capital firm SoftBank and AI chip giant Nvidia (NVDA), with whom Intel will partner on custom hardware.
During the post-earnings conference call on Thursday, investors will be hoping for updates from executives on those investments and whether they change the outlook for Intel's struggling foundry business
The deals have at least been a lifeline for Intel’s stock, which was treading water until rumors of White House negotiations began to circulate in early August. Intel shares have risen 90% since the start of the year, and all of those gains have come in the last three months.
Still, analysts are on the whole skeptical that the stock can maintain its recent momentum. Five of the seven analysts with current ratings tracked by Visible Alpha have assigned Intel stock a “Hold” rating, while two suggest selling. The average price target of about $30.60 represents nearly 20% downside from Monday's closing level.
Do you have a news tip for Investopedia reporters? Please email us at
[email protected]
2025-10-21 10:506mo ago
2025-10-21 06:366mo ago
Northrop Grumman Releases Third Quarter 2025 Financial Results
FALLS CHURCH, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) has released its third quarter 2025 financial results. A copy of the earnings release has been furnished in the company’s Form 8-K filing and is also available on the company's investor relations website at http://investor.northropgrumman.com.
Earnings Call Webcast
As previously announced, Northrop Grumman will webcast its earnings conference call at 9:30 a.m. Eastern time today. A live audio broadcast of the conference call will be available on http://investor.northropgrumman.com.
About Northrop Grumman
Northrop Grumman is a leading global aerospace and defense technology company. Our pioneering solutions equip our customers with the capabilities they need to connect and protect the world, and push the boundaries of human exploration across the universe. Driven by a shared purpose to solve our customers’ toughest problems, our employees define possible every day.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, Oct. 21:
CI&T Inc. (CINT - Free Report) : This strategy, design, and software engineering services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.3% over the last 60 days.
CI&T has a price-to-earnings ratio (P/E) of 13.55, compared with 13.60 for the industry. The company possesses a Value Score of A.
Newmont Corporation (NEM - Free Report) : This producer and explorer of gold and other metals carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.
Newmont has a price-to-earnings ratio (P/E) of 16.29, compared with 24.48 for the S&P 500. The company possesses a Value Score of B.
Daktronics, Inc. (DAKT - Free Report) : This electronic display systems company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.
Daktronics has a price-to-earnings ratio (P/E) of 17.94, compared with 24.48 for the S&P 500. The company possesses a Value Score of B.
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
2025-10-21 10:506mo ago
2025-10-21 06:446mo ago
HMS Networks AB (publ) (HMNKF) Q3 2025 Earnings Call Transcript
HMS Networks AB (publ) (OTCPK:HMNKF) Q3 2025 Earnings Call October 21, 2025 3:00 AM EDT
Company Participants
Staffan Dahlstrom - Co-Founder, CEO & President
Joakim Nideborn - CFO & Deputy CEO
Conference Call Participants
Simon Granath - ABG Sundal Collier Holding ASA, Research Division
Joachim Gunell - DNB Carnegie, Research Division
Gustav Berneblad - Nordea Markets, Research Division
Jesper Stugemo - Handelsbanken Capital Markets AB, Research Division
Thomas Blikstad - Pareto Securities AS, Research Division
Presentation
Operator
Welcome to the HMS Networks Q3 Presentation for 2025. [Operator Instructions]
Now I will hand the conference over to CEO, Staffan Dahlstrom; and CFO, Joakim Nideborn. Please go ahead.
Staffan Dahlstrom
Co-Founder, CEO & President
Thank you, operator. Good morning, everybody. Welcome to this quarter 3 report. Greetings from a sunny Stockholm, and we're also pleased me, Joakim, to have some sunshine in this report. And the agenda for today, is that I will do a quick snapshot of where we are and our strategy, a little bit of business update, and then Joakim will do a deep dive in the financial summary, and we finish up with some Q&A at the end.
So we published our quarter 3 this morning and some good signs, we think, good level on net sales. We are back on organic growth that really makes us happy. We also have some headwinds with currency. Joakim will dive into that later. Order intake, fantastic, plus 26%. But keep in mind that we had a quite weak quarter last year, quarter 3. So comparables are not that challenging. But still, 26% is still 26%. That's really good. And we continue to deliver good adjusted EBIT, both SEK 244 million in adjusted EBIT, but a margin of 27% is good for us, and we're very pleased to see this. We also can conclude that when we talk about adjustment in the EBIT, it's very little of this kind of reorganization things during acquisitions. So it's very
Recommended For You
2025-10-21 10:506mo ago
2025-10-21 06:456mo ago
Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Monday, November 3, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2025. A detailed press release will be issued the morning of November 3, 2025 before the securities markets open.
The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors.
ABOUT PEDIATRIX MEDICAL GROUP
Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine and neonatology complemented by multiple pediatric subspecialties. The group’s high-quality, evidence-based care is bolstered by significant investments in research, education, quality-improvement and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through approximately 4,400 affiliated physicians and other clinicians. To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn and the Pediatrix blog. Investment information can be found at www.pediatrix.com/investors.
Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to the Company’s objectives, plans, strategies and financial performance, statements regarding the amount, timing and execution of, and sources of funding for, repurchases under the repurchase program, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future . These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by the Company’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and the Company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in the Company’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well the Company’s current reports on Form 8-K, filed with the Securities and Exchange Commission, and include the impact of the Company’s practice portfolio management plans and whether the Company is able to achieve the expected favorable impact to Adjusted EBITDA therefrom; the impact of the Company’s termination of its then third-party revenue cycle management provider and transition to a hybrid revenue cycle management model with one or more new third-party service providers, including any transition costs associated therewith; the impact of surprise billing legislation; the effects of economic conditions on the Company’s business; the effects of the Affordable Care Act, the One Big Beautiful Bill Act and potential additional healthcare reform; the Company’s relationships with government-sponsored or funded healthcare programs, including Medicare and Medicaid, and with managed care organizations and commercial health insurance payors; the Company’s ability to comply with the terms of its debt financing arrangements; the impact of management transitions; the timing and contribution of future acquisitions or organic growth initiatives; the effects of share repurchases; and the effects of the Company’s transformation initiatives, including its reorientation on, and growth strategy for, its hospital-based and maternal fetal medicine businesses.
More News From Pediatrix Medical Group, Inc.
2025-10-21 10:506mo ago
2025-10-21 06:456mo ago
Unitil Schedules Third Quarter 2025 Earnings Release and Conference Call
HAMPTON, N.H., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its third quarter 2025 earnings after the market closes on November 3, 2025. Unitil will host its conference call and webcast on November 4, 2025 at 2:00 p.m. (ET) to review its quarterly results. Related presentation materials will be available before the call on the Company’s Investors page at investors.unitil.com.
The conference call will be broadcast live in listen-only mode on the Company’s Investors page at investors.unitil.com. Interested parties may access dial information for the call by registering via web link here. An archive of the webcast will be available for one year on the website at investors.unitil.com.
About Unitil Corporation
Unitil Corporation provides energy for life by safely and reliably delivering electricity and natural gas in New England. We are committed to the communities we serve and to developing people, business practices, and technologies that lead to the delivery of dependable, more efficient energy. Unitil Corporation is a public utility holding company with operations in Maine, New Hampshire and Massachusetts. Together, Unitil’s operating utilities serve approximately 109,400 electric customers and 97,600 natural gas customers. For more information about our people, technologies, and community involvement please visit unitil.com.
For more information please contact:
Christopher Goulding – Investor Relations
Phone: 603-773-6466
Email: [email protected]
, /PRNewswire/ -- Miami International Holdings, Inc. (NYSE: MIAX), a technology-driven leader in building and operating regulated financial markets across multiple asset classes, will release its financial results for the third quarter ended September 30, 2025 after the close of market trading on Wednesday, November 5, 2025. A conference call with remarks by the company's senior management will begin at 5:00 p.m. ET.
Participants can access the call at 866-652-5200 using conference ID "10203428" (international dial-in 412-317-6060. A slide presentation will be available in the "Events & Presentations" section of MIAX's website at https://ir.miaxglobal.com/ after the earnings release is issued. The call will also be available via webcast on the "Events & Presentations" section of MIAX's website or by clicking on the webcast link here.
About MIAX
Miami International Holdings, Inc. (NYSE: MIAX) is a technology-driven leader in building and operating regulated financial markets across multiple asset classes and geographies. MIAX® operates nine exchanges across options, futures, equities and international markets including MIAX® Options, MIAX Pearl®, MIAX Emerald®, MIAX Sapphire®, MIAX Pearl Equities™, MIAX Futures™, MIAXdx™, The Bermuda Stock Exchange (BSX) and The International Stock Exchange (TISE). MIAX also owns Dorman Trading, a full-service Futures Commission Merchant. To learn more about MIAX please visit www.miaxglobal.com.
Disclaimer and Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are based on management's current expectations and are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements. Additional risks and uncertainties that may cause actual results to differ materially include the risks and uncertainties listed in Miami International Holdings, Inc.'s (together with its subsidiaries, the Company) public filings with the Securities and Exchange Commission. In providing forward-looking statements, the Company is not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise.
All third-party trademarks (including logos and icons) referenced by the Company remain the property of their respective owners. Unless specifically identified as such, the Company's use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between the owners of these trademarks and the Company. Any references by the Company to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
Media Contact:
Andy Nybo, SVP, Chief Communications Officer
[email protected]
SOURCE MIAX
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-21 10:506mo ago
2025-10-21 06:456mo ago
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
Third quarter revenues of $2.82 billion, up 13.1% from 2024
Third quarter reported diluted earnings per share ("EPS") of $2.16, up 8.5% from 2024; and adjusted diluted EPS of $2.60, up 13.0% from 2024
Year-to-date cash provided by operations of $1.4 billion, up 63.1% from 2024
Full year 2025 reported diluted EPS now expected to be between $8.58 and $8.66; and adjusted diluted EPS is expected to be between $9.76 and $9.84
, /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the third quarter ended September 30, 2025.
"We delivered another quarter of robust top- and bottom-line growth, underscoring strong demand for our clinical solutions and diligent execution of our strategy," said Jim Davis, Chairman, CEO and President. "Revenues grew 13.1%, including 6.8% organic growth, driven by broad-based adoption of our clinical innovations, contributions from acquisitions, and growth in our consumer channel as we build our presence as the preferred lab engine inside top health and wellness brands. We also announced an agreement with Corewell Health to create a major lab services joint venture serving the state of Michigan. In addition, we will deploy our comprehensive Co-Lab Solutions across Corewell's nearly two dozen hospitals. Given our strong performance year-to-date, we are again raising our full year 2025 guidance."
Recent highlights:
Entered into an agreement with Corewell Health to establish a lab services joint venture in Michigan. In addition, Quest will deploy a comprehensive suite of Co-Lab Solutions, from reference testing and lab analytics to supply chain and blood management, supporting quality, innovation access and productivity. With this collaboration, annual revenues for Co-Lab Solutions are expected to reach approximately $1 billion next year as services scale across 21 Corewell hospitals.
Completed the acquisition of select dialysis testing assets from Fresenius Medical Care and, under a separate enterprise agreement, began to scale clinical lab testing for Fresenius Medical Care's U.S. dialysis centers serving approximately 200,000 dialysis patients annually.
Formed collaborations to be the lab engine inside the mobile apps of WHOOP, the human performance company, and ŌURA Health, maker of the world's leading smart ring, to serve growing consumer interest in wellness and preventive health.
Announced a collaboration with Epic to be the technology partner for Project Nova, a multi-year initiative to streamline systems and improve experiences for patients and providers, regardless of the electronic health record system they use.
Published data in Neurology® Clinical Practice on the confirmatory accuracy of two Quest AD-Detect® tests for aiding Alzheimer's disease diagnosis.
Announced collaborations that leverage Quest's national scale in phlebotomy and connectivity to broaden access to cancer-screening liquid biopsy tests.
Secured FDA breakthrough device designation for our Haystack MRD™ test and formed collaborations with Mass General Brigham and Rutgers Cancer Institute to trial Haystack MRD in guiding postoperative therapy decisions.
Named Thomas Koch, a veteran of the lab and medical device industries, to be the company's senior vice president of R&D.
Recognized as a Top Corporate Wellness Innovator by Fast Company for our leadership in employee well-being.
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
Change
2025
2024
Change
(dollars in millions, except per share data)
Reported:
Net revenues
$ 2,816
$ 2,488
13.1 %
$ 8,229
$ 7,251
13.5 %
Diagnostic Information Services revenues
$ 2,755
$ 2,427
13.5 %
$ 8,043
$ 7,058
14.0 %
Revenue per requisition
0.8 %
0.2 %
Requisition volume
12.5 %
13.8 %
Organic requisition volume
3.9 %
1.8 %
Operating income (a)
$ 386
$ 330
16.8 %
$ 1,170
$ 985
18.7 %
Operating income as a percentage of net revenues (a)
13.7 %
13.3 %
0.4 %
14.2 %
13.6 %
0.6 %
Net income attributable to Quest Diagnostics (a)
$ 245
$ 226
8.5 %
$ 747
$ 649
15.0 %
Diluted EPS (a)
$ 2.16
$ 1.99
8.5 %
$ 6.57
$ 5.74
14.5 %
Cash provided by operations
$ 563
$ 356
57.4 %
$ 1,421
$ 870
63.1 %
Capital expenditures
$ 144
$ 106
37.0 %
$ 369
$ 302
22.3 %
Adjusted (a):
Operating income
$ 458
$ 385
18.9 %
$ 1,330
$ 1,132
17.5 %
Operating income as a percentage of net revenues
16.3 %
15.5 %
0.8 %
16.2 %
15.6 %
0.6 %
Net income attributable to Quest Diagnostics
$ 296
$ 262
13.1 %
$ 845
$ 758
11.5 %
Diluted EPS
$ 2.60
$ 2.30
13.0 %
$ 7.43
$ 6.70
10.9 %
(a)
For further details impacting the year-over-year comparisons related to operating income, operating income as a percentage of net revenues, net income attributable to Quest Diagnostics, and diluted EPS, see note 2 of the financial tables attached below.
Updated Guidance for Full Year 2025
The company updates its full year 2025 guidance as follows:
Updated Guidance
Prior Guidance
Low
High
Low
High
Net revenues
$10.96 billion
$11.00 billion
$10.80 billion
$10.92 billion
Net revenues increase
11.0 %
11.4 %
9.4 %
10.6 %
Reported diluted EPS
$8.58
$8.66
$8.60
$8.80
Adjusted diluted EPS
$9.76
$9.84
$9.63
$9.83
Cash provided by operations
Approximately $1.8 billion
Approximately $1.55 billion
Capital expenditures
Approximately $500 million
Approximately $500 million
Note on Non-GAAP Financial Measures
As used in this press release the term "reported" refers to measures under accounting principles generally accepted in the United States ("GAAP"). The term "adjusted" refers to non-GAAP operating performance measures that exclude special items such as restructuring and integration charges, amortization expense, excess tax benefits ("ETB") associated with stock-based compensation, gains and losses associated with changes in the carrying value of our strategic investments, impairment charges and other items.
Non-GAAP adjusted measures are presented because management believes those measures are useful adjuncts to GAAP results. Non-GAAP adjusted measures should not be considered as an alternative to the corresponding measures determined under GAAP. Management may use these non-GAAP measures to evaluate our performance period over period and relative to competitors, to analyze the underlying trends in our business, to establish operational budgets and forecasts and for incentive compensation purposes. We believe that these non-GAAP measures are useful to investors and analysts to evaluate our performance period over period and relative to competitors, as well as to analyze the underlying trends in our business and to assess our performance. The additional tables below include reconciliations of non-GAAP adjusted measures to GAAP measures.
Conference Call Information
Quest Diagnostics will hold its quarterly conference call to discuss financial results beginning at 8:30 a.m. Eastern Time today. The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, passcode: 7895081; or via live webcast on our website at www.QuestDiagnostics.com/investor. We suggest participants dial in approximately 10 minutes before the call.
A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or, from approximately 10:30 a.m. Eastern Time on October 21, 2025 until midnight Eastern Time on November 4, 2025, by phone at 866-388-5361 for domestic callers or 203-369-0416 for international callers. Anyone listening to the call is encouraged to read our periodic reports, on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.
Forward Looking Statements
The statements in this press release which are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, uncertain and volatile economic conditions, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government policies, including related to trade, and regulations, changing relationships with customers, payers, suppliers or strategic partners, acquisitions and other factors discussed in the company's most recently filed Annual Report on Form 10-K and in any of the company's subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the "Business," "Risk Factors," "Cautionary Factors that May Affect Future Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of those reports.
This earnings release, including the attached financial tables, is available online in the Newsroom section at www.QuestDiagnostics.com.
ADDITIONAL TABLES FOLLOW
Quest Diagnostics Incorporated and Subsidiaries
Consolidated Statements of Operations
For the Three and Nine Months Ended September 30, 2025 and 2024
(in millions, except per share data)
(unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
Net revenues
$ 2,816
$ 2,488
$ 8,229
$ 7,251
Operating costs and expenses and other operating income:
Cost of services
1,867
1,677
5,474
4,865
Selling, general and administrative
501
448
1,463
1,304
Amortization of intangible assets
39
32
117
90
Other operating expense, net
23
1
5
7
Total operating costs and expenses, net
2,430
2,158
7,059
6,266
Operating income
386
330
1,170
985
Other income (expense):
Interest expense, net
(66)
(49)
(200)
(136)
Other income, net
8
15
18
27
Total non-operating expense, net
(58)
(34)
(182)
(109)
Income before income taxes and equity in earnings of equity method investees
328
296
988
876
Income tax expense
(77)
(65)
(233)
(205)
Equity in earnings of equity method investees, net of taxes
8
6
35
14
Net income
259
237
790
685
Less: Net income attributable to noncontrolling interests
14
11
43
36
Net income attributable to Quest Diagnostics
$ 245
$ 226
$ 747
$ 649
Earnings per share attributable to Quest Diagnostics' common stockholders:
Basic
$ 2.18
$ 2.01
$ 6.66
$ 5.80
Diluted
$ 2.16
$ 1.99
$ 6.57
$ 5.74
Weighted average common shares outstanding:
Basic
112
112
112
111
Diluted
113
113
113
112
Quest Diagnostics Incorporated and Subsidiaries
Consolidated Balance Sheets
September 30, 2025 and December 31, 2024
(in millions, except per share data)
(unaudited)
September 30,
2025
December 31,
2024
Assets
Current assets:
Cash and cash equivalents
$ 432
$ 549
Accounts receivable, net
1,456
1,304
Inventories
186
188
Prepaid expenses and other current assets
333
351
Total current assets
2,407
2,392
Property, plant and equipment, net
2,145
2,113
Operating lease right-of-use assets
649
651
Goodwill
8,901
8,856
Intangible assets, net
1,662
1,763
Investments in equity method investees
137
123
Other assets
296
255
Total assets
$ 16,197
$ 16,153
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and accrued expenses
$ 1,457
$ 1,394
Current portion of long-term debt
504
602
Current portion of long-term operating lease liabilities
173
173
Total current liabilities
2,134
2,169
Long-term debt
5,171
5,615
Long-term operating lease liabilities
534
535
Other liabilities
982
938
Redeemable noncontrolling interest
81
83
Stockholders' equity:
Quest Diagnostics stockholders' equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2025
and December 31, 2024; 162 shares issued as of both September 30, 2025 and December 31,
2024
2
2
Additional paid-in capital
2,355
2,361
Retained earnings
9,837
9,360
Accumulated other comprehensive loss
(40)
(88)
Treasury stock, at cost; 51 shares as of both September 30, 2025 and December 31, 2024
(4,896)
(4,857)
Total Quest Diagnostics stockholders' equity
7,258
6,778
Noncontrolling interests
37
35
Total stockholders' equity
7,295
6,813
Total liabilities and stockholders' equity
$ 16,197
$ 16,153
Quest Diagnostics Incorporated and Subsidiaries
Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2025 and 2024
(in millions)
(unaudited)
Nine Months Ended
September 30,
2025
2024
Cash flows from operating activities:
Net income
$ 790
$ 685
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
425
358
Provision for credit losses
2
4
Deferred income tax expense (benefit)
118
(21)
Stock-based compensation expense
63
61
Other, net
37
17
Changes in operating assets and liabilities:
Accounts receivable
(153)
(140)
Accounts payable and accrued expenses
113
(102)
Income taxes payable
(1)
31
Other assets and liabilities, net
27
(23)
Net cash provided by operating activities
1,421
870
Cash flows from investing activities:
Business acquisitions, net of cash acquired
(51)
(1,781)
Capital expenditures
(369)
(302)
Other investing activities, net
(20)
37
Net cash used in investing activities
(440)
(2,046)
Cash flows from financing activities:
Proceeds from borrowings
410
1,846
Repayments of debt
(1,011)
(302)
Purchases of treasury stock
(150)
—
Exercise of stock options
61
52
Employee payroll tax withholdings on stock issued under stock-based compensation plans
(44)
(24)
Dividends paid
(263)
(247)
Distributions to noncontrolling interest partners
(43)
(35)
Other financing activities, net
(61)
(36)
Net cash (used in) provided by financing activities
(1,101)
1,254
Effect of exchange rate changes on cash and cash equivalents and restricted cash
3
—
Net change in cash and cash equivalents and restricted cash
(117)
78
Cash and cash equivalents and restricted cash, beginning of period
549
686
Cash and cash equivalents and restricted cash, end of period
$ 432
$ 764
Cash paid during the period for:
Interest
$ 167
$ 167
Income taxes
$ 112
$ 179
Notes to Financial Tables
1) The computation of basic and diluted earnings per common share is as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
(in millions, except per share data)
Amounts attributable to Quest Diagnostics' common stockholders:
Net income attributable to Quest Diagnostics
$ 245
$ 226
$ 747
$ 649
Less: earnings allocated to participating securities
2
1
4
3
Earnings available to Quest Diagnostics' common stockholders - basic and diluted
$ 243
$ 225
$ 743
$ 646
Weighted average common shares outstanding - basic
112
112
112
111
Effect of dilutive securities:
Stock options and performance share units
1
1
1
1
Weighted average common shares outstanding - diluted
113
113
113
112
Earnings per share attributable to Quest Diagnostics' common stockholders:
Basic
$ 2.18
$ 2.01
$ 6.66
$ 5.80
Diluted
$ 2.16
$ 1.99
$ 6.57
$ 5.74
2) The following tables reconcile reported GAAP results to non-GAAP adjusted results:
Three Months Ended September 30, 2025
(dollars in millions, except per share data)
Operating
income
Operating
income as a
percentage of
net revenues
Income tax
expense (e)
Equity in
earnings of
equity method
investees, net
of taxes
Net income
attributable to
Quest
Diagnostics
Diluted EPS
As reported
$ 386
13.7 %
$ (77)
$ 8
$ 245
$ 2.16
Restructuring and integration charges (a)
11
0.4
(2)
—
9
0.07
Other charges (b)
22
0.8
(6)
—
16
0.15
Amortization expense
39
1.4
(10)
—
29
0.25
ETB
—
—
(3)
—
(3)
(0.03)
As adjusted
$ 458
16.3 %
$ (98)
$ 8
$ 296
$ 2.60
Nine Months Ended September 30, 2025
(dollars in millions, except per share data)
Operating
income
Operating
income as a
percentage of
net revenues
Income tax
expense (e)
Equity in
earnings of
equity method
investees, net
of taxes
Net income
attributable to
Quest
Diagnostics
Diluted EPS
As reported
$ 1,170
14.2 %
$ (233)
$ 35
$ 747
$ 6.57
Restructuring and integration charges (a)
37
0.5
(9)
—
28
0.24
Other charges (b)
52
0.6
(12)
—
40
0.36
Gains and losses on investments (c)
—
—
1
(1)
(2)
(0.01)
Other gains (d)
(46)
(0.5)
14
(8)
(40)
(0.36)
Amortization expense
117
1.4
(30)
—
87
0.76
ETB
—
—
(15)
—
(15)
(0.13)
As adjusted
$ 1,330
16.2 %
$ (284)
$ 26
$ 845
$ 7.43
Three Months Ended September 30, 2024
(dollars in millions, except per share data)
Operating
income
Operating
income as a
percentage of
net revenues
Income tax
expense (e)
Equity in
earnings of
equity method
investees, net
of taxes
Net income
attributable to
Quest
Diagnostics
Diluted EPS
As reported
$ 330
13.3 %
$ (65)
$ 6
$ 226
$ 1.99
Restructuring and integration charges (a)
18
0.7
(3)
—
15
0.13
Other charges (b)
5
0.2
—
—
4
0.04
Gains and losses on investments (c)
—
—
—
2
2
0.02
Other gains (d)
—
—
2
—
(6)
(0.06)
Amortization expense
32
1.3
(8)
—
24
0.21
ETB
—
—
(3)
—
(3)
(0.03)
As adjusted
$ 385
15.5 %
$ (77)
$ 8
$ 262
$ 2.30
Nine Months Ended September 30, 2024
(dollars in millions, except per share data)
Operating
income
Operating
income as a
percentage of
net revenues
Income tax
expense (e)
Equity in
earnings of
equity method
investees, net
of taxes
Net income
attributable to
Quest
Diagnostics
Diluted EPS
As reported
$ 985
13.6 %
$ (205)
$ 14
$ 649
$ 5.74
Restructuring and integration charges (a)
45
0.6
(10)
—
35
0.31
Other charges (b)
12
0.2
—
—
11
0.10
Gains and losses on investments (c)
—
—
(3)
11
8
0.07
Other gains (d)
—
—
2
—
(6)
(0.06)
Amortization expense
90
1.2
(23)
—
67
0.59
ETB
—
—
(6)
—
(6)
(0.05)
As adjusted
$ 1,132
15.6 %
$ (245)
$ 25
$ 758
$ 6.70
(a)
For each of the three and nine months ended September 30, 2025 and 2024, the pre-tax impact represents costs primarily associated with workforce reductions and integration costs incurred in connection with further restructuring and integrating our business. The following table summarizes the pre-tax impact of restructuring and integration charges on our consolidated statements of operations:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
(dollars in millions)
Cost of services
$ 1
$ 5
$ 8
$ 19
Selling, general and administrative
10
15
29
28
Other operating expense, net
—
(2)
—
(2)
Operating income
$ 11
$ 18
$ 37
$ 45
(b)
The pre-tax impacts for both the three and nine months ended September 30, 2025 include a $15 million charge to earnings related to legal matters. Additionally, the three and nine months ended September 30, 2025 include impairment charges of $5 million and $29 million, respectively, on certain long-lived assets related to the exit of a business. Also, each of the three and nine months ended September 30, 2025 and 2024 include losses associated with the change in the fair value of the contingent consideration accrual associated with previous acquisitions. The following table summarizes the pre-tax impact of these other charges on our consolidated statements of operations:
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
2025
2024
(dollars in millions)
Selling, general and administrative
$ —
$ 1
$ —
$ 2
Other operating expense, net
22
4
52
10
Operating income
$ 22
$ 5
$ 52
$ 12
(c)
For each of the three and nine months ended September 30, 2025 and 2024, the pre-tax impact represents gains and losses associated with changes in the carrying value of our strategic investments, principally recorded in equity in earnings of equity method investees, net of taxes.
(d)
The nine months ended September 30, 2025 include a $46 million pre-tax gain, recorded in other operating expense, net, from a payroll tax credit under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") associated with the retention of employees. Additionally, the nine months ended September 30, 2025 include a pre-tax gain, recorded in equity in earnings of equity method investees, net of taxes, representing a non-recurring gain related to a lease. For the three and nine months ended September 30, 2024, other income, net includes a non-recurring pre-tax gain associated with a foreign exchange forward contract utilized in conjunction with an acquisition. The following table summarizes the pre-tax impact of these other gains on our consolidated statements of operations:
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
2025
2024
(dollars in millions)
Other operating expense, net
$ —
$ —
$ 46
$ —
Other income, net
$ —
$ 8
$ —
$ 8
Equity in earnings of equity method investees, net of taxes
$ —
$ —
$ 8
$ —
(e)
For restructuring and integration charges, other gains/charges, gains and losses on investments and amortization expense, income tax impacts, where recorded, were primarily calculated using combined statutory income tax rates of 25.5% for both 2025 and 2024. No income tax impact was recorded on gains/losses associated with the change in the fair value of the contingent consideration accrual associated with previous acquisition.
3)
For both the three and nine months ended September 30, 2025, we repurchased 0.9 million shares of our common stock for $150 million. As of September 30, 2025, $0.7 billion remained available under our share repurchase authorization.
4)
The outlook for adjusted diluted EPS represents management's estimates for the full year 2025 before the impact of special items. Further impacts to earnings related to special items may occur throughout 2025. Additionally, the amount of ETB is dependent upon employee stock option exercises and our stock price, which are difficult to predict. The following table reconciles our 2025 outlook for diluted EPS under GAAP to our outlook for adjusted diluted EPS:
Low
High
Diluted EPS
$ 8.58
$ 8.66
Restructuring and integration charges (a)
0.30
0.30
Amortization expense (b)
1.02
1.02
Other charges (c)
0.39
0.39
Other gains (d)
(0.36)
(0.36)
Gains and losses on investments (e)
(0.01)
(0.01)
ETB
(0.16)
(0.16)
Adjusted diluted EPS
$ 9.76
$ 9.84
(a)
Represents estimated pre-tax charges of $45 million primarily associated with workforce reductions and integration costs incurred in connection with further restructuring and integrating our business. Income tax benefits were primarily calculated using a combined statutory income tax rate of 25.5%.
(b)
Represents estimated pre-tax amortization expenses of $154 million. Income tax benefits were primarily calculated using a combined statutory income tax rate of 25.5%.
(c)
Includes a $29 million pre-tax impairment charge on certain long-lived assets related to the exit of a business and a $15 million charge to earnings related to legal matters. Additionally, includes estimated pre-tax net charges of $11 million associated with the estimated change in the fair value of the contingent consideration accrual associated with previous acquisitions. Such estimate is subject to the risks and uncertainties discussed in the "Forward Looking Statements" section above. No income tax impacts were recorded on the changes associated with the contingent consideration accrual. Income tax benefits on the other charges were calculated using a combined statutory income tax rate of 25.5%.
(d)
Includes a pre-tax gain of $46 million related to a payroll tax credit under the CARES Act associated with the retention of employees. Additionally, includes a non-recurring pre-tax gain of $8 million related to a lease. Income tax impacts were calculated using a combined statutory income tax rate of 25.5%.
(e)
Income tax impacts were calculated using a combined statutory income tax rate of 25.5%.
SOURCE Quest Diagnostics
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
It isn't possible to predict the future, but you can prepare for it.
Price is what you pay, but value is what you get, and it's easy to forget that axiom when the chart tilts south. Bitcoin's (BTC -2.89%) recent slide is a perfect example of this, as over the 30-day period ending on Oct. 17, its price declined about 9%, punctuated by the Oct. 10 flash crash that briefly pushed it even lower, near $105,000.
Pullbacks this size happen even in healthy uptrends, but this one arrived alongside macro worries spurred by newly announced tariffs on China. Nonetheless, many investors, especially crypto natives, are wondering aloud whether the coin's three-year bull run, which saw its price rise by 460%, is over. If it is, a bear cycle may be coming up next, so let's evaluate the situation carefully.
Image source: Getty Images.
What this pullback tells us
A short spell of downside sparked by external macro factors says more about investors' nerves and the fragility of the current crypto market sentiment than it does about Bitcoin's design or the validity of its investment thesis.
There is no new protocol update that suddenly enables issuing more coins or that something fundamental has changed irrevocably or otherwise. Bitcoin still has a hard limit of 21 million coins that can ever exist, with its mining difficulty mediated by periodic halvings, which make it harder to produce more with the same amount of effort.
But when it comes to placating skittish investors, zooming in on the factors driving the downturn can help a lot to shore up long-term conviction.
The October price slide coincided with a broad sell-off in risk assets and tariff headlines, not a blockchain failure. Bitcoin is not one of the altcoins that were shown to be nearly without a purchase bid during the flash crash. In other words, this recent decline was not caused by a loss of confidence in the asset itself or any malfunction of the protocol. It was caused largely by traders using excessive leverage, or debt, to trade illiquid altcoins.
If the bear case for the coin is that such a pullback marks the end of the halving-cycle bull leg, the burden of proof is on those making that claim. And so far, the proof doesn't exist. A 9% retreat from Bitcoin's all-time highs amid severe crypto market turbulence is not strong evidence by itself.
Furthermore, exchange-traded funds (ETFs) holding Bitcoin did not show panicky outflows during the flash crash, which matters significantly for gauging structural demand. Aggregate U.S. spot ETF flows around Oct. 10 were outflows of about $4.5 million, hardly a sign of investors stampeding for the door. If big, steady buyers and asset managers remain steady, it lowers the odds that a garden-variety dip morphs into a prolonged decline cycle.
That doesn't mean downside risk for holders is now gone.
If macro conditions worsen, and they might, Bitcoin can fall even lower. It's unclear whether the persistent sovereign and corporate Bitcoin buying will be enough to countervail that trend or boost its price.
Either way, the thesis for owning it relies on its consistently more constrained supply mechanics and its ongoing adoption. And those have not changed.
What to do about it
So, what should investors do with a 9% dip and some scary headlines? One reasonable approach is to buy the dip and be ready to hold it for the next few years, which is what I'll be doing.
But being aware of the future possibilities is smart, too.
In the next few months, prices can and will swing as new and evolving macro narratives come and go. In that vein, dollar-cost averaging (DCA) can reduce your risk of regretting your investment while letting you continue to add to your position when fear is elevated. Try to change your perspective and view deep dips as opportunities rather than emotional ordeals.
No matter what happens, remember that over the years, the halving schedule plus steady institutional use point to higher prices, even if the path is bumpy. If the bull run is over now, so be it; even if it is, your task is to ensure that you capture the most value, and that means planning ahead to own Bitcoin and letting its scarcity carry the price later on.
Alex Carchidi has positions in Bitcoin. The Motley Fool has positions in and recommends Bitcoin. The Motley Fool has a disclosure policy.
2025-10-21 09:506mo ago
2025-10-21 05:006mo ago
Winklevoss-Led Gemini Exchange Unveils New Credit Card Featuring Solana Rewards
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure
Gemini (GEMI), the cryptocurrency exchange founded by billionaire twins Cameron and Tyler Winklevoss, has officially launched the Solana (SOL) edition of its credit card on October 20, enabling customers to earn up to 4% back in SOL rewards on their purchases.
Nearly 300% Increase In SOL Rewards Over One Year
A standout feature of the new credit card is the ability for users to automatically stake their Solana rewards, yielding up to 6.77% back. This is a first for Gemini customers, who can opt in to this feature when signing up for the card or choose it as their reward option if they are existing users.
Notably, Gemini reported that customers who held their SOL rewards for at least a year experienced impressive growth, with rewards increasing by 299.1% as of July 27, 2025—one of the best performances among cryptocurrencies available on the platform.
Additionally, the Gemini Credit Card is designed with user convenience in mind, featuring no annual fees, no charges for receiving crypto rewards, and no foreign transaction fees.
Earlier this year, Gemini expanded its offerings by launching institutional staking for Solana. This initiative enables exchange-traded funds (ETFs), corporations, and high-net-worth clients to stake their SOL directly through Gemini Custody.
This move, which began on June 23, included partnerships with firms like DeFi Dev Corp., managing over 2 million SOL, and Purpose Investments, a Canadian issuer of a Solana ETF.
Gemini And Solana Team Up For 48-Hour Streaming Event
In addition to the credit card launch, Gemini has partnered with Solana to host a 48-hour nonstop livestream on X (formerly Twitter), commencing October 21, directly from the Gemini headquarters in New York City.
These developments add to a significant year for the cryptocurrency exchange, which recently made its debut on the Nasdaq, with its stock GEMI, raising $425 million on the first day of its initial public offering (IPO).
The Winklevoss twins’ exchange joins the ranks of other crypto firms that have gone public this year, including Circle (CRCL), the issuer of the second-largest stablecoin (USDC), and Bullish (BLSH), backed by another crypto billionaire Peter Thiel.
The daily chart shows GEMI’s valuation trending downwards after initial excitement surrounding its debut. Source: GEMI on TradingView.com
As of this writing, GEMI, the cryptocurrency exchange’s stock with a market cap of $2.7 billion, is trading at $20.29. This price is below the company’s initial public offering price of $28.
Similarly, the Solana price has erased nearly all of its year-to-date gains, dropping 20% and 21% in the last fourteen and thirty days, respectively. This leaves SOL with only 17% gains year-to-date and down 36% from all-time high levels.
Featured image from DALL-E, chart from TradingView.com
Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.
2025-10-21 09:506mo ago
2025-10-21 05:006mo ago
TAO Synergies snaps up 54K Bittensor tokens amid $11M boost – Details
Key Takeaways
What is TAO Synergies doing amid Bittensor’s price decline?
TAO Synergies is aggressively accumulating TAO tokens, expanding its holdings to over 54,000.
What is driving continued bearish pressure on TAO’s price?
Persistent selling by other investors is outweighing accumulation, pushing TAO below key technical levels.
Following a rejection at $460, Bittensor [TAO] has faced intense bearish pressure, reaching a low of $403. In fact, at the time of writing, Bittensor was trading at $404, marking a 10.42% decline on daily charts.
Amid this price decline, institutional investors are taking the opportunity to buy the dip.
TAO Synergies increase Bittensor holdings
Notably, as TAO retraced on its price charts, TAO Synergies shifted to accumulation. On the 20th of October, TAO Synergies (TAOX ), a Bittensor Treasury company, announced that through acquisition and staking, it increased its holdings.
As such, the company expanded its TAO portfolio to 54,058 TAO tokens, becoming the largest publicly traded holder of Bittensor.
Following the acquisition, entrepreneur James Altucher noted that,
“By scaling our TAO holdings to over 54,000 tokens, we’re not only holding a crypto asset, we’re also staking our claim in a network that’s redefining entrepreneurship and innovation.”
Such a massive acquisition during a market downturn indicates a strong long-term commitment to the project.
TAO Synergies raised $11 million
Notably, the recent token acquisition comes just days after the firm announced it had secured funding through private placement.
According to the team, a private funding backed by DCG and James Altucher raised $11 million, which is yet to be deployed.
These funds will be used to purchase TAO tokens and explore other revenue-generating opportunities, thereby accruing more TAO within the Bittensor ecosystem.
Source: Marketwatch
Notably, since TAOX shifted to an aggressive accumulation strategy for the AI coin, its value has surged significantly. In fact, over the past month, TAO Synergies is up 59% with its market cap hitting $31 million.
Bittensor still faces bearish pressure
Surprisingly, despite this accumulation, other investors remain bearish and continue to aggressively sell.
According to CryptoQuant data, sellers have dominated the market for four consecutive days, as evidenced by Spot Taker CVD.
Source: CryptoQuant
This metric has remained red since the 16th of October, indicating seller dominance. As a result, the altcoin has recorded a negative Buy-Sell Delta over this period.
Source: Coinalyze
On the 21st of October, for example, Bittensor recorded 40,000 in sell volume and 32,600 in buy volume. This resulted in a negative delta of 7,400, indicating strong spot selling pressure.
Mapping TAO’s path to recovery
Although TAO Synergies continues to accumulate Bittensor tokens, this activity has not yet boosted TAO’s price. The reason is clear: many investors are aggressively selling, creating strong downward pressure on the market.
As a result, TAO’s Relative Strength Index (RSI) fell to 56, at press time, and formed a bearish crossover, signaling growing seller dominance.
At the same time, the token dropped below its short-term moving average, further confirming bearish momentum.
Source: TradingView
Therefore, if these market conditions persist, TAO will likely make more losses on its price charts. A drop from here will see Bittensor retrace to $378, with the 21DMA serving as critical support at $367.
However, if TAO Synergies manages to absorb the selling pressure, TAO will reclaim 9DMA at $416 and eye $460.
2025-10-21 09:506mo ago
2025-10-21 05:056mo ago
Jack Dorsey Reignites Debate Over Bitcoin's Identity: “Bitcoin Is Not Crypto”
Jack Dorsey, Twitter’s co-founder and a long-time Bitcoin supporter, has once again sparked debate in the digital finance world. His recent post claiming “Bitcoin is not crypto” has reignited discussion over Bitcoin’s identity—whether it belongs to the broader crypto industry or stands apart entirely.
In brief
Jack Dorsey’s “Bitcoin is not crypto” statement renews debate over Bitcoin’s true purpose in the digital economy.
Bitcoin maximalists and crypto supporters clash over whether Bitcoin belongs to or stands apart from the wider crypto world.
Dorsey emphasizes Bitcoin as money, citing its white paper’s focus on peer-to-peer electronic cash, not speculation.
Critics question Bitcoin’s scalability, while others see Dorsey’s stance as reinforcing its role as a real digital currency.
Bitcoin’s Role in the Digital Economy Sparks Fresh Industry Debate
Dorsey, often rumored to have ties to Bitcoin’s mysterious creator, Satoshi Nakamoto, made headlines this week after reiterating his stance on the coin’s identity. The brief post, shared on X (formerly Twitter) on Sunday, drew thousands of comments and revived long-standing debates about Bitcoin’s true purpose and position in the digital economy.
Dorsey’s statement comes amid growing tension between Bitcoin maximalists—who see BTC as the only legitimate digital currency—and supporters of the broader crypto ecosystem, which includes thousands of alternative coins and blockchain projects.
Many in the community noted that Satoshi Nakamoto once described Bitcoin as a “peer-to-peer cryptocurrency,” suggesting that Bitcoin is indeed part of the crypto family. However, Dorsey emphasized the word currency, arguing that Bitcoin’s foundation lies in its function as money rather than as a speculative digital asset.
The conversation also revived old rumors linking Dorsey to Nakamoto. Earlier this year, Seán Murray of deBanked published circumstantial evidence connecting Dorsey to Bitcoin’s creation. None of the claims has been verified, and Dorsey denied the speculation in a 2020 interview with Lex Fridman, jokingly saying, “No, and if I were, would I tell you?”
Bitcoin’s Original Vision Resurfaces Amid Industry Debate
To support his view, Dorsey pointed to Bitcoin’s white paper, published in 2008, which makes no mention of the term “crypto.” Instead, the document defines the coin as a “peer-to-peer electronic cash system” that relies on “cryptographic proof instead of trust.”
Satoshi Nakamoto’s posts on the Bitcointalk forum also described the firstborn crypto as a “digital currency using cryptography and a distributed network.” For Dorsey, this distinction matters—he sees Bitcoin not as another asset in the crypto market but as a revolutionary monetary system designed to replace traditional intermediaries.
BTC Positioned as Everyday Money, Not a Speculative Asset
Just before his “not crypto” statement, Dorsey posted another message on X: “Bitcoin is money.” He linked the idea to his ongoing work at Block, the financial services company he leads, and its payments subsidiary, Square.
Dorsey highlighted recent progress toward zero-fee BTC transactions through Square’s payment system, citing a user’s claim that every local merchant at a market had adopted Bitcoin payments thanks to the initiative. His focus remains on promoting the asset’s use as a practical payment tool, in line with its original purpose as peer-to-peer electronic cash.
He has also encouraged other platforms, such as Signal Messenger, to integrate Bitcoin payments—further illustrating his belief that the coin’s future lies in utility rather than speculation.
Dorsey’s stance drew mixed responses, with critics pointing to Bitcoin’s scalability issues as a drawback to it becoming a full peer-to-peer electronic system. According to them, slower transaction speeds and higher fees make it impractical for everyday payments.
Others argue that his rejection of the “crypto” label reflects the ongoing divide between Bitcoin purists and those who support broader blockchain innovation.
David Schwartz, Ripple’s outgoing chief technology officer, weighed in on the discussion in a recent X post. Schwartz suggested that Dorsey’s message likely aimed to position BTC as a functional payment system rather than a speculative investment.
He noted, however, that Dorsey’s exact intent remains unclear—reflecting the broader uncertainty surrounding the comment within the crypto community.
Regardless of interpretation, Dorsey’s statement has once again placed Bitcoin’s essence at the center of public debate—forcing both believers and skeptics to re-examine what Bitcoin truly represents in the evolving digital economy.
Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.
Join the program
A
A
Lien copié
James G.
James Godstime is a crypto journalist and market analyst with over three years of experience in crypto, Web3, and finance. He simplifies complex and technical ideas to engage readers. Outside of work, he enjoys football and tennis, which he follows passionately.
DISCLAIMER
The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.
2025-10-21 09:506mo ago
2025-10-21 05:056mo ago
Polygon CEO questions loyalty to Ethereum amid growing criticism of the Foundation
South Korean exchange Upbit listed Synfutures (F), causing the token's price to surge over 120%.Synfutures is a decentralized derivatives DEX that dominates Base chain liquidity and RWA trading.The listing triggered a massive spike in F trading volume despite a general market downturn.Upbit, South Korea’s largest cryptocurrency exchange, announced on Tuesday that Synfutures (F) will be listed on its Korean Won market.
This move marks the exchange’s second consecutive day of new listings.
Synfutures: A Next-Gen Decentralized Derivatives ExchangeThe exclusive listing immediately fueled market interest, causing the Synfutures price to surge over 121.1% above the previous day’s close shortly after the announcement, according to Coingecko data. At the time of writing, the token was trading at $0.01474, a 58.2% gain from the prior day.
Sponsored
Sponsored
Synfutures operates as a decentralized derivatives exchange (DEX), characterized by its deployment of a fully on-chain Automated Market Maker (AMM) known as ‘Oyster AMM.‘
This system is specifically designed to maximize liquidity efficiency. The platform offers Concentrated Liquidity AMM (CLAMM) and leverage features, aiming to serve both professional market makers and general users.
A key feature of Synfutures is its support for perpetual futures trading on various assets. These assets include conventional cryptocurrencies and Real World Assets (RWA) such as West Texas Intermediate (WTI) crude oil and Gold. The native Synfutures token (F) is utilized for staking and governance within the exchange ecosystem.
Dominance in the Base EcosystemSynfutures has rapidly established itself as a leading derivatives exchange. It is capturing approximately 80% of the trading volume on Coinbase’s Base chain. The platform attracts significant attention because it provides a seamless market structure for liquidity providers (LPs) and active traders within the base ecosystem.
Consequently, it is increasingly being evaluated as a top-tier derivative DEX, following the ranks of dYdX and Uniswap.
Furthermore, Synfutures is expanding its real-world utility by integrating the GameFi and NFT markets through its NFT derivatives platform, NFTunes. Future plans include adding AI-driven predictive trading features.
Trading Volume Spikes Amid Market DownturnUpbit announced that it supports F token trading on the Ethereum network and advised users to verify the network before depositing tokens. The exchange also noted that the listing timeline could be delayed if the token does not achieve sufficient liquidity after the announcement.
Despite a general downturn in the broader cryptocurrency market on Tuesday, the Upbit listing has triggered a surge in F trading volume. This indicates strong investor interest in the newly listed asset.
Coingecko data shows that F’s trading volume jumped ninefold compared to the previous days’. This massive increase occurred within just three hours of the listing
Disclaimer
In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
In a detailed post, Buterin credited Polygon for its major contributions to Ethereum's growth, technological innovation, and even real-world humanitarian efforts. His remarks highlight how blockchain teams are not only shaping the future of decentralized technology but also making a difference beyond finance.
2025-10-21 09:506mo ago
2025-10-21 05:166mo ago
Solana Company Moves Forward with Resale to Support HSDT Price Discovery, HSDT Drops 12%
A Solana Treasury company has recently announced a bold step that sets it apart from other DATs.
Solana Company, formerly known as Helius Medical Technologies, has announced that it will move forward with making its resale registration effective, a process that lets early investors sell restricted shares on the open market. The company said that it’s playing “offense”, emphasizing its commitment to growth.
A resale registration lets early investors sell on the open market once it’s effective – unlocking restricted shares for trading.
It's inevitable for all DATs.
"Ripping off the band-aid" is the approach we are confidently taking, while many other DATs are choosing to stall.
— Solana Company $HSDT (@Solana_Company) October 20, 2025 Instead of delaying its scheduled registration for the resale of shares purchased during the recent private placement, the company chose to move forward as planned, while similar firms are holding back amid market uncertainty.
The company says is taking a “rip off the band-aid” approach, hoping that this will help create market equilibrium for HSDT and support better long-term price discovery.
What does this mean for HSDT?With the resale registration statement now effective, HSDT will rank among the largest Solana DATs by effective market cap, making it an attractive option for institutional investors seeking exposure to Solana.
“The pressure on our stock price that comes with the effectiveness of the resale registration statement will likely shake out weak hands, but we believe this will also establish a remaining foundation of committed long-term shareholders,” Executive Chairman Joseph Lee said in a statement.
The firm also clarified that if HSDT trades below its net asset value in the days ahead, that simply means investors have the chance to buy one dollar of Solana for less than a dollar.
Building the “Berkshire Hathaway of the Solana ecosystem”The company plans to show how HSDT can actively accumulate Solana, buying more SOL per share than most investors could on their own. It aims to generate 7%+ yield through institutional-grade staking, not available to individual investors. It also plans to use the capital markets to acquire more Solana and deploy capital strategically during market dislocations.
“When the non-believers are flushed out, HSDT can continue to accrete Solana per share. We can buy aggressively when others are fearful. We believe we can compound Solana per share holdings through disciplined capital allocation,” Lee said.
The team aims to build the “Berkshire Hathaway of the Solana ecosystem”, a vehicle built to grow shareholder value, maintain a strong balance sheet, and trade at a premium.
Lately, PIPEs (Private placement in a public equity deals), have become a popular way for new digital asset treasury firms to quickly raise capital and build cryptocurrency holdings. However, some firms saw their stock prices drop sharply once PIPE shares started trading, raising questions about whether the approach works long-term in crypto markets.
HSDT is down about 12% over the past day and is currently trading at $6.87. Over the past month, the stock has fallen roughly 60%. Earlier this month, Solana Company revealed that it has partnered with Coinbase, BitGo, and Anchorage Digital as custodians for its growing Solana (SOL) treasury.
Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.
Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.
Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2025-10-21 09:506mo ago
2025-10-21 05:176mo ago
SpaceX moves $270 million worth of bitcoin in first transfer since July: Arkham
ETH price has remained below $4,000 as investors seek yield-bearing assets despite increasing interest rates.
Staking yields of 3.5%-4.2% maintain institutional interest despite macroeconomic tightening.
A breakout above $4,400 might propel ETH to $4,800-$5,000, boosting the Ethereum outlook.
The expansion of tokenization and real-world assets on Ethereum could boost on-chain income potential.
The downside risks include a stronger USD, higher Treasury yields, and regulatory pressure on staking.
Near term, ETH price predictions anticipate a range of $3,800 to $4,400, with upside potential provided yield demand remains strong.
The Ethereum forecast is based on whether yield-driven demand offsets macroeconomic challenges in a protracted high-rate environment.
ETH price remains flat, slightly below $4,000, as investors seek assets with meaningful income in a high-rate market.
The cryptocurrency’s capacity to create staking revenue and fee rewards has prompted speculation over whether ETH could emerge as the “yield crypto” of this cycle, combining income creation and network functionality.
ETH price market info
ETH 1d chart, Source: crypto.news
As of late October 2025, Ethereum is trading around $3,900-$4,000, having fallen from prior highs near $4,500. The market remains cautious but supportive, with Ethereum outperforming most Layer-1 competitors. Institutional flows have remained resilient, thanks in part to Ethereum’s staking attractiveness.
Average staking yields range from 3.5% to 4.2%, with certain platforms advertising higher yearly returns. This has positioned Ethereum as a relatively stable, yield-bearing asset in a market that remains characterized by constrained liquidity and high interest rates.
Upside outlook
The endurance of yield-seeking capital, as well as the network’s ability to attract and retain stakeholders, supports ETH’s bullish thesis. A decisive break above the $4,400 resistance level might pave the way for a move to $4,800-$5,000, or possibly $6,000 in more extreme cases.
The dual character of Ethereum (ETH), which serves as both a productive asset through staking and the foundation of decentralized finance, enhances its medium-term prospects. On-chain data indicating dropping exchange balances and increasing staking participation point to a tightening supply, which supports the price over time.
If ETH maintains its current speed, the next phase might be fueled by institutional staking acceptance and the expansion of tokenization of real-world assets on the Ethereum blockchain.
These improvements could improve the overall yield structure and strengthen the Ethereum outlook, positioning it as the premier asset for investors seeking long-term crypto profits.
Downside risks
Several negative concerns continue to cloud Ethereum’s progress. Rising US Treasury yields and a stronger dollar may make traditional fixed-income investments more appealing, drawing liquidity away from risky assets such as cryptocurrency. Failure to hold support around $3,800 might lead to a deeper decline to the $3,500-$3,600 range.
Regulatory monitoring of staking services is also a danger to sentiment and participation rates, and any decline in global risk appetite might have an impact on Ethereum and the entire crypto complex.
Furthermore, liquidity conditions in decentralized finance remain fragile, and a rapid surge in redemptions from staking protocols may exacerbate volatility. A prolonged macro tightening cycle or a slew of regulatory interventions aimed at capping yields might derail Ethereum’s reputation as a stable yield-bearing crypto asset.
ETH price prediction based on current levels
ETH support and resistance levels, Source: Tradingview
In the near term, ETH price prediction models project the cryptocurrency to swing between $3,800 and $4,400. A good move over $4,400 would likely indicate resumed positive momentum, with potential targets of $4,800–$5,000, but a collapse below $3,800 would expose it to additional losses.
Overall, the Ethereum forecast depends on whether demand for yield and network utility can continue to outweigh the macroeconomic disadvantages of a lengthy high-rate cycle.
The overall trend remains positive, with analysts noting that Ethereum has repeatedly defended important technical levels despite market turbulence.
If macroeconomic conditions stabilize and risk appetite increases, ETH might be one of the first major cryptocurrencies to attempt new highs due to its yield-driven demand and supply-limiting burn mechanism.
Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.
On-chain monitoring revealed that SpaceX recently transferred $286 million worth of Bitcoin to two unmarked addresses after three months of no on-chain activity.
Summary
SpaceX transferred 2,395 BTC, worth about $268 million, to two new wallets after three months of inactivity.
The transfers come as Bitcoin’s price falls below $110,000, prompting market watchers to monitor SpaceX’s activity closely for signs of a potential sell-off despite traders viewing the move as standard housekeeping.
After three months of inactivity, a wallet owned by Elon Musk’s space exploration company has recently transferred a total of 2,395 BTC to two on-chain addresses. Currently, both addresses are only holding BTC, with no indication that the holdings have been sold or moved to other wallets.
Based on current market prices, the company’s Bitcoin (BTC) transfer is currently valued at around $268 million. One address beginning with bc1qq78 received around 1,187 BTC, which is valued at $128.35 million. At press time, the address only holds Bitcoin and no other assets.
Meanwhile, the second address, beginning with bc1qj7e, received a Bitcoin transfer of about 1,208 BTC. Its holdings are currently valued at $130.4 million, with no other assets held aside from the recent SpaceX transfer.
On-chain analyst Ai Yi, who highlighted the two transfers based on information from Arkham Intelligence, surmised in a post that the move could just be a routine wallet reorganization, considering the firm had to pay a transfer fee to Coinbase Prime just minutes before the transactions were made. It is widely known that SpaceX’s holdings are currently custodied with Coinbase Prime.
Therefore, the two unmarked wallets could possibly belong to SpaceX as well, even though they are currently unmarked by Arkham Intelligence.
SpaceX recently moved 2,395 BTC to two new addresses | Source: Arkham Intelligence
The last time Musk’s company moved its crypto assets was back in July 2025. At the time, the wallet moved 1,308 BTC after three years of being dormant. The transfer was valued at $152 million based on market prices back then. However, the receiving address at the time was recognized as a Coinbase Prime Custody wallet.
After today’s transfers, SpaceX’s wallet currently holds a total of 5,790 BTC, which is equal to $626.7 million based on current market prices. Its holdings have gone down 2.98% in the past 24 hours, following Bitcoin’s drop below $110,000.
According to data from Bitcoin Treasuries, SpaceX’s BTC holdings amounted to 8,285 BTC before the transfers were made. This means that the firm’s holdings were valued at $895.38 million.
Having held Bitcoin in its portfolio since 2021, the company’s BTC trove of 5,790 BTC is still relatively larger compared to companies like KindlyMD, Semler Scientific, and GameStop Corp. Though it is still trailing far behind Galaxy Digital, Trump Media & Technology Group, Riot Platforms, and Musk’s other company, Tesla.
What could SpaceX’s BTC moves mean for the market?
The last time SpaceX’s wallet moved Bitcoin was in July 2025. At the time, the move sparked concerns among traders who feared the company might be offloading its holdings and could very well trigger widespread selling pressure.
However, much like the discourse surrounding today’s transfer, some traders have downplayed the risks. Many of them stated that the move could just be the firm shifting its holdings to a fresh wallet, an act deemed as simply “routine housekeeping.” Therefore, it should not be cause for alarm.
This time, the decision to move a large chunk of its funds to two new wallets coincides with a major drop in Bitcoin’s value. On Oct. 21, Bitcoin dropped 2.76% from a high of $111,555 to just around $107,000. The largest cryptocurrency by market cap is currently trading at around $107,875.
The asset has continued its downward trend, having declined by 3.76% in the past week following a series of crypto market crashes. Market traders may be watching SpaceX closely in case of a sell-off that could trigger similar moves across the market that would lead to more downward pressure on the price of Bitcoin.
BTC bears regained control, and the asset lost most the gains from yesterday.
The cryptocurrency market reversed its trajectory today (October 21), with numerous leading digital assets charting significant declines.
BTC slipped to approximately $107,500, while altcoins like ASTER experienced much more painful losses.
Red Day for BTC
The primary cryptocurrency started the new business week on the right foot, with its valuation climbing to as high as $111,500. However, the uptick was short-lived, and the bears regained control once again.
Over the past several hours, BTC charted a substantial red candle and dipped to roughly $107,500, representing a 3% plunge on a daily scale and a 13% crash on a two-week basis.
BTC Price, Source: TradingView
The renewed downtrend of the asset caused some analysts to envision dark scenarios and even the potential end of the bull run. X user Dr Profit, for instance, claimed that a drop below the critical level of $101,700 may confirm a bear market. On the other hand, different factors like the reduced amount of BTC stored on exchanges hint that it’s not all doom and gloom.
Following BTC’s price retreat, its market capitalization has shrunk to around $2.14 trillion, while its dominance over altcoins stands at approximately 58%.
The Alts Head South, too
The leading alternative coins have followed BTC’s example and witnessed even greater declines. Ethereum (ETH) plunged by 4.5% to the current $3,860, Ripple’s XRP dipped well below $2.50, while Solana (SOL) tumbled by 5% to $184.
You may also like:
4-Year Bitcoin Cycle Is a ‘Big Misunderstanding’ – PlanB
Analyst: Bitcoin Drop Near $101,700 Could Confirm a New Bear Market
This is the Critical Level to Watch for Bitcoin’s Price This Week
Aster (ASTER) is the biggest loser from crypto’s top 100 club, collapsing by 12% on a 24-hour scale. Mantle (MNT) and Hyperliquid (HYPE) follow next with drops of 10% and 8%, respectively.
Among the very few altcoins in green territory today are ChainOpera AI (COAI), Provenance Blockchain (HASH), and Zcash (ZEC). The total cryptocurrency market capitalization has slipped to roughly $3.73 trillion, meaning a 3.2% decrease for the day.
XRP is trading at $2.48 as of October 21, 2025, gaining 4.15% in the past 24 hours as the cryptocurrency recovers from recent volatility while the market digests a landmark institutional development.
2025-10-21 09:506mo ago
2025-10-21 05:296mo ago
Institutional Access to stETH Nears Reality as VanEck Pushes First ETF
VanEck seeks SEC approval for the first U.S. stETH ETF, signaling major institutional momentum for Ethereum and the growing liquid-staking market.
Emir Abyazov2 min read
21 October 2025, 09:29 AM
VanEck Files to Launch First stETH ETF in the U.S.Investment firm VanEck has submitted a Form S-1 to the U.S. Securities and Exchange Commission (SEC), requesting approval to launch the VanEck Lido Staked ETH ETF — a product designed to give institutional investors direct exposure to stETH, the liquid-staking token representing Ethereum staked through the Lido protocol.
The proposed ETF would hold stETH and rely on verified smart contracts, deep secondary-market liquidity, and integration with custodians and exchanges. Since launch, Lido users have earned more than $2 billion in staking rewards, and the protocol’s total value locked now exceeds $33 billion.
Source: DefiLIamaAccording to Kian Gilbert, Head of Institutional Relations at the Lido Ecosystem Foundation, the filing reflects growing recognition of liquid staking as a core pillar of the Ethereum ecosystem. He emphasized that Lido aims to merge decentralization with institutional-grade standards.
SEC Position on Liquid StakingThe press release also notes that the SEC has previously clarified that issuance, redemption, and trading of liquid-staking tokens are not treated as regulated securities activities when performed under established technical and administrative processes.
If approved, VanEck’s product would become the first U.S. ETF backed by stETH, potentially opening the door to broader institutional use. Recently, we also reported the appearance of Canary Capital’s TRUMP ETF on the DTCC list — further evidence of accelerating ETF activity across emerging digital-asset categories.
Globally, regulators and institutions are rapidly embracing crypto-based financial products. Canada and Europe already offer spot Bitcoin and Ethereum ETFs, which have attracted steady inflows from traditional asset managers.
Hong Kong is also positioning itself as a digital-asset hub with new ETF approvals aimed at competing with U.S. markets. As adoption grows, more jurisdictions are shaping clearer frameworks to bring crypto exposure into mainstream portfolios.
ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!
Emir Abyazov
Editor-in-Chief at Coinpaper, scaling data-driven editorial ops, SEO-led discovery, and audience-first storytelling across crypto, AI, and fintech.
Read more about
Ethereum
2025-10-21 09:506mo ago
2025-10-21 05:316mo ago
Ethereum fails again above $4K as traders grow frustrated with shakeouts
Declining spot buying and mounting spot Ethereum ETF outflows signal weak demand, risking further losses for Ether.
Ether’s bear flag projects a 20% price drop to $3,100.
Ether (ETH) fell to $3,800 on Tuesday, after failing to hold $4,000, as spot Ethereum ETF investors continued their net redemptions. This came as the technical setup pointed to a deeper correction for ETH price.
Ether price faces “strong resistance” at $4,000Ether’s 16% recovery from $3,500 low reached on Oct. 11 was curtailed by selling around the $4,000 psychological barrier.
This shows that “there is a strong resistance at $4K,” said trader Philakone in an X post on Monday.
Note that the last time the ETH/USD pair was rejected from this zone was in December 2024, before a 66% price drop, as shown in the chart below.
ETH/USD daily chart. Source: Cointelegraph/TradingViewBulls must, therefore, push and sustain the price above $4,000 to secure the recovery.
“This has been a hard level to break for the bulls and is pretty critical in the short/mid term going forward,” said analyst Daan Crypto Trades in a recent X post.
A decisive daily candlestick close above this level will get ETH “back into the previous price range and leave these lows behind,” the analyst wrote, adding:
“It’s going to be an interesting battle around that ~$4.1K level.”ETH/USD three-day chart. Source: Daan Crypto TradesThis level “defines whether this pullback becomes a deeper correction or a brief reset, said fellow analyst Jas Crypto, adding:
“If bulls defend $4K, momentum could rebuild toward $5K.”As Cointelegraph reported, bulls will have to drive the Ether price above the $4,000-$4,300 supply zone to signal the start of a new uptrend.
Lack of new buyers keeps ETH below $4,000Ether’s ability to hold above $4,000 appears limited for now due to the absence of buyers.
The spot volume delta metric, an indicator that measures the net difference between buying and selling trade volumes, reveals that net spot buying on exchanges remains negative, despite the recent attempts at recovery.
This suggests that price rebound may lack the momentum derived from consistent buying pressure, potentially leading to a deeper pullback.
Without real demand, any breakout attempt might lack the strength required to push ETH above key levels.
Ether’s spot volume delta. Source: GlassnodeDemand for spot Ethereum ETFs has also been decreasing, with these investment products posting outflows six out of the last eight days, data from SoSoValue shows.
Monday alone saw Ether ETFs shed $145.7 million, bringing total net outflows over the past eight days to $640.5 million.
Spot Ethereum ETF flows table. Source: SoSoValueAs such, ETF inflows must return, and new ETH buyers must step in for the bulls to have a shot at getting back to $5,000.
Ether’s bear flag breakdown targets $3,100ETH price is expected to resume its prevailing bearish momentum after the confirmation of a classic bearish pattern.
Ether’s price action over the past 14 days has led to the formation of a bear flag pattern on the 12-hour chart, as shown in the figure below. The price broke below the lower boundary of the flag at $4,000 on Tuesday, signaling the start of a significant breakdown.
The measured target from the flagpole’s height comes to be around $3,120, an approximately 20% drop from the current price.
ETH/USD daily chart. Source: Cointelegraph/TradingViewThe relative strength index is still below the 50 mark, suggesting that the market conditions still favor the downside.
Despite this bearish outlook, traders remain optimistic about Ether’s upside potential, citing bullish signals from credit conditions and persistent buying by Ethereum treasury companies.
Popular analyst Jelle said that Ether is just retesting a key breakout level around $4,000 before resuming its uptrend.
“This looks very ready for a rapid expansion higher.”Judging from sentiment on CT, you'd think $ETH was in the gutter - but it's just holding the breakout area as support.
This looks very ready for a rapid expansion higher.
Shakeouts are working, it seems. pic.twitter.com/IUpfnpf5VQ
— Jelle (@CryptoJelleNL) October 15, 2025
This article does not contain investment advice or recommendations. Every investment and trading move involves risk, and readers should conduct their own research when making a decision.
2025-10-21 09:506mo ago
2025-10-21 05:336mo ago
Pi Network News: Is the Platform-Level Dream Achievable by 2025?
Pi Network is evolving beyond its initial phase as a mobile mining experiment into a fully unified blockchain ecosystem. The latest developments support real-world finance, gaming, and technological applications.
A crypto expert argues that for Pi to achieve long-term growth and stability, it must expand its platform-level applications to align directly with the broader crypto economy and everyday users’ needs.
How Can Pi Network Drive Large Adoption?Pi Network has the potential to become a major unified blockchain ecosystem, but this is only possible by focusing on essential infrastructure and practical applications. The network should strengthen its technical foundation with tools like cross-chain bridges to facilitate faster transactions, establish a decentralized identity system, and implement DAO governance.
Expanding this infrastructure would enable real-world use cases such as payments, asset tokenization, AI applications, NFT markets, and derivative trading, attracting more users.
With over 60 million users and 256 mainnet dApps, combining financial, social, and technological applications into a single ecosystem could position Pi as a mass crypto gateway. This integration may drive large-scale adoption and greater economic empowerment for its global user community.
“The future expansion of Pi Network is not about isolated additions but a vision-driven progression around the unified blockchain system,” the expert added.
Can This Stabilize Pi Price?Pi Coin is currently priced at $0.2029, with a 24-hour trading volume of $14.25 million. This represents a decline of approximately 93% from its all-time high in February 2025. As the token continues to navigate extreme volatility, the expansion of its technical ecosystem could create opportunities to increase adoption.
Broader utility through AI, RWA (real-world assets), and DeFi (decentralized finance) could boost demand for Pi Coin by strengthening its use cases. However, while these developments may indirectly support the token’s price, they do not guarantee absolute price stability.
Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.
Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.
Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2025-10-21 09:506mo ago
2025-10-21 05:366mo ago
Bitcoin (BTC) Rejected again: $100,000 Target if Bounce Fails
Bitcoin has moved into dangerous territory. The bears have the upper hand as a move further down to $100,000 is starting to become a distinct possibility. Will the $BTC price take the plunge, or will a last-ditch bounce save the day?
How far down will this reversal impulse take $BTC?
Source: TradingView
The 8-hour chart for $BTC shows how the price has been staying in the top half of the descending channel, except of course for the huge fakeout that resulted in the all-time high. That said, the price has just confirmed below a major trendline. It now remains for the price to come down to the full extent of this reversal impulse, whatever that may be.
The $109,000 horizontal support has failed, at least on this time frame, and now the $BTC price is testing horizontal support at $107,400. More horizontal support can be found at $105,600, and then the mid-point of the channel should also act as a good support, as it has done up to now.
The last line in the sand is probably $98,000. This level also concurs with the bottom of the channel. In order to save the bull market, the price would need to bounce hard and fast from there.
$98,000 an obvious level for a bounce?
Source: TradingView
Zooming out into the daily time frame it can be seen that the $BTC price could be about to drop through the 200-day SMA. In itself, this isn’t the end of the world for $BTC given that the 200-day SMA has been breached for an extended period three times so far in this bull market. That said, it is another support level that could fall by the wayside.
As one can see, possibly the most obvious level for a bounce is in fact the $98,000 horizontal support. A candle wick down to the bottom of the descending channel would perhaps provide some balance and symmetry into the bargain.
Notwithstanding, this kind of a move would probably spread fear and terror throughout the crypto market. Not just any last vestiges of leverage could be expunged from the market, but quite possibly many spot positions would also be sold - a likely environment for a huge rally back to the upside …
50-week SMA is the definitive bull market support
Source: TradingView
The weekly chart view for the $BTC price provides some crucial information. The main standout here is the 50-week simple moving average (SMA). This average has provided support to the bull market all the way through up to now. Only the odd short candle wick has pierced through it at what were very difficult, but pivotal times for the Bitcoin bulls.
If the 50-week SMA is to continue to provide that last support, it would suggest that the $BTC price won’t in fact go all the way down to the $98,000 level. $100,000 might just be a possibility if a candle wick came down that far.
Of course, there is the possibility that the 50-week SMA could provide the signal that the bull market is over, should the price close and confirm below.
One last factor to consider is the Stochastic RSI. The negative price action since the all-time high has helped to bring the indicators almost down to the bottom. If one looks left at the last time this occurred, one can observe the near 70% rally that took place. Things may be balanced on a knife edge, but they may be far from over yet.
Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.